{"head":{"vars":["iri","label","def"]},"results":{"bindings":[{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100000"},"label":{"xml:lang":"en","type":"literal","value":"has_age"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100196"},"label":{"xml:lang":"en","type":"literal","value":"has_organism_attribute"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25190"},"def":{"xml:lang":"en","type":"literal","value":"A human being."},"label":{"xml:lang":"en","type":"literal","value":"Person"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25150"},"def":{"xml:lang":"en","type":"literal","value":"How long something has existed; elapsed time since birth."},"label":{"xml:lang":"en","type":"literal","value":"Age"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100027"},"label":{"xml:lang":"en","type":"literal","value":"has_unit"}},{"iri":{"type":"uri","value":"http://purl.obolibrary.org/obo/UO_0000036"},"def":{"xml:lang":"en","type":"literal","value":"A time unit which is equal to 12 months which is science is taken to be equal to 365.25 days."},"label":{"xml:lang":"en","type":"literal","value":"year"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100042"},"label":{"xml:lang":"en","type":"literal","value":"has_value"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100004"},"label":{"xml:lang":"en","type":"literal","value":"has_intent"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100076"},"label":{"xml:lang":"en","type":"literal","value":"conceptually_related_to"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T058"},"def":{"xml:lang":"en","type":"literal","value":"An activity of or relating to the practice of medicine or involving the care of patients."},"label":{"xml:lang":"en","type":"literal","value":"Health Care Activity"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25725"},"def":{"xml:lang":"en","type":"literal","value":"An anticipated outcome that is the purpose for actions taken, thus guiding the action."},"label":{"xml:lang":"en","type":"literal","value":"Intent"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100005"},"label":{"xml:lang":"en","type":"literal","value":"has_heart_disorder"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100020"},"label":{"xml:lang":"en","type":"literal","value":"has_disease"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C3079"},"def":{"xml:lang":"en","type":"literal","value":"A non-neoplastic or neoplastic disorder that affects the heart and/or the pericardium. Representative examples include endocarditis, pericarditis, atrial myxoma, cardiac myeloid sarcoma, and pericardial malignant mesothelioma."},"label":{"xml:lang":"en","type":"literal","value":"Heart Disorder"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100008"},"label":{"xml:lang":"en","type":"literal","value":"has_neoplasm"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T191"},"def":{"xml:lang":"en","type":"literal","value":"A new and abnormal growth of tissue in which the growth is uncontrolled and progressive. The growths may be malignant or benign."},"label":{"xml:lang":"en","type":"literal","value":"Neoplastic Process"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100015"},"label":{"xml:lang":"en","type":"literal","value":"has_age_at_pathology"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100016"},"label":{"xml:lang":"en","type":"literal","value":"has_age_at_diagnosis"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100017"},"label":{"xml:lang":"en","type":"literal","value":"has_age_at_start_rt"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100018"},"label":{"xml:lang":"en","type":"literal","value":"has_biological_sex"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C28421"},"def":{"xml:lang":"en","type":"literal","value":"The assemblage of physical properties or qualities by which male is distinguished from female; the physical difference between male and female; the distinguishing peculiarity of male or female."},"label":{"xml:lang":"en","type":"literal","value":"Sex"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100019"},"label":{"xml:lang":"en","type":"literal","value":"brings_about"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100083"},"label":{"xml:lang":"en","type":"literal","value":"functionally_related_to"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100198"},"label":{"xml:lang":"en","type":"literal","value":"brought_about_by"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100082"},"label":{"xml:lang":"en","type":"literal","value":"has_occurrence"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C16960"},"def":{"xml:lang":"en","type":"literal","value":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary."},"label":{"xml:lang":"en","type":"literal","value":"Patient"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100021"},"label":{"xml:lang":"en","type":"literal","value":"has_histology"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100022"},"label":{"xml:lang":"en","type":"literal","value":"has_finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C3262"},"def":{"xml:lang":"en","type":"literal","value":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias."},"label":{"xml:lang":"en","type":"literal","value":"Neoplasm"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C4741"},"def":{"xml:lang":"en","type":"literal","value":"A classification system grouping neoplasms according to their cellular characteristics."},"label":{"xml:lang":"en","type":"literal","value":"Neoplasm by Morphology"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T033"},"def":{"xml:lang":"en","type":"literal","value":"That which is discovered by direct observation or measurement of an organism attribute or condition, including the clinical history of the patient. The history of the presence of a disease is a 'Finding' and is distinguished from the disease itself."},"label":{"xml:lang":"en","type":"literal","value":"Finding"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100023"},"label":{"xml:lang":"en","type":"literal","value":"has_prescribed_radiation_dose"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100260"},"label":{"xml:lang":"en","type":"literal","value":"has_dose"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100024"},"label":{"xml:lang":"en","type":"literal","value":"has_procedure"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100205"},"label":{"xml:lang":"en","type":"literal","value":"uses"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25218"},"def":{"xml:lang":"en","type":"literal","value":"An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects."},"label":{"xml:lang":"en","type":"literal","value":"Intervention or Procedure"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100025"},"label":{"xml:lang":"en","type":"literal","value":"has_stage"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100026"},"label":{"xml:lang":"en","type":"literal","value":"has_survival"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100212"},"label":{"xml:lang":"en","type":"literal","value":"has_property"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100028"},"label":{"xml:lang":"en","type":"literal","value":"has_vital_status"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100029"},"label":{"xml:lang":"en","type":"literal","value":"is_diagnosed_with"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100208"},"label":{"xml:lang":"en","type":"literal","value":"diagnosed_by"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100030"},"label":{"xml:lang":"en","type":"literal","value":"is_staged_with"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100031"},"label":{"xml:lang":"en","type":"literal","value":"temporally_related_to"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100040"},"label":{"xml:lang":"en","type":"literal","value":"associated_with"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100032"},"label":{"xml:lang":"en","type":"literal","value":"follows"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100034"},"label":{"xml:lang":"en","type":"literal","value":"precedes"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100033"},"label":{"xml:lang":"en","type":"literal","value":"is_adjuvant_to"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100035"},"label":{"xml:lang":"en","type":"literal","value":"co-occurs_with"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100036"},"label":{"xml:lang":"en","type":"literal","value":"is_concurrent_with"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100037"},"label":{"xml:lang":"en","type":"literal","value":"is_neo_adjuvant_to"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100038"},"label":{"xml:lang":"en","type":"literal","value":"is_when"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100039"},"label":{"xml:lang":"en","type":"literal","value":"is_treated_in"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100202"},"label":{"xml:lang":"en","type":"literal","value":"has_location"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C19326"},"def":{"xml:lang":"en","type":"literal","value":"Institutions with an organized medical staff for the medical care, treatment, and cure of the sick and wounded, for the study of disease, and for the training of physicians, nurses, and allied health personnel."},"label":{"xml:lang":"en","type":"literal","value":"Clinics and Hospitals"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100061"},"label":{"xml:lang":"en","type":"literal","value":"has_person_identifier"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100318"},"label":{"xml:lang":"en","type":"literal","value":"has_id"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100060"},"def":{"xml:lang":"en","type":"literal","value":"An identifier which is used to uniquely identify a person in a certain context (cohort, hospital, trial). Can be a pseudonym."},"label":{"xml:lang":"en","type":"literal","value":"Person Identifier"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100077"},"label":{"xml:lang":"en","type":"literal","value":"delineation_of"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100213"},"label":{"xml:lang":"en","type":"literal","value":"measurement_of"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T017"},"def":{"xml:lang":"en","type":"literal","value":"A normal or pathological part of the anatomy or structural organization of an organism."},"label":{"xml:lang":"en","type":"literal","value":"Anatomical Structure"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100081"},"label":{"xml:lang":"en","type":"literal","value":"occurs_in"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100197"},"label":{"xml:lang":"en","type":"literal","value":"causes"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100199"},"label":{"xml:lang":"en","type":"literal","value":"caused_by"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100200"},"label":{"xml:lang":"en","type":"literal","value":"spatially_related_to"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100201"},"label":{"xml:lang":"en","type":"literal","value":"location_of"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100203"},"label":{"xml:lang":"en","type":"literal","value":"indicates"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100204"},"label":{"xml:lang":"en","type":"literal","value":"indicated_by"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100206"},"label":{"xml:lang":"en","type":"literal","value":"used_by"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100207"},"label":{"xml:lang":"en","type":"literal","value":"diagnoses"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100209"},"label":{"xml:lang":"en","type":"literal","value":"measures"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100210"},"label":{"xml:lang":"en","type":"literal","value":"measured_by"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100211"},"label":{"xml:lang":"en","type":"literal","value":"property_of"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100214"},"label":{"xml:lang":"en","type":"literal","value":"has_measurement"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100215"},"label":{"xml:lang":"en","type":"literal","value":"degree_of"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100216"},"label":{"xml:lang":"en","type":"literal","value":"has_degree"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100217"},"label":{"xml:lang":"en","type":"literal","value":"uses_ACE_inhibitor"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100218"},"label":{"xml:lang":"en","type":"literal","value":"has_performance_status"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C20641"},"def":{"xml:lang":"en","type":"literal","value":"A measure of how well a patient is able to perform ordinary tasks and carry out daily activities."},"label":{"xml:lang":"en","type":"literal","value":"Performance Status"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100219"},"label":{"xml:lang":"en","type":"literal","value":"has_AJCC_version"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100267"},"label":{"xml:lang":"en","type":"literal","value":"has_version"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48232"},"def":{"xml:lang":"en","type":"literal","value":"A cancer finding in the TNM system that is relevant to the diagnosis of cancer."},"label":{"xml:lang":"en","type":"literal","value":"Cancer TNM Finding"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100051"},"def":{"xml:lang":"en","type":"literal","value":"Edition of the American Joint Commission on Cancer (AJCC) Cancer Staging Manual."},"label":{"xml:lang":"en","type":"literal","value":"AJCC Edition"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100220"},"label":{"xml:lang":"en","type":"literal","value":"has_body_mass_index"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100221"},"label":{"xml:lang":"en","type":"literal","value":"has_body_part"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100236"},"label":{"xml:lang":"en","type":"literal","value":"has_part"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100222"},"label":{"xml:lang":"en","type":"literal","value":"has_chemo_timing"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100231"},"label":{"xml:lang":"en","type":"literal","value":"has_method"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100223"},"label":{"xml:lang":"en","type":"literal","value":"has_count"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100224"},"label":{"xml:lang":"en","type":"literal","value":"has_fraction_count"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100225"},"label":{"xml:lang":"en","type":"literal","value":"has_image_count"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100226"},"label":{"xml:lang":"en","type":"literal","value":"has_patient_count"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100227"},"label":{"xml:lang":"en","type":"literal","value":"has_count_pet_5g"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100228"},"label":{"xml:lang":"en","type":"literal","value":"has_date"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100229"},"label":{"xml:lang":"en","type":"literal","value":"has_alive_last_checked_date"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100230"},"label":{"xml:lang":"en","type":"literal","value":"method_of"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100232"},"label":{"xml:lang":"en","type":"literal","value":"indicates"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100233"},"label":{"xml:lang":"en","type":"literal","value":"indicated_by"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100234"},"label":{"xml:lang":"en","type":"literal","value":"physically_related_to"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100235"},"label":{"xml:lang":"en","type":"literal","value":"part_of"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100238"},"label":{"xml:lang":"en","type":"literal","value":"has_cause_of_death"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100239"},"label":{"xml:lang":"en","type":"literal","value":"has_chemo_start_date"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100241"},"label":{"xml:lang":"en","type":"literal","value":"has_clinical_m_stage"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100243"},"label":{"xml:lang":"en","type":"literal","value":"has_clinical_stage"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100242"},"label":{"xml:lang":"en","type":"literal","value":"has_clinical_n_stage"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100244"},"label":{"xml:lang":"en","type":"literal","value":"has_clinical_t_stage"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100247"},"label":{"xml:lang":"en","type":"literal","value":"has_cumulative_dose"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100248"},"label":{"xml:lang":"en","type":"literal","value":"has_body_height"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C94488"},"def":{"xml:lang":"en","type":"literal","value":"The height of a person while standing."},"label":{"xml:lang":"en","type":"literal","value":"Stature"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100249"},"label":{"xml:lang":"en","type":"literal","value":"has_body_weight"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C81328"},"def":{"xml:lang":"en","type":"literal","value":"The weight of a subject."},"label":{"xml:lang":"en","type":"literal","value":"Body Weight"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100250"},"label":{"xml:lang":"en","type":"literal","value":"has_date_of_death"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100251"},"label":{"xml:lang":"en","type":"literal","value":"has_date_of_diagnosis"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100252"},"label":{"xml:lang":"en","type":"literal","value":"has_date_of_procedure"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100253"},"label":{"xml:lang":"en","type":"literal","value":"has_death"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100254"},"label":{"xml:lang":"en","type":"literal","value":"has_death_finding"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100255"},"label":{"xml:lang":"en","type":"literal","value":"has_comorbidity"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2991"},"def":{"xml:lang":"en","type":"literal","value":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function."},"label":{"xml:lang":"en","type":"literal","value":"Disease or Disorder"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100257"},"label":{"xml:lang":"en","type":"literal","value":"has_disease_date"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100258"},"label":{"xml:lang":"en","type":"literal","value":"has_disease_finding"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100259"},"label":{"xml:lang":"en","type":"literal","value":"has_disease_qualifier"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100297"},"label":{"xml:lang":"en","type":"literal","value":"has_qualifier"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100261"},"label":{"xml:lang":"en","type":"literal","value":"has_duration"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100262"},"label":{"xml:lang":"en","type":"literal","value":"has_dysphagia"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100263"},"label":{"xml:lang":"en","type":"literal","value":"has_dyspnea"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100264"},"label":{"xml:lang":"en","type":"literal","value":"has_fev1_percentage"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100265"},"label":{"xml:lang":"en","type":"literal","value":"has_fev1_test"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25714"},"def":{"xml:lang":"en","type":"literal","value":"A form or variant of a type or original; one of a sequence of copies of a program, each incorporating new modifications."},"label":{"xml:lang":"en","type":"literal","value":"Version"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100268"},"label":{"xml:lang":"en","type":"literal","value":"has_fraction_dose"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100269"},"label":{"xml:lang":"en","type":"literal","value":"has_fractionation_part"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100271"},"label":{"xml:lang":"en","type":"literal","value":"has_hypertension"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100273"},"label":{"xml:lang":"en","type":"literal","value":"has_life"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100274"},"label":{"xml:lang":"en","type":"literal","value":"has_marital_status"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25188"},"def":{"xml:lang":"en","type":"literal","value":"A demographic parameter indicating a person's current conjugal status."},"label":{"xml:lang":"en","type":"literal","value":"Marital Status"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100275"},"label":{"xml:lang":"en","type":"literal","value":"has_max_esophagus_dose"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100276"},"label":{"xml:lang":"en","type":"literal","value":"has_mean_esophagus_dose"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100277"},"label":{"xml:lang":"en","type":"literal","value":"has_mean_lung_dose"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100278"},"label":{"xml:lang":"en","type":"literal","value":"has_modality"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100280"},"label":{"xml:lang":"en","type":"literal","value":"has_nodal_tumor_volume"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100313"},"label":{"xml:lang":"en","type":"literal","value":"has_tumor_volume"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100281"},"label":{"xml:lang":"en","type":"literal","value":"has_overall_duration"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100282"},"label":{"xml:lang":"en","type":"literal","value":"has_pacs_patient"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100283"},"label":{"xml:lang":"en","type":"literal","value":"has_pacs_series"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100284"},"label":{"xml:lang":"en","type":"literal","value":"has_pacs_study"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100285"},"label":{"xml:lang":"en","type":"literal","value":"has_pathological_m_stage"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100287"},"label":{"xml:lang":"en","type":"literal","value":"has_pathological_stage"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100286"},"label":{"xml:lang":"en","type":"literal","value":"has_pathological_n_stage"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100288"},"label":{"xml:lang":"en","type":"literal","value":"has_pathological_t_stage"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100291"},"label":{"xml:lang":"en","type":"literal","value":"has_patient_finding"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100292"},"label":{"xml:lang":"en","type":"literal","value":"has_patient_guid"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100314"},"label":{"xml:lang":"en","type":"literal","value":"has_uid"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100319"},"def":{"xml:lang":"en","type":"literal","value":"A globally unique identifier identifying a patient."},"label":{"xml:lang":"en","type":"literal","value":"Patient GUID"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100293"},"label":{"xml:lang":"en","type":"literal","value":"has_primary_tumor_volume"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100295"},"label":{"xml:lang":"en","type":"literal","value":"has_procedure_date"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100296"},"label":{"xml:lang":"en","type":"literal","value":"has_procedure_duration"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100298"},"label":{"xml:lang":"en","type":"literal","value":"has_rt_dose"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100299"},"label":{"xml:lang":"en","type":"literal","value":"has_rt_end_date"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100300"},"label":{"xml:lang":"en","type":"literal","value":"has_rt_start_date"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100301"},"label":{"xml:lang":"en","type":"literal","value":"has_radiation_therapy"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100302"},"label":{"xml:lang":"en","type":"literal","value":"has_secondary_neoplasm"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100303"},"label":{"xml:lang":"en","type":"literal","value":"has_series"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100304"},"label":{"xml:lang":"en","type":"literal","value":"has_series_guid"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100305"},"label":{"xml:lang":"en","type":"literal","value":"has_series_uid"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100306"},"label":{"xml:lang":"en","type":"literal","value":"has_smoking_status"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100307"},"label":{"xml:lang":"en","type":"literal","value":"has_study"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100308"},"label":{"xml:lang":"en","type":"literal","value":"has_study_guid"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100309"},"label":{"xml:lang":"en","type":"literal","value":"has_study_uid"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100310"},"label":{"xml:lang":"en","type":"literal","value":"has_surgical_procedure"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100311"},"label":{"xml:lang":"en","type":"literal","value":"has_survival_time"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100312"},"label":{"xml:lang":"en","type":"literal","value":"has_tumor_burden"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100315"},"label":{"xml:lang":"en","type":"literal","value":"has_volume"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100317"},"label":{"xml:lang":"en","type":"literal","value":"has_date_observed"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100327"},"label":{"xml:lang":"en","type":"literal","value":"has_birth"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25155"},"def":{"xml:lang":"en","type":"literal","value":"The event of being born."},"label":{"xml:lang":"en","type":"literal","value":"Birth"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100331"},"label":{"xml:lang":"en","type":"literal","value":"has_recurrence_status"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100332"},"label":{"xml:lang":"en","type":"literal","value":"has_recurrence_time"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100337"},"label":{"xml:lang":"en","type":"literal","value":"has_chemo_end_date"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100343"},"label":{"xml:lang":"en","type":"literal","value":"has_laterality"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25185"},"def":{"xml:lang":"en","type":"literal","value":"Dominant use or manifestations of one side of the body versus the other; referring to a side of the body or of a structure."},"label":{"xml:lang":"en","type":"literal","value":"Laterality"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100389"},"label":{"xml:lang":"en","type":"literal","value":"process_of"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100391"},"label":{"xml:lang":"en","type":"literal","value":"has_process"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100392"},"label":{"xml:lang":"en","type":"literal","value":"manifestation_of"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100395"},"label":{"xml:lang":"en","type":"literal","value":"has_manifestation"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100394"},"label":{"xml:lang":"en","type":"literal","value":"has_overall_stage"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100396"},"label":{"xml:lang":"en","type":"literal","value":"result_of"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100397"},"label":{"xml:lang":"en","type":"literal","value":"has_result"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100398"},"label":{"xml:lang":"en","type":"literal","value":"affects"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100399"},"label":{"xml:lang":"en","type":"literal","value":"affected_by"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100408"},"label":{"xml:lang":"en","type":"literal","value":"disrupts"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100400"},"label":{"xml:lang":"en","type":"literal","value":"manages"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100401"},"label":{"xml:lang":"en","type":"literal","value":"managed_by"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100402"},"label":{"xml:lang":"en","type":"literal","value":"treats"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100403"},"label":{"xml:lang":"en","type":"literal","value":"treated_by"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100404"},"label":{"xml:lang":"en","type":"literal","value":"complicates"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100405"},"label":{"xml:lang":"en","type":"literal","value":"complicated_by"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100406"},"label":{"xml:lang":"en","type":"literal","value":"prevents"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100407"},"label":{"xml:lang":"en","type":"literal","value":"prevented_by"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100409"},"label":{"xml:lang":"en","type":"literal","value":"disrupted_by"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100410"},"label":{"xml:lang":"en","type":"literal","value":"performs"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100411"},"label":{"xml:lang":"en","type":"literal","value":"performed_by"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100412"},"label":{"xml:lang":"en","type":"literal","value":"exhibits"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100413"},"label":{"xml:lang":"en","type":"literal","value":"exhibited_by"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100414"},"label":{"xml:lang":"en","type":"literal","value":"produces"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100415"},"label":{"xml:lang":"en","type":"literal","value":"produced_by"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100416"},"label":{"xml:lang":"en","type":"literal","value":"practices"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100417"},"label":{"xml:lang":"en","type":"literal","value":"practiced_by"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100418"},"label":{"xml:lang":"en","type":"literal","value":"interacts_with"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100419"},"label":{"xml:lang":"en","type":"literal","value":"carries_out"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100420"},"label":{"xml:lang":"en","type":"literal","value":"carried_out_by"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100421"},"label":{"xml:lang":"en","type":"literal","value":"contains"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100422"},"label":{"xml:lang":"en","type":"literal","value":"contained_in"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100423"},"label":{"xml:lang":"en","type":"literal","value":"consists_of"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100432"},"label":{"xml:lang":"en","type":"literal","value":"constitutes"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100424"},"label":{"xml:lang":"en","type":"literal","value":"connected_to"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100425"},"label":{"xml:lang":"en","type":"literal","value":"interconnects"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100431"},"label":{"xml:lang":"en","type":"literal","value":"interconnected_by"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100426"},"label":{"xml:lang":"en","type":"literal","value":"branch_of"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100427"},"label":{"xml:lang":"en","type":"literal","value":"tributary_of"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100430"},"label":{"xml:lang":"en","type":"literal","value":"has_tributary"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100428"},"label":{"xml:lang":"en","type":"literal","value":"ingredient_of"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100429"},"label":{"xml:lang":"en","type":"literal","value":"has_ingredient"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100433"},"label":{"xml:lang":"en","type":"literal","value":"has_branch"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100434"},"label":{"xml:lang":"en","type":"literal","value":"adjacent_to"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100435"},"label":{"xml:lang":"en","type":"literal","value":"surrounds"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100436"},"label":{"xml:lang":"en","type":"literal","value":"surrounded_by"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100437"},"label":{"xml:lang":"en","type":"literal","value":"traverses"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100438"},"label":{"xml:lang":"en","type":"literal","value":"traversed_by"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100439"},"label":{"xml:lang":"en","type":"literal","value":"conceptual_part_of"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100440"},"label":{"xml:lang":"en","type":"literal","value":"has_conceptual_part"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100441"},"label":{"xml:lang":"en","type":"literal","value":"evaluation_of"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100442"},"label":{"xml:lang":"en","type":"literal","value":"has_evaluation"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100443"},"label":{"xml:lang":"en","type":"literal","value":"assesses_effect_of"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100451"},"label":{"xml:lang":"en","type":"literal","value":"analyzes"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100444"},"label":{"xml:lang":"en","type":"literal","value":"assessed_for_effect_by"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100452"},"label":{"xml:lang":"en","type":"literal","value":"analyzed_by"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100445"},"label":{"xml:lang":"en","type":"literal","value":"issue_in"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100446"},"label":{"xml:lang":"en","type":"literal","value":"has_issue"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100447"},"label":{"xml:lang":"en","type":"literal","value":"derivative_of"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100448"},"label":{"xml:lang":"en","type":"literal","value":"has_derivative"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100449"},"label":{"xml:lang":"en","type":"literal","value":"developmental_form_of"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100450"},"label":{"xml:lang":"en","type":"literal","value":"has_developmental_form"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/P100041"},"label":{"xml:lang":"en","type":"literal","value":"at_date_time"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C101516"},"def":{"xml:lang":"en","type":"literal","value":"Any action or response, without curative intent, that mitigates some or all of the unpleasant effects of a disease or condition."},"label":{"xml:lang":"en","type":"literal","value":"Palliative"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C101642"},"def":{"xml:lang":"en","type":"literal","value":"Radiation therapy that is administered to augment or stimulate other treatment modalities or to minimize or prevent disease recurrence."},"label":{"xml:lang":"en","type":"literal","value":"Adjuvant Radiotherapy"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C15313"},"def":{"xml:lang":"en","type":"literal","value":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation."},"label":{"xml:lang":"en","type":"literal","value":"Radiation Therapy"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C15675"},"def":{"xml:lang":"en","type":"literal","value":"Any therapy that is administered to augment or stimulate other treatment modalities or to minimize or prevent disease recurrence subsequent to the main treatment plan."},"label":{"xml:lang":"en","type":"literal","value":"Adjuvant Therapy"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C102955"},"def":{"xml:lang":"en","type":"literal","value":"Any of the major arteries or veins attached to the cardiac atria or ventricles. This includes the aorta, superior and inferior vena cava and the pulmonary arteries and veins."},"label":{"xml:lang":"en","type":"literal","value":"Great Blood Vessel"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T023"},"def":{"xml:lang":"en","type":"literal","value":"A collection of cells and tissues which are localized to a specific area or combine and carry out one or more specialized functions of an organism. This ranges from gross structures to small components of complex organs. These structures are relatively localized in comparison to tissues."},"label":{"xml:lang":"en","type":"literal","value":"Body Part, Organ, or Organ Component"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C103267"},"def":{"xml:lang":"en","type":"literal","value":"An indication that a surgical margin is in close proximity to the excised tumor."},"label":{"xml:lang":"en","type":"literal","value":"Narrow Surgical Margin"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C41227"},"def":{"xml:lang":"en","type":"literal","value":"One of the criteria for assessment of the effectiveness of given surgical procedure in achieving the local control of a neoplasm and the adequacy of tumor removal. It is defined by the tissue plane through which the dissection has been done and the actual or potential neoplastic tissue which has been left outside the boundary of a resected specimen within the patient. There are four types of surgical margins: intracapsular or intralesional, marginal, wide, and radical."},"label":{"xml:lang":"en","type":"literal","value":"Surgical Margin"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C104933"},"def":{"xml:lang":"en","type":"literal","value":"Radiation therapy delivered to the whole volume of target tissue by a single rotation of the linear accelerator gantry."},"label":{"xml:lang":"en","type":"literal","value":"Volume Modulated Arc Therapy"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C104941"},"def":{"xml:lang":"en","type":"literal","value":"Proton beam radiation therapy in which magnets deflect and steer the proton beam."},"label":{"xml:lang":"en","type":"literal","value":"Scanning Proton Beam Therapy"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C66897"},"def":{"xml:lang":"en","type":"literal","value":"A type of external beam radiation therapy using a beam of protons. It has the advantage of precisely localizing the radiation dose on the targeted tissue and avoiding damage to the healthy surrounding tissues."},"label":{"xml:lang":"en","type":"literal","value":"Proton Beam Radiation Therapy"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C104942"},"def":{"xml:lang":"en","type":"literal","value":"Proton beam radiation therapy in which the proton beam is spread by placing scattering material in the path of the protons."},"label":{"xml:lang":"en","type":"literal","value":"Scattering Proton Beam Therapy"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C105721"},"def":{"xml:lang":"en","type":"literal","value":"A performance status scale designed to assess disease progression and its affect on the daily living abilities of the patient."},"label":{"xml:lang":"en","type":"literal","value":"ECOG Performance Status"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25400"},"def":{"xml:lang":"en","type":"literal","value":"A scale used to assess how a patient's disease is progressing and assess how the disease affects the daily living abilities of the patient."},"label":{"xml:lang":"en","type":"literal","value":"Zubrod Performance Status"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C105722"},"def":{"xml:lang":"en","type":"literal","value":"Fully active, able to carry on all pre-disease performance without restriction."},"label":{"xml:lang":"en","type":"literal","value":"ECOG Performance Status 0"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C105723"},"def":{"xml:lang":"en","type":"literal","value":"Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work."},"label":{"xml:lang":"en","type":"literal","value":"ECOG Performance Status 1"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C105725"},"def":{"xml:lang":"en","type":"literal","value":"Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours."},"label":{"xml:lang":"en","type":"literal","value":"ECOG Performance Status 2"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C105726"},"def":{"xml:lang":"en","type":"literal","value":"Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours."},"label":{"xml:lang":"en","type":"literal","value":"ECOG Performance Status 3"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C105727"},"def":{"xml:lang":"en","type":"literal","value":"Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair."},"label":{"xml:lang":"en","type":"literal","value":"ECOG Performance Status 4"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C105728"},"def":{"xml:lang":"en","type":"literal","value":"Dead."},"label":{"xml:lang":"en","type":"literal","value":"ECOG Performance Status 5"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C106304"},"def":{"xml:lang":"en","type":"literal","value":"A pathologic grading system used to evaluate the tumor response to preoperative chemotherapy and radiation."},"label":{"xml:lang":"en","type":"literal","value":"Tumor Regression Grade"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T185"},"def":{"xml:lang":"en","type":"literal","value":"A term or system of terms denoting an arrangement by class or category."},"label":{"xml:lang":"en","type":"literal","value":"Classification"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C11197"},"def":{"xml:lang":"en","type":"literal","value":"One of several chemotherapy regimens that include leucovorin calcium (calcium folinate), 5-fluorouracil and oxaliplatin and which may be used in the treatment of advanced-stage and metastatic colorectal cancer. FOLFOX regimens differ in agent dosing and administration schedule and include FOLFOX 4, FOLFOX 6, modified FOLFOX 6 (mFOLFOX 6) and FOLFOX 7."},"label":{"xml:lang":"en","type":"literal","value":"FOLFOX Regimen"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63586"},"label":{"xml:lang":"en","type":"literal","value":"Chemotherapy Regimen Used to Treat Colorectal Carcinoma"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1181"},"label":{"xml:lang":"en","type":"literal","value":"Oxaliplatin"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C505"},"label":{"xml:lang":"en","type":"literal","value":"Fluorouracil"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C607"},"label":{"xml:lang":"en","type":"literal","value":"Leucovorin Calcium"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C112376"},"def":{"xml:lang":"en","type":"literal","value":"Forced expiratory volume in one second as a proportion of the predicted normal value. (CDISC)"},"label":{"xml:lang":"en","type":"literal","value":"Percent Predicted Forced Expiratory Volume in 1 Second"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25613"},"def":{"xml:lang":"en","type":"literal","value":"A fraction or ratio with 100 understood as the denominator."},"label":{"xml:lang":"en","type":"literal","value":"Percentage"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C112816"},"def":{"xml:lang":"en","type":"literal","value":"A plot of a cumulative dose-volume frequency distribution that graphically summarizes the simulated radiation distribution within a volume of interest of a patient which would result from a proposed radiation treatment plan."},"label":{"xml:lang":"en","type":"literal","value":"Dose Volume Histogram"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T170"},"def":{"xml:lang":"en","type":"literal","value":"A conceptual entity resulting from human endeavor. Concepts assigned to this type generally refer to information created by humans for some purpose."},"label":{"xml:lang":"en","type":"literal","value":"Intellectual Product"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C112913"},"def":{"xml:lang":"en","type":"literal","value":"The gross palpable or visible/demonstrable extent and location of malignant growth."},"label":{"xml:lang":"en","type":"literal","value":"Gross Target Volume"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100598"},"def":{"xml:lang":"en","type":"literal","value":"The Gross Tumor Volume (GTV) is the gross demonstrable extent and location of the tumor. The  GTV  may  consist  of  a  primary  tumor (primary  tumor  GTV  or  GTV-T),  metastatic regional node(s) (nodal GTV or GTV-N), or distant metastasis (metastatic GTV, or GTV-M). Typically, different GTVs are defined for the primary tumor and the regional node(s). But in some particular clinical situations, it might well be that the metastatic  node  cannot  be  distinguished  from  the primary tumor, e.g., a nasopharyngeal undifferentiated carcinoma infiltrating posterolaterally into the retropharyngeal space, including possible infiltrated nodes. In such situations, a single GTV encompassing both the primary tumor and the node(s) may be delineated. (ICRU 83)\nFor more information: http://dx.doi.org/10.1093/jicru/ndq001"},"label":{"xml:lang":"en","type":"literal","value":"Gross Tumor Volume"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100607"},"def":{"xml:lang":"en","type":"literal","value":"A Target Volume is a volume of tissue or of a geometrical concept forming the target for irradiation during radiation oncology."},"label":{"xml:lang":"en","type":"literal","value":"Target Volume"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C113716"},"def":{"xml:lang":"en","type":"literal","value":"Resection of the rectum for cancer through an incision in the lower abdomen."},"label":{"xml:lang":"en","type":"literal","value":"Low Anterior Resection"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/RCD/X20Y4"},"label":{"xml:lang":"en","type":"literal","value":"Anterior resection of rectum"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C113730"},"def":{"xml:lang":"en","type":"literal","value":"A morphologic qualifier indicating that the grade of a neoplasm cannot be assessed."},"label":{"xml:lang":"en","type":"literal","value":"Grade X"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C28076"},"def":{"xml:lang":"en","type":"literal","value":"A term that refers to the cellular differentiation of a malignant cellular infiltrate. A cancer is defined through grades I-IV (or 1-4), or as well, moderately, poorly differentiated or undifferentiated."},"label":{"xml:lang":"en","type":"literal","value":"Disease Grade Qualifier"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116430"},"def":{"xml:lang":"en","type":"literal","value":"3-Dimensional conformal radiation therapy that is designed to compensate for motion of the tumor and surrounding normal tissue during each treatment session."},"label":{"xml:lang":"en","type":"literal","value":"4-Dimensional Conformal Radiation Therapy"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100639"},"def":{"xml:lang":"en","type":"literal","value":"A procedure in which internal motion is managed of organs and/or regions of interest (e.g. tumors) during radiotherapy or imaging or another therapeutic or imaging procedure. This management can be implicit in the procedure (e.g. 4D-CT) are added to any procedure (e.g. breath hold). The motion can be due to respiration, circulation, peristalsis, swallowing, etc. Both procedures to prevent motion (e.g. breath hold) and/or deal with motion (e.g. gating) are part of this class of concepts. Not meant here are procedures meant to deal with the overal motion of the patient (e.g immobilisation)."},"label":{"xml:lang":"en","type":"literal","value":"Motion Management Procedure"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116441"},"def":{"xml:lang":"en","type":"literal","value":"Computed tomography scans designed to minimize motion artifacts. 4DCT can be accomplished by collecting data for the duration of the patient's respiratory cycle and by oversampling CT data acquisition at each slice."},"label":{"xml:lang":"en","type":"literal","value":"4-Dimensional Computed Tomography"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C17204"},"def":{"xml:lang":"en","type":"literal","value":"A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis."},"label":{"xml:lang":"en","type":"literal","value":"Computed Tomography"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116509"},"def":{"xml:lang":"en","type":"literal","value":"A surgical technique that uses a specially designed robotic system to aid with a laparoscopic surgical procedure."},"label":{"xml:lang":"en","type":"literal","value":"Robot-Assisted Laparoscopic Surgery"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C15725"},"def":{"xml:lang":"en","type":"literal","value":"Surgery done with the aid of a laparoscope. A laparoscope is a thin, tube-like instrument with a light and a lens for viewing. It may also have a tool to remove tissue to be checked under a microscope for signs of disease."},"label":{"xml:lang":"en","type":"literal","value":"Laparoscopic Surgery"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T121"},"def":{"xml:lang":"en","type":"literal","value":"A substance used in the treatment or prevention of pathologic disorders. This includes substances that occur naturally in the body and are administered therapeutically."},"label":{"xml:lang":"en","type":"literal","value":"Pharmacologic Substance"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C118286"},"def":{"xml:lang":"en","type":"literal","value":"Stereotactic radiation therapy in which one or several maximum dose radiation treatments are delivered targeting cancers of the body, excluding the brain or spine."},"label":{"xml:lang":"en","type":"literal","value":"Stereotactic Body Radiation Therapy"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C120274"},"def":{"xml:lang":"en","type":"literal","value":"The presence of macroscopically visible residual tumor at the edge of a surgically excised specimen."},"label":{"xml:lang":"en","type":"literal","value":"Macroscopically Positive Surgical Margin"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48620"},"def":{"xml:lang":"en","type":"literal","value":"Indicates the presence of tumor cells at the edge of a surgically excised specimen."},"label":{"xml:lang":"en","type":"literal","value":"Positive Surgical Margin"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C120277"},"def":{"xml:lang":"en","type":"literal","value":"The presence of microscopically visible residual tumor at the edge of a surgically excised specimen that otherwise looks macroscopically normal."},"label":{"xml:lang":"en","type":"literal","value":"Grossly Negative and Microscopically Positive Surgical Margin"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C120284"},"def":{"xml:lang":"en","type":"literal","value":"The size of a tumor in its greatest dimension."},"label":{"xml:lang":"en","type":"literal","value":"Tumor Size"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25681"},"def":{"xml:lang":"en","type":"literal","value":"The physical magnitude of something."},"label":{"xml:lang":"en","type":"literal","value":"Size"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C12218"},"def":{"xml:lang":"en","type":"literal","value":"A combination of multiple drugs used in standard or clinical trial treatments. The order, dosage or dosing interval of the individual ingredients may not be specified."},"label":{"xml:lang":"en","type":"literal","value":"Chemotherapy Regimen or Agent Combination"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C15697"},"def":{"xml:lang":"en","type":"literal","value":"A treatment plan that specifies the dosage, the schedule, and the duration of treatment."},"label":{"xml:lang":"en","type":"literal","value":"Treatment Regimen"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C12253"},"def":{"xml:lang":"en","type":"literal","value":"The upper one third of esophagus in which the muscle layer is composed of muscle cells of the striated type."},"label":{"xml:lang":"en","type":"literal","value":"Upper Third of the Esophagus"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma55269"},"def":{"xml:lang":"en","type":"literal","value":"Organ segment which is regional part of esophagus. Examples: cervical part of esophagus, vertebral segment of esophagus."},"label":{"xml:lang":"en","type":"literal","value":"Segment of esophagus"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C12254"},"def":{"xml:lang":"en","type":"literal","value":"The middle one third of the esophagus in which the muscle layer is composed of muscle cells of the striated and smooth types."},"label":{"xml:lang":"en","type":"literal","value":"Middle Third of the Esophagus"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C12255"},"def":{"xml:lang":"en","type":"literal","value":"The lower one third of the esophagus in which the muscle layer is composed of muscle cells predominantly of the smooth type."},"label":{"xml:lang":"en","type":"literal","value":"Lower Third of the Esophagus"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C123603"},"def":{"xml:lang":"en","type":"literal","value":"The disappearance of all signs of cancer, supported by pathological examination."},"label":{"xml:lang":"en","type":"literal","value":"Pathologic Complete Response"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C50995"},"def":{"xml:lang":"en","type":"literal","value":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression."},"label":{"xml:lang":"en","type":"literal","value":"Disease Response"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C12512"},"def":{"xml:lang":"en","type":"literal","value":"The part of the brain above the tentorium cerebellum. (NCI)\nFor most authors, this is the cerebral hemispheres plus the basal ganglia, but most clinicians do not include the basal ganglia."},"label":{"xml:lang":"en","type":"literal","value":"Supratentorial Brain"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C125609"},"def":{"xml:lang":"en","type":"literal","value":"Positron emission tomography imaging collected over time. It is designed to capture the internal movement of organs and the metabolism of the tumor. It creates the most complete and accurate information on the tumor and provides information how the tumor moves with breathing and other body motions."},"label":{"xml:lang":"en","type":"literal","value":"4D PET Scan"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C17007"},"def":{"xml:lang":"en","type":"literal","value":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered."},"label":{"xml:lang":"en","type":"literal","value":"Positron Emission Tomography"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1275"},"def":{"xml:lang":"en","type":"literal","value":"A semisynthetic vinca alkaloid. Vinorelbine binds to tubulin and prevents formation of the mitotic spindle, resulting in the arrest of tumor cell growth in metaphase. This agent may also interfere with amino acid, cyclic AMP. and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis."},"label":{"xml:lang":"en","type":"literal","value":"Vinorelbine"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1282"},"def":{"xml:lang":"en","type":"literal","value":"A second-generation platinum compound with a broad spectrum of antineoplastic properties. Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue. This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition. This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic. (NCI04)"},"label":{"xml:lang":"en","type":"literal","value":"Carboplatin"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1450"},"def":{"xml:lang":"en","type":"literal","value":"A chemotherapy compound that contains a platinum atom. Platinum compounds do not contain alkyl groups but do cause DNA crosslinks and adducts similar to alkylating agents. DNA crosslinks and adducts ultimately lead to the induction of apoptosis."},"label":{"xml:lang":"en","type":"literal","value":"Platinum Compound"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1331"},"def":{"xml:lang":"en","type":"literal","value":"An alkaloid isolated or derived synthetically from Podophyllum peltatum that can bind to and inhibit topoisomerase II and its function in ligating cleaved DNA molecules, resulting in the accumulation of single- or double-strand DNA breaks, the inhibition of DNA replication and transcription, and apoptotic cell death."},"label":{"xml:lang":"en","type":"literal","value":"Epipodophyllotoxin Compound"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T104"},"def":{"xml:lang":"en","type":"literal","value":"A chemical or chemicals viewed from the perspective of their structural characteristics. Included here are concepts which can mean either a salt, an ion, or a compound (e.g., Bromates and Bromides)."},"label":{"xml:lang":"en","type":"literal","value":"Chemical Viewed Structurally"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C13345"},"def":{"xml:lang":"en","type":"literal","value":"A surgically created opening from an area inside the body to the outside."},"label":{"xml:lang":"en","type":"literal","value":"Stoma"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T020"},"def":{"xml:lang":"en","type":"literal","value":"An abnormal structure, or one that is abnormal in size or location, found in or deriving from a previously normal structure. Acquired abnormalities are distinguished from diseases even though they may result in pathological functioning (e.g., hernias incarcerate)."},"label":{"xml:lang":"en","type":"literal","value":"Acquired Abnormality"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C136485"},"def":{"xml:lang":"en","type":"literal","value":"A stage term referring to invasive lung cancer. It includes: T1c, N0, M0. T1c: Tumor measuring more than 2 cm but 3 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (adapted from AJCC)"},"label":{"xml:lang":"en","type":"literal","value":"Stage IA3"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C27975"},"def":{"xml:lang":"en","type":"literal","value":"Invasive cancer confined to the original anatomic site of growth without lymph node involvement. The definition of stage IA depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IA is defined as follows: T1, N0, M0. T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for bone cancer, stage IA is defined as follows: T1, N0, M0, G1, GX. T1: Tumor 8 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated-low grade. GX: Grade cannot be assessed. (partially adapted from AJCC 8th ed.)"},"label":{"xml:lang":"en","type":"literal","value":"Stage IA"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1411"},"def":{"xml:lang":"en","type":"literal","value":"A compound extracted from the Pacific yew tree Taxus brevifolia with antineoplastic activity. Paclitaxel binds to tubulin and inhibits the disassembly of microtubules, thereby resulting in the inhibition of cell division. This agent also induces apoptosis by binding to and blocking the function of the apoptosis inhibitor protein Bcl-2 (B-cell Leukemia 2). (NCI04)"},"label":{"xml:lang":"en","type":"literal","value":"Paclitaxel"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1490"},"def":{"xml:lang":"en","type":"literal","value":"A type of drug that blocks cell growth by stopping mitosis (cell division). Taxanes interfere with microtubules (cellular structures that help move chromosomes during mitosis). They are used to treat cancer. A taxane is a type of mitotic inhibitor and a type of antimicrotubule agent."},"label":{"xml:lang":"en","type":"literal","value":"Taxane Compound"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C141461"},"def":{"xml:lang":"en","type":"literal","value":"A stage term that refers to a cancer in which the primary site is unknown (not detectable by clinical or radiologic examination). The definition of occult stage depends on the particular type of cancer that it refers to; for example, for breast cancer, occult stage is defined as cancer presenting with axillary lymph node metastasis without a primary in the breast being found; for non-small cell lung carcinoma, occult stage is defined as cancer detectable by sputum cytology only and the primary tumor is undetectable radiographically or during bronchoscopy."},"label":{"xml:lang":"en","type":"literal","value":"Occult Stage"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C28108"},"label":{"xml:lang":"en","type":"literal","value":"Disease Stage Qualifier"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C14151"},"def":{"xml:lang":"en","type":"literal","value":"Unable to be removed with surgery."},"label":{"xml:lang":"en","type":"literal","value":"Unresectable"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C28103"},"label":{"xml:lang":"en","type":"literal","value":"Disease Treatment Qualifier"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C14162"},"def":{"xml:lang":"en","type":"literal","value":"Describes tumor cells that have lost some of the appearance of normal cells. They tend to grow and spread at a faster rate than well differentiated tumor cells."},"label":{"xml:lang":"en","type":"literal","value":"Moderately Differentiated"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C18000"},"def":{"xml:lang":"en","type":"literal","value":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems."},"label":{"xml:lang":"en","type":"literal","value":"Histologic Grade"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C14167"},"def":{"xml:lang":"en","type":"literal","value":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread."},"label":{"xml:lang":"en","type":"literal","value":"Poorly Differentiated"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C14171"},"def":{"xml:lang":"en","type":"literal","value":"Describes tumor cells that generally retain the appearance of normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells."},"label":{"xml:lang":"en","type":"literal","value":"Well Differentiated"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C14284"},"def":{"xml:lang":"en","type":"literal","value":"An adult, female human."},"label":{"xml:lang":"en","type":"literal","value":"Woman"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C16576"},"def":{"xml:lang":"en","type":"literal","value":"A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both."},"label":{"xml:lang":"en","type":"literal","value":"Female"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C14366"},"def":{"xml:lang":"en","type":"literal","value":"An adult, male human."},"label":{"xml:lang":"en","type":"literal","value":"Man"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C20197"},"def":{"xml:lang":"en","type":"literal","value":"A person who belongs to the sex that normally produces sperm. The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both."},"label":{"xml:lang":"en","type":"literal","value":"Male"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C15189"},"def":{"xml:lang":"en","type":"literal","value":"The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis."},"label":{"xml:lang":"en","type":"literal","value":"Biopsy"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C18020"},"def":{"xml:lang":"en","type":"literal","value":"Any procedure or test to diagnose a disease or disorder."},"label":{"xml:lang":"en","type":"literal","value":"Diagnostic Procedure"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C15212"},"def":{"xml:lang":"en","type":"literal","value":"Use of two or more simultaneous or consecutive treatment modalities; e.g., surgery + radiation, or radiation + immunotherapy. Does not refer to use of two or more chemotherapeutic agents."},"label":{"xml:lang":"en","type":"literal","value":"Multimodality Therapy"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T061"},"def":{"xml:lang":"en","type":"literal","value":"A procedure, method, or technique designed to prevent a disease or a disorder, or to improve physical function, or used in the process of treating a disease or injury."},"label":{"xml:lang":"en","type":"literal","value":"Therapeutic or Preventive Procedure"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100256"},"def":{"xml:lang":"en","type":"literal","value":"Use of one treatment modalities; e.g., surgery or radiation or chemotherapy. Can refer to use of two or more chemotherapeutic agents. Can refer to use of two or more radiotherapy modalities (e.g. a combination of brachytherapy and teletherapy)."},"label":{"xml:lang":"en","type":"literal","value":"Unimodality Therapy"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1526"},"def":{"xml:lang":"en","type":"literal","value":"A semi-synthetic, second-generation taxane derived from a compound found in the European yew tree, Taxus baccata. Docetaxel displays potent and broad antineoplastic properties; it binds to and stabilizes tubulin, thereby inhibiting microtubule disassembly which results in cell- cycle arrest at the G2/M phase and cell death. This agent also inhibits pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and displays immunomodulatory and pro-inflammatory properties by inducing various mediators of the inflammatory response. Docetaxel has been studied for use as a radiation-sensitizing agent. (NCI04)"},"label":{"xml:lang":"en","type":"literal","value":"Docetaxel"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C15266"},"def":{"xml:lang":"en","type":"literal","value":"Creation of a surgical opening into the abdominal cavity."},"label":{"xml:lang":"en","type":"literal","value":"Laparotomy"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C15329"},"def":{"xml:lang":"en","type":"literal","value":"A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery."},"label":{"xml:lang":"en","type":"literal","value":"Surgical Procedure"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C15275"},"def":{"xml:lang":"en","type":"literal","value":"Surgical removal of lymph nodes, usually done to assess the spread of cancer."},"label":{"xml:lang":"en","type":"literal","value":"Lymphadenectomy"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C15305"},"def":{"xml:lang":"en","type":"literal","value":"The excision of part or all of a lung."},"label":{"xml:lang":"en","type":"literal","value":"Pneumonectomy"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C15655"},"def":{"xml:lang":"en","type":"literal","value":"Surgery performed on the thoracic organs, most commonly the lungs and the heart."},"label":{"xml:lang":"en","type":"literal","value":"Thoracic Surgical Procedure"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C49236"},"def":{"xml:lang":"en","type":"literal","value":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process."},"label":{"xml:lang":"en","type":"literal","value":"Therapeutic Procedure"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C15358"},"def":{"xml:lang":"en","type":"literal","value":"A non-surgical procedure that was developed to deliver one or several maximum dose targeted radiation treatments for cancers in the brain or spine."},"label":{"xml:lang":"en","type":"literal","value":"Stereotactic Radiosurgery"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C15360"},"def":{"xml:lang":"en","type":"literal","value":"Chemotherapy that is administered subsequent to the main treatment plan to minimize or prevent disease recurrence."},"label":{"xml:lang":"en","type":"literal","value":"Adjuvant Chemotherapy"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C15632"},"def":{"xml:lang":"en","type":"literal","value":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases."},"label":{"xml:lang":"en","type":"literal","value":"Chemotherapy"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C15382"},"def":{"xml:lang":"en","type":"literal","value":"A treatment using gamma rays, a type of high-energy radiation that can be tightly focused on small tumors or other lesions in the head or neck, so very little normal tissue receives radiation. The gamma rays are aimed at the tumor from many different angles at once, and deliver a large dose of radiation exactly to the tumor in one treatment session. This procedure is a type of stereotactic radiosurgery."},"label":{"xml:lang":"en","type":"literal","value":"Gamma Knife"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C15654"},"def":{"xml:lang":"en","type":"literal","value":"Dividing the total dose of radiation therapy into several smaller, equal doses delivered over a period of several days."},"label":{"xml:lang":"en","type":"literal","value":"Fractionation"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C15665"},"def":{"xml:lang":"en","type":"literal","value":"Treatment given as a first step to shrink a tumor before the main treatment, which is usually surgery, is given. Examples of neoadjuvant therapy include chemotherapy, radiation therapy, and hormone therapy. It is a type of induction therapy."},"label":{"xml:lang":"en","type":"literal","value":"Neoadjuvant Therapy"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C15688"},"def":{"xml:lang":"en","type":"literal","value":"Continuation of treatment for an extended period of time to prevent relapse."},"label":{"xml:lang":"en","type":"literal","value":"Maintenance Therapy"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C16033"},"def":{"xml:lang":"en","type":"literal","value":"The activity of monitoring a person's health over time after treatment."},"label":{"xml:lang":"en","type":"literal","value":"Follow-up"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C16035"},"def":{"xml:lang":"en","type":"literal","value":"A process by which a dose of radiation is automatically shaped to closely conform to the entire volume of the tumor, so that surrounding normal tissue is spared and treatment toxicity is decreased."},"label":{"xml:lang":"en","type":"literal","value":"3-Dimensional Conformal Radiation Therapy"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C16120"},"def":{"xml:lang":"en","type":"literal","value":"Surgery performed on any part of the abdominal region of the body."},"label":{"xml:lang":"en","type":"literal","value":"Abdominal Surgical Procedure"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C16135"},"def":{"xml:lang":"en","type":"literal","value":"An advanced form of 3-Dimensional Conformal Radiation Therapy (3D CRT) that involves the use of varying intensities of small radiation beams to produce dosage distributions that are more precise than those possible with 3D CRT."},"label":{"xml:lang":"en","type":"literal","value":"Intensity-Modulated Radiation Therapy"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C16180"},"def":{"xml:lang":"en","type":"literal","value":"Surgery for rectal cancer involving precise removal of an intact mesorectal envelope with tumor-free margins. Associated with local recurrence rates below 5% in clinical trials."},"label":{"xml:lang":"en","type":"literal","value":"Total Mesorectal Excision"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C64982"},"label":{"xml:lang":"en","type":"literal","value":"Therapeutic Surgical Procedure"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C16358"},"def":{"xml:lang":"en","type":"literal","value":"A general indicator of the body fat an individual is carrying based upon the ratio of weight to height."},"label":{"xml:lang":"en","type":"literal","value":"Body Mass Index"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T201"},"def":{"xml:lang":"en","type":"literal","value":"An observable or measurable property or state of an organism of clinical interest."},"label":{"xml:lang":"en","type":"literal","value":"Clinical Attribute"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C16457"},"def":{"xml:lang":"en","type":"literal","value":"The coexistence of two or more disease processes."},"label":{"xml:lang":"en","type":"literal","value":"Comorbidity"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T047"},"def":{"xml:lang":"en","type":"literal","value":"A condition which alters or interferes with a normal process, state, or activity of an organism. It is usually characterized by the abnormal functioning of one or more of the host's systems, parts, or organs. Included here is a complex of symptoms descriptive of a disorder."},"label":{"xml:lang":"en","type":"literal","value":"Disease or Syndrome"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C16493"},"def":{"xml:lang":"en","type":"literal","value":"The person or authoritative body who provided the information."},"label":{"xml:lang":"en","type":"literal","value":"Data Source"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T080"},"def":{"xml:lang":"en","type":"literal","value":"A concept which is an assessment of some quality, rather than a direct measurement."},"label":{"xml:lang":"en","type":"literal","value":"Qualitative Concept"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C16809"},"def":{"xml:lang":"en","type":"literal","value":"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders."},"label":{"xml:lang":"en","type":"literal","value":"Magnetic Resonance Imaging"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1723"},"def":{"xml:lang":"en","type":"literal","value":"A recombinant, chimeric monoclonal antibody directed against the epidermal growth factor (EGFR) with antineoplastic activity. Cetuximab binds to the extracellular domain of the EGFR, thereby preventing the activation and subsequent dimerization of the receptor; the decrease in receptor activation and dimerization may result in an inhibition in signal transduction and anti-proliferative effects. This agent may inhibit EGFR-dependent primary tumor growth and metastasis. EGFR is overexpressed on the cell surfaces of various solid tumors."},"label":{"xml:lang":"en","type":"literal","value":"Cetuximab"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C17357"},"def":{"xml:lang":"en","type":"literal","value":"The assemblage of properties that distinguish people on the basis of the societal roles expected for the two sexes."},"label":{"xml:lang":"en","type":"literal","value":"Gender"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T032"},"def":{"xml:lang":"en","type":"literal","value":"A property of the organism or its major parts."},"label":{"xml:lang":"en","type":"literal","value":"Organism Attribute"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C17427"},"def":{"xml:lang":"en","type":"literal","value":"Discontinuation of the habit of smoking."},"label":{"xml:lang":"en","type":"literal","value":"Smoking Cessation"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T055"},"def":{"xml:lang":"en","type":"literal","value":"Behavior exhibited by a human or an animal that is not a direct result of interaction with other members of the species, but which may have an effect on others."},"label":{"xml:lang":"en","type":"literal","value":"Individual Behavior"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C17610"},"def":{"xml:lang":"en","type":"literal","value":"A small volume of blood removed for testing or storage."},"label":{"xml:lang":"en","type":"literal","value":"Blood Sample"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C70699"},"def":{"xml:lang":"en","type":"literal","value":"Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products."},"label":{"xml:lang":"en","type":"literal","value":"Biospecimen"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1794"},"label":{"xml:lang":"en","type":"literal","value":"Capecitabine"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C18009"},"def":{"xml:lang":"en","type":"literal","value":"A tumor sample, or entire tumor that is removed for microscopic examination."},"label":{"xml:lang":"en","type":"literal","value":"Tumor Tissue"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C19697"},"def":{"xml:lang":"en","type":"literal","value":"A piece of tissue removed from an organism for examination, analysis, or propagation."},"label":{"xml:lang":"en","type":"literal","value":"Tissue Sample"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T060"},"def":{"xml:lang":"en","type":"literal","value":"A procedure, method, or technique used to determine the nature or identity of a disease or disorder. This excludes procedures which are primarily carried out on specimens in a laboratory."},"label":{"xml:lang":"en","type":"literal","value":"Diagnostic Procedure"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1804"},"def":{"xml:lang":"en","type":"literal","value":"An anticancer drug that stops tumor cells from growing by blocking the ability of cells to make DNA. It belongs to the family of drugs called thymidylate synthase inhibitors."},"label":{"xml:lang":"en","type":"literal","value":"Raltitrexed"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1820"},"def":{"xml:lang":"en","type":"literal","value":"A methylazirinopyrroloindoledione antineoplastic antibiotic isolated from the bacterium Streptomyces caespitosus and other Streptomyces bacterial species. Bioreduced mitomycin C generates oxygen radicals, alkylates DNA, and produces interstrand DNA cross-links, thereby inhibiting DNA synthesis. Preferentially toxic to hypoxic cells, mitomycin C also inhibits RNA and protein synthesis at high concentrations."},"label":{"xml:lang":"en","type":"literal","value":"Mitomycin"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T195"},"def":{"xml:lang":"en","type":"literal","value":"A pharmacologically active compound produced by growing microorganisms which kill or inhibit growth of other microorganisms."},"label":{"xml:lang":"en","type":"literal","value":"Antibiotic"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T093"},"def":{"xml:lang":"en","type":"literal","value":"An established organization which carries out specific functions related to health care delivery or research in the life sciences."},"label":{"xml:lang":"en","type":"literal","value":"Health Care Related Organization"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C19796"},"def":{"xml:lang":"en","type":"literal","value":"An indication of a person's current tobacco and nicotine consumption as well as some indication of smoking history."},"label":{"xml:lang":"en","type":"literal","value":"Smoking Status"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C20188"},"def":{"xml:lang":"en","type":"literal","value":"A set of concepts that results from or is influenced by criteria or activities associated with the social environment of a person."},"label":{"xml:lang":"en","type":"literal","value":"Social Circumstances"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T077"},"def":{"xml:lang":"en","type":"literal","value":"A broad type for grouping abstract entities or concepts."},"label":{"xml:lang":"en","type":"literal","value":"Conceptual Entity"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C20200"},"def":{"xml:lang":"en","type":"literal","value":"The result of an action."},"label":{"xml:lang":"en","type":"literal","value":"Outcome"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2039"},"def":{"xml:lang":"en","type":"literal","value":"A recombinant humanized monoclonal antibody directed against the vascular endothelial growth factor (VEGF), a pro-angiogenic cytokine. Bevacizumab binds to VEGF and inhibits VEGF receptor binding, thereby preventing the growth and maintenance of tumor blood vessels."},"label":{"xml:lang":"en","type":"literal","value":"Bevacizumab"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C21514"},"def":{"xml:lang":"en","type":"literal","value":"Terms used to indicate units of time or other terms associated with time."},"label":{"xml:lang":"en","type":"literal","value":"Temporal Qualifier"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C247"},"def":{"xml:lang":"en","type":"literal","value":"Any substance that inhibits angiotensin-converting enzyme (ACE), an enzyme that catalyzes the conversion of angiotensin I to angiotensin II. Inhibition of ACE results in a reduction in angiotensin II and angiotensin II-induced aldosterone secretion, causing vasodilation and natriuresis."},"label":{"xml:lang":"en","type":"literal","value":"ACE Inhibitor"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T120"},"def":{"xml:lang":"en","type":"literal","value":"A chemical viewed from the perspective of its functional characteristics or pharmacological activities."},"label":{"xml:lang":"en","type":"literal","value":"Chemical Viewed Functionally"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T040"},"def":{"xml:lang":"en","type":"literal","value":"A physiologic function of the organism as a whole, of multiple organ systems, or of multiple organs or tissues."},"label":{"xml:lang":"en","type":"literal","value":"Organism Function"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25164"},"def":{"xml:lang":"en","type":"literal","value":"The particular day, month and year an event has happened or will happen."},"label":{"xml:lang":"en","type":"literal","value":"Date"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T079"},"def":{"xml:lang":"en","type":"literal","value":"A concept which pertains to time or duration."},"label":{"xml:lang":"en","type":"literal","value":"Temporal Concept"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T082"},"def":{"xml:lang":"en","type":"literal","value":"A location, region, or space, generally having definite boundaries."},"label":{"xml:lang":"en","type":"literal","value":"Spatial Concept"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T016"},"def":{"xml:lang":"en","type":"literal","value":"Modern man, the only remaining species of the Homo genus."},"label":{"xml:lang":"en","type":"literal","value":"Human"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25208"},"def":{"xml:lang":"en","type":"literal","value":"The vertical force exerted by a mass as a result of gravity."},"label":{"xml:lang":"en","type":"literal","value":"Weight"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100246"},"def":{"xml:lang":"en","type":"literal","value":"An abstract concept which is any specification of how many or how much of something there is."},"label":{"xml:lang":"en","type":"literal","value":"Quantity"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25228"},"def":{"xml:lang":"en","type":"literal","value":"Being or located on or directed toward the side of the body to the east when facing north."},"label":{"xml:lang":"en","type":"literal","value":"Right"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25229"},"def":{"xml:lang":"en","type":"literal","value":"Being or located on or directed toward the side of the body to the west when facing north."},"label":{"xml:lang":"en","type":"literal","value":"Left"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25330"},"def":{"xml:lang":"en","type":"literal","value":"The period of time during which something continues."},"label":{"xml:lang":"en","type":"literal","value":"Duration"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25334"},"def":{"xml:lang":"en","type":"literal","value":"The linear extent in space from one end of something to the other end, or the extent of something from beginning to end."},"label":{"xml:lang":"en","type":"literal","value":"Length"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25335"},"def":{"xml:lang":"en","type":"literal","value":"The amount of three dimensional space occupied by an object or the capacity of a space or container."},"label":{"xml:lang":"en","type":"literal","value":"Volume"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25347"},"def":{"xml:lang":"en","type":"literal","value":"The vertical measurement or distance from the base to the top of an object; the vertical dimension of extension."},"label":{"xml:lang":"en","type":"literal","value":"Height"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25364"},"def":{"xml:lang":"en","type":"literal","value":"One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing."},"label":{"xml:lang":"en","type":"literal","value":"Identifier"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25419"},"def":{"xml:lang":"en","type":"literal","value":"The transitional zone between the moist, hairless, modified skin of the anal canal and the perianal skin."},"label":{"xml:lang":"en","type":"literal","value":"Anal Margin"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25463"},"def":{"xml:lang":"en","type":"literal","value":"To determine the number or amount of something; the result of this activity."},"label":{"xml:lang":"en","type":"literal","value":"Count"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25488"},"def":{"xml:lang":"en","type":"literal","value":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time."},"label":{"xml:lang":"en","type":"literal","value":"Dose"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25514"},"def":{"xml:lang":"en","type":"literal","value":"A part, a fragment of a whole."},"label":{"xml:lang":"en","type":"literal","value":"Fraction"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25563"},"def":{"xml:lang":"en","type":"literal","value":"A boundary line or the area immediately inside the boundary."},"label":{"xml:lang":"en","type":"literal","value":"Margin"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25621"},"def":{"xml:lang":"en","type":"literal","value":"Any system designed to expedite the sorting and delivery of mail by assigning a series of alphanumeric codes to each delivery area. Also used to refer to any individual delivery area code."},"label":{"xml:lang":"en","type":"literal","value":"Postal Code"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25653"},"def":{"xml:lang":"en","type":"literal","value":"Capable of being removed by surgery."},"label":{"xml:lang":"en","type":"literal","value":"Resectable"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25717"},"def":{"xml:lang":"en","type":"literal","value":"The state or condition of being living or deceased; also includes the case where the vital status is unknown."},"label":{"xml:lang":"en","type":"literal","value":"Vital Status"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T169"},"def":{"xml:lang":"en","type":"literal","value":"A concept which is of interest because it pertains to the carrying out of a process or activity."},"label":{"xml:lang":"en","type":"literal","value":"Functional Concept"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26871"},"def":{"xml:lang":"en","type":"literal","value":"A non-neoplastic or neoplastic disorder that affects the respiratory system. Representative examples include pneumonia, chronic obstructive pulmonary disease, pulmonary failure, lung adenoma, lung carcinoma, and tracheal carcinoma."},"label":{"xml:lang":"en","type":"literal","value":"Respiratory System Disorder"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C27672"},"def":{"xml:lang":"en","type":"literal","value":"A non-neoplastic disorder that affects the heart and/or vessels. Representative examples include myocardial infarction, endocarditis, arteriosclerosis, thrombosis, and lymphedema."},"label":{"xml:lang":"en","type":"literal","value":"Non-Neoplastic Cardiovascular Disorder"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2931"},"def":{"xml:lang":"en","type":"literal","value":"A non-neoplastic or neoplastic disorder affecting the heart or the vessels (arteries, veins and lymph vessels). Representative examples of non-neoplastic cardiovascular disorders are endocarditis and hypertension. Representative examples of neoplastic cardiovascular disorders are endocardial myxoma and angiosarcoma."},"label":{"xml:lang":"en","type":"literal","value":"Cardiovascular Disorder"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C27966"},"def":{"xml:lang":"en","type":"literal","value":"Invasive cancer confined to the original anatomic site of growth without lymph node involvement."},"label":{"xml:lang":"en","type":"literal","value":"Stage I"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C27970"},"def":{"xml:lang":"en","type":"literal","value":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites."},"label":{"xml:lang":"en","type":"literal","value":"Stage III"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C27971"},"def":{"xml:lang":"en","type":"literal","value":"Cancer that has spread to distant anatomic sites beyond its original site of growth."},"label":{"xml:lang":"en","type":"literal","value":"Stage IV"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C27976"},"def":{"xml:lang":"en","type":"literal","value":"Invasive cancer confined to the original anatomic site of growth without lymph node involvement. The definition of stage IB depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IB is defined as follows: (T0, N1mi, M0); (T1, N1mi, M0). T0: No evidence of primary tumor. T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. N1mi: Nodal micrometastases. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for bone cancer, stage IB is defined as follows: (T2, N0, M0, G1, G2, GX); (T3, N0, M0, G1, G2, GX). T2: Tumor more than 8 cm in greatest dimension. T3: Discontinuous tumors in the primary bone site. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated-low grade. G2: Moderately differentiated-low grade. GX: Grade cannot be assessed. (partially adapted from AJCC 7th ed.)"},"label":{"xml:lang":"en","type":"literal","value":"Stage IB"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C27977"},"def":{"xml:lang":"en","type":"literal","value":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites. The definition of stage IIIA depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIIA is defined as follows: (T0, N2, M0); (T1, N2, M0); (T2, N2, M0); (T3, N1, M0); (T3, N2, M0). T0: No evidence of primary tumor. T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension. T3: Tumor more than 50 mm in greatest dimension. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N2: Metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed or matted; or in clinically detected ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastases. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for cervical cancer, stage IIIA is defined as follows: T3a, N0, M0. T3a: Tumor involves lower third of vagina, no extension to pelvic wall. N0: No regional lymph node metastasis. M0: No distant metastasis. (partially adapted from AJCC 7th ed.)"},"label":{"xml:lang":"en","type":"literal","value":"Stage IIIA"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C27978"},"def":{"xml:lang":"en","type":"literal","value":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites. The definition of stage IIIB depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIIB is defined as follows: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0). T4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules). N0: No regional lymph node metastasis. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N2: Metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed or matted; or in clinically detected ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastases. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for cervical cancer, stage IIIB is defined as follows: (T3b, Any N, M0); (T1-3, N1, M0). T3: Tumor extends to pelvic wall and/or involves lower third of vagina, and/or causes hydronephrosis or non-functioning kidney. T3b: Tumor extends to pelvic wall and/or causes hydronephrosis or non-functioning kidney. N1: Regional lymph node metastasis. M0: No distant metastasis. (partially adapted from AJCC 7th ed.)"},"label":{"xml:lang":"en","type":"literal","value":"Stage IIIB"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C27979"},"def":{"xml:lang":"en","type":"literal","value":"Cancer that has spread to distant anatomic sites beyond its original site of growth. The definition of stage IVA depends on the particular type of cancer that it refers to; for example, for bone cancer, stage IVA is defined as follows: Any T, N0, M1a, Any G. N0: No regional lymph node metastasis. M1a: Distant metastasis to lung; for vaginal cancer, stage IVA is defined as follows: T4, Any N, M0. T4: Tumor invades mucosa of the bladder or rectum and/or extends beyond the true pelvis (bullous edema is not sufficient evidence to classify a tumor as T4). M0: No distant metastasis. (partially adapted from AJCC 7th ed.)"},"label":{"xml:lang":"en","type":"literal","value":"Stage IVA"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C27980"},"def":{"xml:lang":"en","type":"literal","value":"Cancer that has spread to distant anatomic sites beyond its original site of growth. The definition of stage IVB depends on the particular type of cancer that it refers to; for example, for bone cancer, stage IVB is defined as follows: (Any T, N1, Any M, Any G); (Any T, Any N, M1b, Any G). N1: Regional lymph node metastasis. M1b: Metastasis to other distant sites; for vaginal cancer, stage IVB is defined as follows: Any T, Any N, M1. M1: Distant metastasis. (partially adapted from AJCC 7th ed.)"},"label":{"xml:lang":"en","type":"literal","value":"Stage IVB"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C27982"},"def":{"xml:lang":"en","type":"literal","value":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites. The definition of stage IIIC depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIIC is defined as follows: Any T, N3, M0. N3: Metastases in ipsilateral infraclavicular (level III) axillary lymph nodes(s) with or without level I, II axillary lymph node involvement; or in clinically detected ipsilateral internal mammary lymph node(s) with clinically evident level I, II axillary lymph node metastases; or metastases in ipsilateral supraclavicular lymph node(s) with or without axillary or internal mammary lymph node involvement. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for appendix carcinoma, stage IIIC is defined as follows: Any T, N2, M0. N2: Metastasis in four or more regional lymph nodes. M0: No distant metastasis. (partially adapted from AJCC 7th ed.)"},"label":{"xml:lang":"en","type":"literal","value":"Stage IIIC"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C27983"},"def":{"xml:lang":"en","type":"literal","value":"A stage term referring to invasive cervical and lung cancer. For cervical cancer, it includes: T1a1, N0, M0. T1a1: Tumor with stromal invasion 3.0 mm or less in depth and 7.0 mm or less in horizontal spread. N0: No regional lymph node metastasis. M0: No distant metastasis. For lung cancer, it includes: (T1mi, N0, M0); (T1a, N0, M0). T1mi: Minimally invasive adenocarcinoma: adenocarcinoma (3 cm or less in greatest dimension) with a predominantly lepidic pattern and 5 mm or less invasion in greatest dimension. T1a: Tumor measuring 1 cm or less in greatest dimension. A superficial, spreading tumor of any size whose invasive component is limited to the bronchial wall and may extend proximal to the main bronchus also is classified as T1a, but these tumors are uncommon. N0: No regional lymph node metastasis. M0: No distant metastasis. (adapted from AJCC)"},"label":{"xml:lang":"en","type":"literal","value":"Stage IA1"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C27984"},"def":{"xml:lang":"en","type":"literal","value":"A stage term referring to invasive cervical cancer and invasive lung cancer. For cervical cancer, it includes: T1a2, N0, M0. T1a2: Tumor with stromal invasion more than 3.0 mm and not more than 5.0 mm with a horizontal spread 7.0 mm or less. N0: No regional lymph node metastasis. M0: No distant metastasis. For lung cancer, it includes: T1b, N0, M0. T1b: Tumor measuring more than 1 cm but 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (adapted from AJCC)"},"label":{"xml:lang":"en","type":"literal","value":"Stage IA2"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C27967"},"def":{"xml:lang":"en","type":"literal","value":"Invasive cancer more extensive than stage I, usually involving local lymph nodes without spread to distant anatomic sites. The definition of stage IIA depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIA is defined as follows: (T0, N1, M0); (T1, N1, M0); (T2, N0, M0). T0: No evidence of primary tumor. T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N0: No regional lymph node metastasis. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for bone cancer, stage IIA is defined as follows: T1, N0, M0, G3, G4. T1: Tumor 8 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G3: Poorly differentiated. G4: Undifferentiated. (partially adapted from AJCC 7th ed.)"},"label":{"xml:lang":"en","type":"literal","value":"Stage IIA"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C28054"},"def":{"xml:lang":"en","type":"literal","value":"Invasive cancer more extensive than stage I, usually involving local lymph nodes without spread to distant anatomic sites."},"label":{"xml:lang":"en","type":"literal","value":"Stage II"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C95805"},"def":{"xml:lang":"en","type":"literal","value":"A term that refers to a TNM finding of a primary tumor limited to the site of growth and indicates microinvasion only."},"label":{"xml:lang":"en","type":"literal","value":"T1mi Stage Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48885"},"label":{"xml:lang":"en","type":"literal","value":"Generic Primary Tumor TNM Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C27968"},"def":{"xml:lang":"en","type":"literal","value":"Invasive cancer more extensive than stage I, usually involving local lymph nodes without spread to distant anatomic sites. The definition of stage IIB depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIB is defined as follows: (T2, N1, MO); (T3, NO, MO). T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension. T3: Tumor more than 50 mm in greatest dimension. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N0: No regional lymph node metastasis. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for bone cancer, stage IIB is defined as follows: T2, N0, M0, G3, G4. T2: Tumor more than 8 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G3: Poorly differentiated. G4: Undifferentiated. (partially adapted from AJCC 7th ed.)"},"label":{"xml:lang":"en","type":"literal","value":"Stage IIB"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C28051"},"def":{"xml:lang":"en","type":"literal","value":"Cancer confined to the epithelium without invasion of the basement membrane."},"label":{"xml:lang":"en","type":"literal","value":"Stage 0"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C28077"},"def":{"xml:lang":"en","type":"literal","value":"A morphologic qualifier indicating that a cancerous lesion is well differentiated."},"label":{"xml:lang":"en","type":"literal","value":"Grade 1"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C28078"},"def":{"xml:lang":"en","type":"literal","value":"A morphologic qualifier indicating that a cancerous lesion is moderately differentiated."},"label":{"xml:lang":"en","type":"literal","value":"Grade 2"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C28079"},"def":{"xml:lang":"en","type":"literal","value":"A morphologic qualifier indicating that a cancerous lesion is poorly differentiated."},"label":{"xml:lang":"en","type":"literal","value":"Grade 3"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C28082"},"def":{"xml:lang":"en","type":"literal","value":"A morphologic qualifier indicating that a cancerous lesion is undifferentiated."},"label":{"xml:lang":"en","type":"literal","value":"Grade 4"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C28384"},"def":{"xml:lang":"en","type":"literal","value":"The total volume of all macroscopic tumor tumors in the body. It is the sum of the primary tumor, macroscopic lymph nodes metastases and distant metastases."},"label":{"xml:lang":"en","type":"literal","value":"Tumor Burden"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C94515"},"def":{"xml:lang":"en","type":"literal","value":"The size of a cancer measured by the amount of space taken up by the tumor. For example, the tumor volume of prostate cancer is the percentage of the prostate taken up by the tumor."},"label":{"xml:lang":"en","type":"literal","value":"Tumor Volume"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2852"},"def":{"xml:lang":"en","type":"literal","value":"A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma."},"label":{"xml:lang":"en","type":"literal","value":"Adenocarcinoma"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C28554"},"def":{"xml:lang":"en","type":"literal","value":"The absence of life or state of being dead. (NCI)"},"label":{"xml:lang":"en","type":"literal","value":"Death"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2926"},"def":{"xml:lang":"en","type":"literal","value":"A group of at least three distinct histological types of lung cancer, including squamous cell carcinoma, adenocarcinoma, and large cell carcinoma.  Non-small cell lung carcinomas have a poor response to conventional chemotherapy."},"label":{"xml:lang":"en","type":"literal","value":"Non-Small Cell Lung Carcinoma"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C7377"},"def":{"xml:lang":"en","type":"literal","value":"A primary or metastatic malignant neoplasm involving the lung."},"label":{"xml:lang":"en","type":"literal","value":"Malignant Lung Neoplasm"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2929"},"def":{"xml:lang":"en","type":"literal","value":"A carcinoma arising from squamous epithelial cells. Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells. Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells. Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma."},"label":{"xml:lang":"en","type":"literal","value":"Squamous Cell Carcinoma"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C3780"},"def":{"xml:lang":"en","type":"literal","value":"A malignant epithelial neoplasm composed of large, atypical cells."},"label":{"xml:lang":"en","type":"literal","value":"Large Cell Carcinoma"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C65151"},"def":{"xml:lang":"en","type":"literal","value":"A malignant epithelial neoplasm characterized by the absence of neoplastic small epithelial cells. A representative example is the lung non-small cell carcinoma."},"label":{"xml:lang":"en","type":"literal","value":"Non-Small Cell Carcinoma"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2985"},"def":{"xml:lang":"en","type":"literal","value":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization."},"label":{"xml:lang":"en","type":"literal","value":"Diabetes Mellitus"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C3009"},"def":{"xml:lang":"en","type":"literal","value":"A non-neoplastic or neoplastic disorder that affects the endocrine system. Representative examples of non-neoplastic disorders include diabetes mellitus, hyperthyroidism, and adrenal gland insufficiency. Representative examples of neoplastic disorders include carcinoid tumor, neuroendocrine carcinoma, and pheochromocytoma."},"label":{"xml:lang":"en","type":"literal","value":"Endocrine System Disorder"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T046"},"def":{"xml:lang":"en","type":"literal","value":"A disordered process, activity, or state of the organism as a whole, of a body system or systems, or of multiple organs or tissues. Included here are normal responses to a negative stimulus as well as patholologic conditions or states that are less specific than a disease. Pathologic functions frequently have systemic effects."},"label":{"xml:lang":"en","type":"literal","value":"Pathologic Function"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C3367"},"def":{"xml:lang":"en","type":"literal","value":"Clinical, laboratory or molecular evidence, or absence of evidence of disease."},"label":{"xml:lang":"en","type":"literal","value":"Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C3445"},"def":{"xml:lang":"en","type":"literal","value":"A reduction in total body weight."},"label":{"xml:lang":"en","type":"literal","value":"Weight Loss"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C35755"},"def":{"xml:lang":"en","type":"literal","value":"A non-neoplastic disorder that affects the respiratory system. Representative examples include pneumonia, chronic obstructive pulmonary disease, pulmonary failure, tracheitis, and tracheal agenesis."},"label":{"xml:lang":"en","type":"literal","value":"Non-Neoplastic Respiratory Disorder"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C3577"},"def":{"xml:lang":"en","type":"literal","value":"The spread of a malignant neoplasm to the lung. This may be from a primary lung malignant neoplasm, or from a malignant neoplasm at a distant site."},"label":{"xml:lang":"en","type":"literal","value":"Metastatic Malignant Neoplasm in the Lung"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C36263"},"def":{"xml:lang":"en","type":"literal","value":"A malignant tumor that has spread from its original (primary) site of growth to another site close to or distant from the primary site."},"label":{"xml:lang":"en","type":"literal","value":"Metastatic Malignant Neoplasm"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C3580"},"def":{"xml:lang":"en","type":"literal","value":"The spread of a malignant neoplasm from a primary site to the skeletal system. The majority of metastatic neoplasms to the bone are carcinomas."},"label":{"xml:lang":"en","type":"literal","value":"Metastatic Malignant Neoplasm in the Bone"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C35933"},"def":{"xml:lang":"en","type":"literal","value":"A malignant tumor that has spread from its original (primary) site of growth to another site distant from the primary site."},"label":{"xml:lang":"en","type":"literal","value":"Distantly Metastatic Malignant Neoplasm"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C35934"},"def":{"xml:lang":"en","type":"literal","value":"Refers to cancer that has grown beyond the original (primary) tumor to nearby lymph nodes or organs and tissues."},"label":{"xml:lang":"en","type":"literal","value":"Locally Metastatic Malignant Neoplasm"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C36255"},"def":{"xml:lang":"en","type":"literal","value":"A neoplasm that arises from a pre-existing lower grade lesion, or as a result of a primary lesion that has spread to secondary sites, or due to a complication of a cancer treatment."},"label":{"xml:lang":"en","type":"literal","value":"Secondary Neoplasm"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C376"},"def":{"xml:lang":"en","type":"literal","value":"An alkylating-like inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity. Cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These cross-links result in apoptosis and cell growth inhibition."},"label":{"xml:lang":"en","type":"literal","value":"Cisplatin"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C37901"},"def":{"xml:lang":"en","type":"literal","value":"A position in relation to its surroundings."},"label":{"xml:lang":"en","type":"literal","value":"Site"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C37987"},"def":{"xml:lang":"en","type":"literal","value":"The organic phenomenon that distinguishes living organisms from nonliving ones; showing characteristics of life."},"label":{"xml:lang":"en","type":"literal","value":"Life"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C38081"},"def":{"xml:lang":"en","type":"literal","value":"A broad range of tests that are performed to assess how well lungs inhale and exhale air and how efficiently they transfer oxygen into the blood."},"label":{"xml:lang":"en","type":"literal","value":"Pulmonary Function Test"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C38083"},"def":{"xml:lang":"en","type":"literal","value":"A measurement of carbon monoxide (CO) transfer from inspired gas to pulmonary capillary blood. During the test, the subject inspires a gas containing CO and one or more tracer gases to allow determination of the gas exchanging capability of the lungs."},"label":{"xml:lang":"en","type":"literal","value":"Carbon Monoxide Diffusing Capability Test"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C38084"},"def":{"xml:lang":"en","type":"literal","value":"A test of lung function, the FEV1 is the volume exhaled during the first second of a forced expiratory maneuver started from the level of total lung capacity. It is the most frequently used index for assessing bronchoconstriction or bronchodilatation."},"label":{"xml:lang":"en","type":"literal","value":"Forced Expiratory Volume in 1 Second"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C3813"},"def":{"xml:lang":"en","type":"literal","value":"A malignant neoplasm that has spread to the brain from another anatomic site or system. The majority are carcinomas (usually lung or breast carcinomas)."},"label":{"xml:lang":"en","type":"literal","value":"Metastatic Malignant Neoplasm in the Brain"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C38155"},"def":{"xml:lang":"en","type":"literal","value":"The return of a disease after a period of remission."},"label":{"xml:lang":"en","type":"literal","value":"Recurrent Disease"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C3910"},"def":{"xml:lang":"en","type":"literal","value":"A molecular or cytogenic abnormality which occurs in either human disease states or disease models."},"label":{"xml:lang":"en","type":"literal","value":"Molecular Abnormality"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T049"},"def":{"xml:lang":"en","type":"literal","value":"A pathologic function inherent to cells, parts of cells, or molecules."},"label":{"xml:lang":"en","type":"literal","value":"Cell or Molecular Dysfunction"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C3915"},"def":{"xml:lang":"en","type":"literal","value":"A neuroendocrine carcinoma composed of small malignant cells which are often said to resemble \"oat cells\" under the microscope. Small cell carcinoma most often affects the lungs. Clinically, this is often a rapidly growing cancer that spreads to distant sites early."},"label":{"xml:lang":"en","type":"literal","value":"Small Cell Carcinoma"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C40413"},"def":{"xml:lang":"en","type":"literal","value":"Diagnostic tests fail to detect presence of disease."},"label":{"xml:lang":"en","type":"literal","value":"No Evidence of Disease"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C40430"},"label":{"xml:lang":"en","type":"literal","value":"BRAF Gene Mutation"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C405"},"def":{"xml:lang":"en","type":"literal","value":"A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities. In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death."},"label":{"xml:lang":"en","type":"literal","value":"Cyclophosphamide"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C41009"},"def":{"xml:lang":"en","type":"literal","value":"A term that helps define and render a concept unique."},"label":{"xml:lang":"en","type":"literal","value":"Qualifier"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C41331"},"def":{"xml:lang":"en","type":"literal","value":"Any unfavorable or unintended symptom, sign, or disease including an abnormal laboratory finding) temporally associated with the use of a medical treatment or procedure that may or may not be considered related to the medical treatment or procedure. Such events can be intervention related, dose related, route related, patient related, or caused by an interaction with another drug(s) or procedure(s)."},"label":{"xml:lang":"en","type":"literal","value":"Adverse Event"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C41361"},"label":{"xml:lang":"en","type":"literal","value":"KRAS Gene Mutation"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C45313"},"def":{"xml:lang":"en","type":"literal","value":"One of the portions into which something is regarded as divided and which together constitute a whole."},"label":{"xml:lang":"en","type":"literal","value":"Part"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C456"},"def":{"xml:lang":"en","type":"literal","value":"An anthracycline antibiotic with antineoplastic activity. Doxorubicin, isolated from the bacterium Streptomyces peucetius var. caesius, is the hydroxylated congener of daunorubicin. Doxorubicin intercalates between base pairs in the DNA helix, thereby preventing DNA replication and ultimately inhibiting protein synthesis. Additionally, doxorubicin inhibits topoisomerase II which results in an increased and stabilized cleavable enzyme-DNA linked complex during DNA replication and subsequently prevents the ligation of the nucleotide strand after double-strand breakage. Doxorubicin also forms oxygen free radicals resulting in cytotoxicity secondary to lipid peroxidation of cell membrane lipids; the formation of oxygen free radicals also contributes to the toxicity of the anthracycline antibiotics, namely the cardiac and cutaneous vascular effects."},"label":{"xml:lang":"en","type":"literal","value":"Doxorubicin"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C46085"},"def":{"xml:lang":"en","type":"literal","value":"The distance between the radial extent of the tumor and the surgical incision used to excise the tumor. This distance is measured microscopically."},"label":{"xml:lang":"en","type":"literal","value":"Circumferential Resection Margin"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C46109"},"def":{"xml:lang":"en","type":"literal","value":"An individual who reports belonging to the cultural gender role distinction of male."},"label":{"xml:lang":"en","type":"literal","value":"Male Gender"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C46110"},"def":{"xml:lang":"en","type":"literal","value":"An individual who reports belonging to the cultural gender role distinction of female."},"label":{"xml:lang":"en","type":"literal","value":"Female Gender"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C4758"},"def":{"xml:lang":"en","type":"literal","value":"A malignant neoplasm that has spread to the liver from another (primary) anatomic site. Such malignant neoplasms may be carcinomas, lymphomas, melanomas, or sarcomas."},"label":{"xml:lang":"en","type":"literal","value":"Metastatic Malignant Neoplasm in the Liver"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C47850"},"def":{"xml:lang":"en","type":"literal","value":"A term referring to the presence of tumor emboli or tumor masses within lymphatic vessels."},"label":{"xml:lang":"en","type":"literal","value":"Lymphatic Invasion"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48558"},"def":{"xml:lang":"en","type":"literal","value":"Diagnostic tests fail to detect presence of metastatic lesions."},"label":{"xml:lang":"en","type":"literal","value":"No Evidence of Metastatic Disease"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48621"},"def":{"xml:lang":"en","type":"literal","value":"Indicates the absence of tumor cells at the edge of a surgically excised specimen."},"label":{"xml:lang":"en","type":"literal","value":"Negative Surgical Margin"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48699"},"def":{"xml:lang":"en","type":"literal","value":"A distant metastasis TNM finding indicating that there is no evidence of distant metastasis."},"label":{"xml:lang":"en","type":"literal","value":"M0 Stage Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48883"},"label":{"xml:lang":"en","type":"literal","value":"Generic Distant Metastasis TNM Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48700"},"def":{"xml:lang":"en","type":"literal","value":"A clinical and/or pathologic distant metastasis TNM finding indicating the spread of cancer to distant anatomic sites."},"label":{"xml:lang":"en","type":"literal","value":"M1 Stage Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48701"},"def":{"xml:lang":"en","type":"literal","value":"A TNM finding indicating the spread of cancer to distant anatomic sites.  The definition of M1a TNM finding depends on the specific type of cancer that it refers to; for example, for colorectal cancer it refers to metastasis confined to one organ or site (e.g., liver, lung, ovary, nonregional node); for prostate cancer it refers to metastasis to non-regional lymph node(s); for bone cancer it refers to metastasis to the lung."},"label":{"xml:lang":"en","type":"literal","value":"M1a Stage Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48702"},"def":{"xml:lang":"en","type":"literal","value":"A TNM finding indicating the spread of cancer to distant anatomic sites.  The definition of M1b TNM finding depends on the specific type of cancer that it refers to; for example, for colorectal cancer it refers to metastases in more than one organ/site or the peritoneum; for prostate cancer it refers to metastasis to bone(s); for bone cancer it refers to metastasis to distant sites other than lung."},"label":{"xml:lang":"en","type":"literal","value":"M1b Stage Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48703"},"def":{"xml:lang":"en","type":"literal","value":"A TNM finding indicating the spread of cancer to distant anatomic sites. The definition of M1c TNM finding depends on the specific type of cancer that it refers to; for example, for prostate cancer it refers to metastasis to anatomic site(s) other than bone, with or without bone disease; for retinoblastoma it refers to central nervous system metastasis; for melanoma of the uvea it refers to distant metastasis, with the largest diameter of the largest metastasis measuring 8.0 cm or more."},"label":{"xml:lang":"en","type":"literal","value":"M1c Stage Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48704"},"def":{"xml:lang":"en","type":"literal","value":"A distant metastasis TNM finding indicating that the status of distant metastasis cannot be assessed."},"label":{"xml:lang":"en","type":"literal","value":"MX Stage Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48705"},"def":{"xml:lang":"en","type":"literal","value":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis."},"label":{"xml:lang":"en","type":"literal","value":"N0 Stage Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48884"},"label":{"xml:lang":"en","type":"literal","value":"Generic Regional Lymph Nodes TNM Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48706"},"def":{"xml:lang":"en","type":"literal","value":"A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to micrometastases or metastases in 1-3 axillary lymph nodes; for cutaneous melanoma it refers to metastasis in 1 regional lymph node; for colorectal cancer it refers to metastases in 1-3 regional lymph nodes; and for bladder cancer it refers to metastasis in 1 regional lymph node in the true pelvis."},"label":{"xml:lang":"en","type":"literal","value":"N1 Stage Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48714"},"def":{"xml:lang":"en","type":"literal","value":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N3 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 10 or more axillary lymph nodes; for cutaneous melanoma it refers to metastases in 4 or more regional lymph nodes; for gastric cancer it refers to metastases in 7 or more regional lymph nodes; and for bladder cancer it refers to metastases in common iliac lymph nodes."},"label":{"xml:lang":"en","type":"literal","value":"N3 Stage Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48718"},"def":{"xml:lang":"en","type":"literal","value":"A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed."},"label":{"xml:lang":"en","type":"literal","value":"NX Stage Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48719"},"def":{"xml:lang":"en","type":"literal","value":"A primary tumor TNM finding indicating that there is no evidence of primary tumor."},"label":{"xml:lang":"en","type":"literal","value":"T0 Stage Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48720"},"def":{"xml:lang":"en","type":"literal","value":"A clinical and/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth."},"label":{"xml:lang":"en","type":"literal","value":"T1 Stage Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48721"},"def":{"xml:lang":"en","type":"literal","value":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth. The definition of T1a TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that is more than 0.1cm, but not more than 0.5 cm in greatest dimension; for kidney cancer it refers to a primary tumor that is 4 cm or less in greatest dimension; and for thyroid cancer it refers to a primary tumor that is 1 cm or less in greatest dimension."},"label":{"xml:lang":"en","type":"literal","value":"T1a Stage Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48722"},"def":{"xml:lang":"en","type":"literal","value":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth. The definition of T1b TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that is more than 0.5 cm, but not more than 1.0 cm in greatest dimension; for kidney cancer it refers to a primary tumor that is more than 4 cm, but not more than 7 cm in greatest dimension; and for thyroid cancer it refers to a primary tumor that is more than 1 cm but not more than 2 cm in greatest dimension."},"label":{"xml:lang":"en","type":"literal","value":"T1b Stage Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48723"},"def":{"xml:lang":"en","type":"literal","value":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth. The definition of T1c TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that is more than 1.0 cm, but not more than 2.0 cm in greatest dimension; for uterine corpus cancer it refers to a primary tumor that invades one-half or more of the myometrium; and for melanoma of the iris it refers to a primary tumor limited to the iris with secondary glaucoma."},"label":{"xml:lang":"en","type":"literal","value":"T1c Stage Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48724"},"def":{"xml:lang":"en","type":"literal","value":"A general term that refers to a TNM finding of primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to primary tumor that is more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for cutaneous melanoma it refers to primary tumor that is 1.01 to 2 mm in thickness, with or without ulceration; for colorectal cancer it refers to primary tumor with invasion into the muscularis propria; and for bladder cancer it refers to primary tumor with invasion into the muscle layer."},"label":{"xml:lang":"en","type":"literal","value":"T2 Stage Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48725"},"def":{"xml:lang":"en","type":"literal","value":"A general term that refers to a TNM finding of a primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2a TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that measures more than 7 cm but less than or equal to 10 cm in greatest dimension, and is limited to the kidney; for bladder cancer it refers to a primary tumor that invades the superficial muscularis propria (inner half); for cervical cancer it refers to a primary tumor that invades beyond the uterus but not to the pelvic wall or to the lower third of vagina and there is no parametrial invasion."},"label":{"xml:lang":"en","type":"literal","value":"T2a Stage Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48726"},"def":{"xml:lang":"en","type":"literal","value":"A general term that refers to a TNM finding of a primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2b TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that measures more than 10 cm in greatest dimension, and is limited to the kidney; for bladder cancer it refers to a primary tumor that invades the deep muscularis propria (outer half); for cervical cancer it refers to a primary tumor that invades beyond the uterus but not to the pelvic wall or to the lower third of vagina and there is parametrial invasion."},"label":{"xml:lang":"en","type":"literal","value":"T2b Stage Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48727"},"def":{"xml:lang":"en","type":"literal","value":"A general term that refers to a TNM finding of a primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2c TNM finding depends on the specific type of cancer that it refers to; for example, for prostate cancer it refers to a primary tumor that involves both lobes of the prostate gland; for ovarian cancer it refers to a primary tumor that involves one or both ovaries with extension or implants on the uterus and/or fallopian tubes, or other pelvic tissues, with malignant cells in either ascites or peritoneal washings; for fallopian tube cancer it refers to a primary tumor with pelvic extension and malignant cells in ascites or peritoneal washings."},"label":{"xml:lang":"en","type":"literal","value":"T2c Stage Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48728"},"def":{"xml:lang":"en","type":"literal","value":"A clinical and/or pathologic primary tumor TNM finding usually indicating that the cancer is locally invasive, without infiltration of adjacent structures."},"label":{"xml:lang":"en","type":"literal","value":"T3 Stage Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48732"},"def":{"xml:lang":"en","type":"literal","value":"A clinical and/or pathologic primary tumor TNM finding indicating direct invasion of adjacent structures by cancer."},"label":{"xml:lang":"en","type":"literal","value":"T4 Stage Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48737"},"def":{"xml:lang":"en","type":"literal","value":"A primary tumor TNM finding indicating that the status of the primary tumor cannot be assessed."},"label":{"xml:lang":"en","type":"literal","value":"TX Stage Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48738"},"def":{"xml:lang":"en","type":"literal","value":"A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ."},"label":{"xml:lang":"en","type":"literal","value":"Tis Stage Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48739"},"def":{"xml:lang":"en","type":"literal","value":"TNM staging performed as part of pathologic specimen."},"label":{"xml:lang":"en","type":"literal","value":"Pathologic TNM Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48786"},"def":{"xml:lang":"en","type":"literal","value":"A general term that refers to a TNM finding of cancer metastases in several regional lymph nodes. The definition of N2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 4-9 axillary lymph nodes; for cutaneous melanoma it refers to metastases in 2-3 regional lymph nodes; for colorectal cancer it refers to metastases in 4 or more regional lymph nodes; and for bladder cancer it refers to metastases in multiple regional lymph nodes in the true pelvis."},"label":{"xml:lang":"en","type":"literal","value":"N2 Stage Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48879"},"def":{"xml:lang":"en","type":"literal","value":"A cancer finding in the TNM system that is not specifically identified as a clinical, pathologic, recurrent (retreatment), or autopsy classification using an accepted prefix in accordance with TNM classification guidelines. Though the 6th Edition of the AJCC Cancer Staging Manual indicates that unspecified TNM staging descriptors may be considered synonymous with the corresponding fully specified clinical category, such omission may lead to ambiguity in meaning, and in practice unqualified descriptors are frequently used with other intended meanings.  The generic TNM concepts in the NCI Thesaurus are intended to explicitly reflect this lack of specification."},"label":{"xml:lang":"en","type":"literal","value":"Generic TNM Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48881"},"def":{"xml:lang":"en","type":"literal","value":"TNM staging performed with access to clinical information only."},"label":{"xml:lang":"en","type":"literal","value":"Clinical TNM Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48886"},"label":{"xml:lang":"en","type":"literal","value":"Pathologic Distant Metastasis TNM Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48887"},"def":{"xml:lang":"en","type":"literal","value":"A pathologic finding about one or more characteristics of a specific cancer, following the rules of the TNM classification system as they pertain to staging of regional lymph nodes."},"label":{"xml:lang":"en","type":"literal","value":"Pathologic Regional Lymph Nodes TNM Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48888"},"def":{"xml:lang":"en","type":"literal","value":"A pathologic finding about one or more characteristics of a specific cancer, following the rules of the TNM classification system as they pertain to staging of the primary tumor."},"label":{"xml:lang":"en","type":"literal","value":"Pathologic Primary Tumor TNM Finding"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48935"},"def":{"xml:lang":"en","type":"literal","value":"Surgical removal of the lymph nodes located in a particular anatomic region. This procedure is commonly performed as a component of cancer staging."},"label":{"xml:lang":"en","type":"literal","value":"Regional Lymph Node Dissection"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48944"},"def":{"xml:lang":"en","type":"literal","value":"One of the three lobes that comprise the right lung."},"label":{"xml:lang":"en","type":"literal","value":"Lobe of the Right Lung"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7311"},"label":{"xml:lang":"en","type":"literal","value":"Lobe of lung"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48945"},"def":{"xml:lang":"en","type":"literal","value":"Either of the two (upper or lower) lobes that comprise the left lung."},"label":{"xml:lang":"en","type":"literal","value":"Lobe of the Left Lung"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C491"},"def":{"xml:lang":"en","type":"literal","value":"A semisynthetic derivative of podophyllotoxin, a substance extracted from the mandrake root Podophyllum peltatum. Possessing potent antineoplastic properties, etoposide binds to and inhibits topoisomerase II and its function in ligating cleaved DNA molecules, resulting in the accumulation of single- or double-strand DNA breaks, the inhibition of DNA replication and transcription, and apoptotic cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle. (NCI04)"},"label":{"xml:lang":"en","type":"literal","value":"Etoposide"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C4917"},"def":{"xml:lang":"en","type":"literal","value":"A highly aggressive subtype of lung carcinoma characterized by the presence of malignant small cells and necrosis. Metastatic disease is usually present at the time of diagnosis."},"label":{"xml:lang":"en","type":"literal","value":"Small Cell Lung Carcinoma"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C50646"},"def":{"xml:lang":"en","type":"literal","value":"A symptom or medical condition that makes a particular treatment or procedure inadvisable because a person is likely to have a bad reaction."},"label":{"xml:lang":"en","type":"literal","value":"Medical Contraindication"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C51625"},"def":{"xml:lang":"en","type":"literal","value":"Surgical removal of a wedge-shaped section of lung."},"label":{"xml:lang":"en","type":"literal","value":"Wedge Resection of Lung"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C51773"},"def":{"xml:lang":"en","type":"literal","value":"Indicates a person currently joined in a legally binding matrimonial union. Classify common law marriage as married. Includes married couples living together and not living together."},"label":{"xml:lang":"en","type":"literal","value":"Married"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C51774"},"def":{"xml:lang":"en","type":"literal","value":"Indicates a person who has never been married or whose marriages have been annulled."},"label":{"xml:lang":"en","type":"literal","value":"Never Married"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C51775"},"def":{"xml:lang":"en","type":"literal","value":"Indicates a person who is no longer married because of the death of his/her spouse and has not remarried."},"label":{"xml:lang":"en","type":"literal","value":"Widowed"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C51776"},"def":{"xml:lang":"en","type":"literal","value":"Indicates a person whose marriage has been legally dissolved and has not remarried."},"label":{"xml:lang":"en","type":"literal","value":"Divorced"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C51777"},"def":{"xml:lang":"en","type":"literal","value":"Indicates a person living apart from his/her spouse by legal arrangement."},"label":{"xml:lang":"en","type":"literal","value":"Separated"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C51949"},"def":{"xml:lang":"en","type":"literal","value":"The determination of the number of lymphocytes in a blood sample."},"label":{"xml:lang":"en","type":"literal","value":"Lymphocyte Count"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T034"},"def":{"xml:lang":"en","type":"literal","value":"The outcome of a specific test to measure an attribute or to determine the presence, absence, or degree of a condition."},"label":{"xml:lang":"en","type":"literal","value":"Laboratory or Test Result"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C53255"},"def":{"xml:lang":"en","type":"literal","value":"A characteristic used to qualify the determination of whether an adverse event is related to medical product or procedure or related to the cancer or related to comorbidities."},"label":{"xml:lang":"en","type":"literal","value":"Adverse Event Attribution Category"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C53256"},"def":{"xml:lang":"en","type":"literal","value":"A characteristic used to qualify the adverse event as clearly not related to the medical intervention."},"label":{"xml:lang":"en","type":"literal","value":"Unrelated to Intervention"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C53257"},"def":{"xml:lang":"en","type":"literal","value":"A characteristic used to qualify the adverse event as unlikely related to the medical intervention. According to WHO causality assessment criteria of suspected adverse reactions it is applicable to a clinical event, including laboratory test abnormality, with a temporal relationship to the medical intervention which makes a causal relationship improbable, and in which other interventions or underlying disease provide plausible explanations."},"label":{"xml:lang":"en","type":"literal","value":"Unlikely Related to Intervention"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C53258"},"def":{"xml:lang":"en","type":"literal","value":"A characteristic indicating that an adverse event may be related to the medical intervention. According to WHO causality assessment criteria of suspected adverse reactions it is applicable to a clinical event, including laboratory test abnormality, with a reasonable time sequence to administration of the drug, but which could also be explained by concurrent disease or other drugs or chemicals. Information on drug withdrawal may be lacking or unclear."},"label":{"xml:lang":"en","type":"literal","value":"Possibly Related to Intervention"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C53259"},"def":{"xml:lang":"en","type":"literal","value":"A characteristic used to qualify the adverse event as likely related to the medical intervention. According to WHO causality assessment criteria of suspected adverse reactions it is applicable to a clinical event, including laboratory test abnormality, with a reasonable time sequence to the medical intervention, unlikely to be attributed to concurrent disease or other medical interventions, and which follows a clinically reasonable response on withdrawal (dechallenge). Rechallenge information is not required to fulfill this definition."},"label":{"xml:lang":"en","type":"literal","value":"Probably Related to Intervention"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C53260"},"def":{"xml:lang":"en","type":"literal","value":"A characteristic used to qualify the adverse event as certainly related to the medical intervention. According to WHO causality assessment criteria of suspected adverse reactions it is applicable to a clinical event, including laboratory test abnormality, occurring in a plausible time relationship to medical intervention, and which cannot be explained by concurrent disease or other interventions. The response to withdrawal of the medical product (dechallenge) should be clinically plausible. The event must be definitive pharmacologically or phenomenologically, using a satisfactory rechallenge procedure if necessary."},"label":{"xml:lang":"en","type":"literal","value":"Definitely Related to Intervention"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C53262"},"def":{"xml:lang":"en","type":"literal","value":"Indicates a person who is a member of an unmarried couple, including same sex couples, living together in longstanding relationships, that are registered or unregistered."},"label":{"xml:lang":"en","type":"literal","value":"Domestic Partnership"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C53288"},"def":{"xml:lang":"en","type":"literal","value":"Not permanent; not lasting; lacking continuity or regularity."},"label":{"xml:lang":"en","type":"literal","value":"Temporary"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C53781"},"label":{"xml:lang":"en","type":"literal","value":"Adverse Event by CTCAE Category"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C84257"},"label":{"xml:lang":"en","type":"literal","value":"Adverse Event by CTCAE v3 Severity Grade"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C53795"},"label":{"xml:lang":"en","type":"literal","value":"Adverse Event Associated with Pulmonary and Upper Respiratory Systems"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C53802"},"label":{"xml:lang":"en","type":"literal","value":"Adverse Event Associated with the Gastrointestinal System"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C53803"},"label":{"xml:lang":"en","type":"literal","value":"Adverse Event Associated with the Heart in General"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C54100"},"def":{"xml:lang":"en","type":"literal","value":"A 128 bit identifier. Depending on the mechanism used to generate it, it is either guaranteed to be different from all other UUIDs/GUIDs generated until 3400 AD or extremely likely to be different. Its relatively small size lends itself well to sorting, ordering, and hashing of all sorts, storing in databases, simple allocation, and ease of programming in general."},"label":{"xml:lang":"en","type":"literal","value":"Universally Unique Identifier"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C70663"},"def":{"xml:lang":"en","type":"literal","value":"A set of characters used as a code that is unique in the context or the system for which it is created. It serves as a means of identification and reference (often instead of a name) for an entity, person, thing, function, procedure, activity, variable, or body of data."},"label":{"xml:lang":"en","type":"literal","value":"Unique Identifier"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C54996"},"def":{"xml:lang":"en","type":"literal","value":"Asymptomatic, transient (<24 hrs) increase by >20 mmHg (diastolic) or to >150/100 if previously WNL; intervention not indicated Pediatric: Asymptomatic, transient (<24 hrs) BP increase >ULN; intervention not indicated"},"label":{"xml:lang":"en","type":"literal","value":"CTCAE Grade 1 Hypertension"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C55060"},"label":{"xml:lang":"en","type":"literal","value":"Hypertension Adverse Event"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C55008"},"def":{"xml:lang":"en","type":"literal","value":"Recurrent or persistent (>=24 hrs) or symptomatic increase by >20 mmHg (diastolic) or to >150/100 if previously WNL; monotherapy may be indicated Pediatric: Recurrent or persistent (>=24 hrs) BP >ULN; monotherapy may be indicated"},"label":{"xml:lang":"en","type":"literal","value":"CTCAE Grade 2 Hypertension"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C55020"},"def":{"xml:lang":"en","type":"literal","value":"Requiring more than one drug or more intensive therapy than previously Pediatric: Same as adult"},"label":{"xml:lang":"en","type":"literal","value":"CTCAE Grade 3 Hypertension"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C55034"},"def":{"xml:lang":"en","type":"literal","value":"Life-threatening consequences (e.g., hypertensive crisis) Pediatric: Same as adult"},"label":{"xml:lang":"en","type":"literal","value":"CTCAE Grade 4 Hypertension"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C55048"},"def":{"xml:lang":"en","type":"literal","value":"Death"},"label":{"xml:lang":"en","type":"literal","value":"CTCAE Grade 5 Hypertension"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C55072"},"def":{"xml:lang":"en","type":"literal","value":"Recurrence of symptoms of a disease at the original site."},"label":{"xml:lang":"en","type":"literal","value":"Recurrent Disease, Primary Site"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C55073"},"def":{"xml:lang":"en","type":"literal","value":"Recurrence of symptoms of a disease, at a site different and away from the original site."},"label":{"xml:lang":"en","type":"literal","value":"Recurrent Disease, Distant Site"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C57176"},"def":{"xml:lang":"en","type":"literal","value":"Symptomatic, able to eat regular diet"},"label":{"xml:lang":"en","type":"literal","value":"CTCAE Grade 1 Dysphagia"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C57795"},"label":{"xml:lang":"en","type":"literal","value":"Dysphagia Adverse Event"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C57299"},"def":{"xml:lang":"en","type":"literal","value":"Symptomatic and altered eating/swallowing (e.g., altered dietary habits, oral supplements); IV fluids indicated <24 hrs"},"label":{"xml:lang":"en","type":"literal","value":"CTCAE Grade 2 Dysphagia"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C57425"},"def":{"xml:lang":"en","type":"literal","value":"Symptomatic and severely altered eating/swallowing (e.g., inadequate oral caloric or fluid intake); IV fluids, tube feedings, or TPN indicated >=24 hrs"},"label":{"xml:lang":"en","type":"literal","value":"CTCAE Grade 3 Dysphagia"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C57560"},"def":{"xml:lang":"en","type":"literal","value":"Life-threatening consequences (e.g., obstruction, perforation)"},"label":{"xml:lang":"en","type":"literal","value":"CTCAE Grade 4 Dysphagia"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C57691"},"def":{"xml:lang":"en","type":"literal","value":"Death"},"label":{"xml:lang":"en","type":"literal","value":"CTCAE Grade 5 Dysphagia"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C58037"},"def":{"xml:lang":"en","type":"literal","value":"Dyspnea on exertion, but can walk 1 flight of stairs without stopping"},"label":{"xml:lang":"en","type":"literal","value":"CTCAE Grade 1 Dyspnea"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C58185"},"label":{"xml:lang":"en","type":"literal","value":"Dyspnea Adverse Event"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C58066"},"def":{"xml:lang":"en","type":"literal","value":"Dyspnea on exertion but unable to walk 1 flight of stairs or 1 city block (0.1km) without stopping"},"label":{"xml:lang":"en","type":"literal","value":"CTCAE Grade 2 Dyspnea"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C58099"},"def":{"xml:lang":"en","type":"literal","value":"Dyspnea with ADL."},"label":{"xml:lang":"en","type":"literal","value":"CTCAE Grade 3 Dyspnea"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C58131"},"def":{"xml:lang":"en","type":"literal","value":"Dyspnea at rest; intubation/ventilator indicated."},"label":{"xml:lang":"en","type":"literal","value":"CTCAE Grade 4 Dyspnea"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C58162"},"def":{"xml:lang":"en","type":"literal","value":"Death."},"label":{"xml:lang":"en","type":"literal","value":"CTCAE Grade 5 Dyspnea"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C61614"},"def":{"xml:lang":"en","type":"literal","value":"A synthetic pyrimidine-based antifolate. Pemetrexed binds to and inhibits the enzyme thymidylate synthase (TS), which catalyses the methylation of 2'-deoxyuridine-5'-monophosphate (dUMP) to 2'-deoxythymidine-5'-monophosphate (dTMP), an essential precursor in DNA synthesis."},"label":{"xml:lang":"en","type":"literal","value":"Pemetrexed"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C62040"},"def":{"xml:lang":"en","type":"literal","value":"A semisynthetic derivative of camptothecin, a cytotoxic, quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata. Irinotecan, a prodrug, is converted to a biologically active metabolite 7-ethyl-10-hydroxy-camptothecin (SN-38) by a carboxylesterase-converting enzyme. One thousand-fold more potent than its parent compound irinotecan, SN-38 inhibits topoisomerase I activity by stabilizing the cleavable complex between topoisomerase I and DNA, resulting in DNA breaks that inhibit DNA replication and trigger apoptotic cell death. Because ongoing DNA synthesis is necessary for irinotecan to exert its cytotoxic effects, it is classified as an S-phase-specific agent."},"label":{"xml:lang":"en","type":"literal","value":"Irinotecan"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C62165"},"def":{"xml:lang":"en","type":"literal","value":"An anterior recumbent body position whereby the person lies on its stomach and faces downward."},"label":{"xml:lang":"en","type":"literal","value":"Prone Position"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C62167"},"def":{"xml:lang":"en","type":"literal","value":"A posterior recumbent body position whereby the person lies on its back and faces upward."},"label":{"xml:lang":"en","type":"literal","value":"Supine Position"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C62220"},"def":{"xml:lang":"en","type":"literal","value":"Serving or tending to restore health; a remedy."},"label":{"xml:lang":"en","type":"literal","value":"Cure"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C68786"},"def":{"xml:lang":"en","type":"literal","value":"Directed to the root or source of a morbid process; to remove the root of a disease or all diseased tissue, as radical surgery."},"label":{"xml:lang":"en","type":"literal","value":"Radical"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C62398"},"def":{"xml:lang":"en","type":"literal","value":"Surgery for rectal cancer that spares the anus and leaves the sphincter intact. Surgery is performed through the anus and removes only the rectal tumor and small amounts of surrounding tissue."},"label":{"xml:lang":"en","type":"literal","value":"Transanal Excision"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C62727"},"def":{"xml:lang":"en","type":"literal","value":"A procedure that uses a computer to create a picture of a tumor to help guide the radiation beam during radiation therapy. The pictures are made using CT, ultrasound, X-ray, or other imaging techniques. Image-guided radiation therapy makes radiation therapy more accurate and causes less damage to healthy tissue."},"label":{"xml:lang":"en","type":"literal","value":"Image Guided Radiation Therapy"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C62731"},"def":{"xml:lang":"en","type":"literal","value":"A type of external beam radiation therapy in which the radiation is delivered slice-by-slice, providing sequential delivery of radiation to different parts of the tumor. This method differs from other forms of radiation therapy in which the entire tumor volume is irradiated at one time."},"label":{"xml:lang":"en","type":"literal","value":"Tomotherapy"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63388"},"def":{"xml:lang":"en","type":"literal","value":"A regimen consisting of fluorouracil and leucovorin, used in both the adjuvant and metastatic disease setting, for the treatment of colorectal cancer. This regimen is also combined with radiation for the treatment of gastric and esophageal cancer.\nThe Mayo Clinic regimen, Roswell Park regimen, and de Gramont regimen are different in the doses and times at which the two drugs are given."},"label":{"xml:lang":"en","type":"literal","value":"FU-LV Regimen"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63536"},"def":{"xml:lang":"en","type":"literal","value":"A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it."},"label":{"xml:lang":"en","type":"literal","value":"Study"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T062"},"def":{"xml:lang":"en","type":"literal","value":"An activity carried out as part of research or experimentation."},"label":{"xml:lang":"en","type":"literal","value":"Research Activity"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63593"},"def":{"xml:lang":"en","type":"literal","value":"A chemotherapy regimen consisting of leucovorin calcium (calcium folinate), 5-fluorouracil, and irinotecan used in the treatment of advanced-stage and metastatic colorectal cancer."},"label":{"xml:lang":"en","type":"literal","value":"FOLFIRI Regimen"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63597"},"def":{"xml:lang":"en","type":"literal","value":"A regimen consisting of capecitabine and oxaliplatin used for the treatment of advanced stage colorectal cancer. This regimen differs from a similar regimen, CAPOX, with regards to the dosing schedule for oxaliplatin."},"label":{"xml:lang":"en","type":"literal","value":"XELOX regimen"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C64247"},"def":{"xml:lang":"en","type":"literal","value":"Not suitable for surgery."},"label":{"xml:lang":"en","type":"literal","value":"Inoperable"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C64848"},"def":{"xml:lang":"en","type":"literal","value":"A quantitative measurement of the amount of hemoglobin present in a sample."},"label":{"xml:lang":"en","type":"literal","value":"Hemoglobin Measurement"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T059"},"def":{"xml:lang":"en","type":"literal","value":"A procedure, method, or technique used to determine the composition, quantity, or concentration of a specimen, and which is carried out in a clinical laboratory. Included here are procedures which measure the times and rates of reactions."},"label":{"xml:lang":"en","type":"literal","value":"Laboratory Procedure"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C65108"},"def":{"xml:lang":"en","type":"literal","value":"A person who was not smoking at the time of the interview and has smoked less than 100 cigarettes in their life."},"label":{"xml:lang":"en","type":"literal","value":"Never Smoker"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C65530"},"def":{"xml:lang":"en","type":"literal","value":"A quinazoline derivative with antineoplastic properties. Competing with adenosine triphosphate, erlotinib reversibly binds to the intracellular catalytic domain of epidermal growth factor receptor (EGFR) tyrosine kinase, thereby reversibly inhibiting EGFR phosphorylation and blocking the signal transduction events and tumorigenic effects associated with EGFR activation."},"label":{"xml:lang":"en","type":"literal","value":"Erlotinib"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C66876"},"def":{"xml:lang":"en","type":"literal","value":"A broad-spectrum antimetabolite and deoxycytidine analogue with antineoplastic activity. Upon administration, gemcitabine is converted into the active metabolites difluorodeoxycytidine diphosphate (dFdCDP) and difluorodeoxycytidine triphosphate (dFdCTP) by deoxycytidine kinase. dFdCTP competes with deoxycytidine triphosphate (dCTP) and is incorporated into DNA. This locks DNA polymerase thereby resulting in \"masked termination\" during DNA replication. On the other hand, dFdCDP inhibits ribonucleotide reductase, thereby decreasing the deoxynucleotide pool available for DNA synthesis. The reduction in the intracellular concentration of dCTP potentiates the incorporation of dFdCTP into DNA."},"label":{"xml:lang":"en","type":"literal","value":"Gemcitabine"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C67147"},"def":{"xml:lang":"en","type":"literal","value":"An adult who has smoked 100 cigarettes in his or her lifetime and who currently smokes cigarettes. Includes daily smokers and non-daily smokers (also known as occasional smokers)."},"label":{"xml:lang":"en","type":"literal","value":"Current Smoker"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C67148"},"def":{"xml:lang":"en","type":"literal","value":"A person who was not smoking at the time of the interview but has smoked at least 100 cigarettes in their life."},"label":{"xml:lang":"en","type":"literal","value":"Former Smoker"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C68618"},"def":{"xml:lang":"en","type":"literal","value":"A characteristic used to qualify the adverse event as unclassified in term of its relation to the medical intervention. According to WHO causality assessment criteria of suspected adverse reactions it is applicable to clinical event, including laboratory test abnormality, reported as an adverse reaction, about which more data is essential for a proper assessment or the additional data are under examination."},"label":{"xml:lang":"en","type":"literal","value":"Conditionally Related to Intervention"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C68619"},"def":{"xml:lang":"en","type":"literal","value":"A characteristic used to qualify the adverse event as unclassifiable in term of its relation to the medical intervention. According to WHO causality assessment criteria of suspected adverse reactions it is applicable to an adverse reaction which cannot be judged because information about it is insufficient or contradictory, and cannot be supplemented or verified."},"label":{"xml:lang":"en","type":"literal","value":"Relation to Intervention Unclassifiable"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C69219"},"def":{"xml:lang":"en","type":"literal","value":"A unique identifier for series of images."},"label":{"xml:lang":"en","type":"literal","value":"Series Instance UID"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C71160"},"def":{"xml:lang":"en","type":"literal","value":"Data type unique identifier within a particular context."},"label":{"xml:lang":"en","type":"literal","value":"Instance Unique Identifier"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C69310"},"def":{"xml:lang":"en","type":"literal","value":"An effectively dimensionless measure of regional tracer uptake calculated as the activity concentration within a 2D region of interest (ROI) or 3D volume of interest (VOI) measured on a PET image (nCi1mL) / [injected dose (nCi) / body weight (g)]."},"label":{"xml:lang":"en","type":"literal","value":"Standardized Uptake Value"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C70838"},"def":{"xml:lang":"en","type":"literal","value":"In image processing, a piece of information which is relevant for solving the computational task related to a certain application, either specific structures in the image itself (e.g., simple structures such as points or edges to more complex structures such as objects) or the result of a general neighborhood operation (feature extractor or feature detector) applied to the image."},"label":{"xml:lang":"en","type":"literal","value":"Image Feature"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T031"},"def":{"xml:lang":"en","type":"literal","value":"Extracellular material, or mixtures of cells and extracellular material, produced, excreted, or accreted by the body. Included here are substances such as saliva, dental enamel, sweat, and gastric acid."},"label":{"xml:lang":"en","type":"literal","value":"Body Substance"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T078"},"def":{"xml:lang":"en","type":"literal","value":"An abstract concept, such as a social, religious or philosophical concept."},"label":{"xml:lang":"en","type":"literal","value":"Idea or Concept"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/ICD10/C34"},"label":{"xml:lang":"en","type":"literal","value":"Malignant neoplasm of bronchus and lung"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C73993"},"def":{"xml:lang":"en","type":"literal","value":"A quantification of lifetime tobacco exposure defined as (number of cigarettes smoked per day x number of years smoked)/20. One pack-year is smoking 20 cigarettes a day for one year."},"label":{"xml:lang":"en","type":"literal","value":"Pack Year"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C7418"},"def":{"xml:lang":"en","type":"literal","value":"A primary or metastatic malignant neoplasm that affects the rectum.  Representative examples include carcinoma, lymphoma, and sarcoma."},"label":{"xml:lang":"en","type":"literal","value":"Malignant Rectal Neoplasm"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/ICD10/C20"},"label":{"xml:lang":"en","type":"literal","value":"Malignant neoplasm of rectum"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C7420"},"def":{"xml:lang":"en","type":"literal","value":"A primary or metastatic malignant neoplasm that affects the rectosigmoid area.  Representative examples include carcinoma, lymphoma, and sarcoma."},"label":{"xml:lang":"en","type":"literal","value":"Malignant Rectosigmoid Neoplasm"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/ICD10/C19"},"label":{"xml:lang":"en","type":"literal","value":"Malignant neoplasm of rectosigmoid junction"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C7919"},"label":{"xml:lang":"en","type":"literal","value":"No Measurable or Evaluable Disease"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C81239"},"def":{"xml:lang":"en","type":"literal","value":"The circumstance or condition that results in the death of a living being."},"label":{"xml:lang":"en","type":"literal","value":"Cause of Death"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C81262"},"def":{"xml:lang":"en","type":"literal","value":"An identifying number within an institution that is used to reference a subject's medical information."},"label":{"xml:lang":"en","type":"literal","value":"Medical Record Number"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C81945"},"label":{"xml:lang":"en","type":"literal","value":"ALK Gene Mutation"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C82572"},"def":{"xml:lang":"en","type":"literal","value":"The interval between two reference points in time."},"label":{"xml:lang":"en","type":"literal","value":"Elapsed Time"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C83083"},"def":{"xml:lang":"en","type":"literal","value":"A sequence of characters used to identify, name, or characterize the study subject."},"label":{"xml:lang":"en","type":"literal","value":"Subject Identifier"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100279"},"def":{"xml:lang":"en","type":"literal","value":"Third version (published 2003-2006) of the Common Terminology Criteria for Adverse Events (CTCAE) system published by the US National Cancer Institute (NCI)."},"label":{"xml:lang":"en","type":"literal","value":"CTCAE v3.0"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C84259"},"label":{"xml:lang":"en","type":"literal","value":"Adverse Event by CTCAE v4 Severity Grade"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100272"},"def":{"xml:lang":"en","type":"literal","value":"Fourth version (published 2009-2010) of the Common Terminology Criteria for Adverse Events (CTCAE) system published by the US National Cancer Institute (NCI)."},"label":{"xml:lang":"en","type":"literal","value":"CTCAE v4.0"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C85402"},"def":{"xml:lang":"en","type":"literal","value":"A specific area of interest defined by a sequence of image overlays or a sequence of contours described as a single point (for a point ROI) or more than one point (representing and open or closed polygon)."},"label":{"xml:lang":"en","type":"literal","value":"Imaging Region of Interest"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C857"},"def":{"xml:lang":"en","type":"literal","value":"A semisynthetic derivative of podophyllotoxin with antineoplastic activity. Teniposide forms a ternary complex with the enzyme topoisomerase II and DNA, resulting in dose-dependent single- and double-stranded breaks in DNA, DNA: protein cross-links, inhibition of DNA strand religation, and cytotoxicity. This agent acts in the late S or early G phase of the cell cycle. (NCI04)"},"label":{"xml:lang":"en","type":"literal","value":"Teniposide"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C91826"},"def":{"xml:lang":"en","type":"literal","value":"A therapeutic surgical procedure in which the anus, rectum, part of the sigmoid colon, and the regional lymph nodes are removed through abdominal and perineal incisions."},"label":{"xml:lang":"en","type":"literal","value":"Abdominoperineal Resection"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C930"},"def":{"xml:lang":"en","type":"literal","value":"A natural alkaloid isolated from the plant Vinca rosea Linn. Vinblastine binds to tubulin and inhibits microtubule formation, resulting in disruption of mitotic spindle assembly and arrest of tumor cells in the M phase of the cell cycle. This agent may also interfere with amino acid, cyclic AMP, and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. (NCI04)"},"label":{"xml:lang":"en","type":"literal","value":"Vinblastine"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C932"},"def":{"xml:lang":"en","type":"literal","value":"A type of drug that blocks cell growth by stopping mitosis (cell division). Vinca alkaloids interfere with microtubules (cellular structures that help move chromosomes during mitosis). They are used to treat cancer. A vinca alkaloid is a type of mitotic inhibitor and a type of antimicrotubule agent."},"label":{"xml:lang":"en","type":"literal","value":"Vinca Alkaloid Compound"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C9311"},"def":{"xml:lang":"en","type":"literal","value":"Primary or metastatic malignant neoplasm involving the cervix. --2003"},"label":{"xml:lang":"en","type":"literal","value":"Malignant Cervical Neoplasm"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C933"},"def":{"xml:lang":"en","type":"literal","value":"A natural alkaloid isolated from the plant Vinca rosea Linn. Vincristine binds irreversibly to microtubules and spindle proteins in S phase of the cell cycle and interferes with the formation of the mitotic spindle, thereby arresting tumor cells in metaphase. This agent also depolymerizes microtubules and may also interfere with amino acid, cyclic AMP, and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. (NCI04)"},"label":{"xml:lang":"en","type":"literal","value":"Vincristine"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C934"},"def":{"xml:lang":"en","type":"literal","value":"A synthetic derivative of vinblastine, a naturally occurring vinca alkaloid. Vindesine binds to and stabilizes tubulin, thereby interrupting tubulin polymerization and preventing the formation of the mitotic spindle and cell division; treated cells are unable to undergo mitosis and are arrested in metaphase. This agent also disrupts macromolecular synthesis. (NCI04)"},"label":{"xml:lang":"en","type":"literal","value":"Vindesine"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C94254"},"def":{"xml:lang":"en","type":"literal","value":"Describes a condition that can be treated by surgery."},"label":{"xml:lang":"en","type":"literal","value":"Operable"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C94448"},"def":{"xml:lang":"en","type":"literal","value":"Surgery to remove a lung tumor in a lobe of the lung and a part of the main bronchus (airway). The ends of the bronchus are rejoined and any remaining lobes are reattached to the bronchus. This surgery is done to save part of the lung."},"label":{"xml:lang":"en","type":"literal","value":"Sleeve Lobectomy"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C94461"},"def":{"xml:lang":"en","type":"literal","value":"The surgical removal of metastases."},"label":{"xml:lang":"en","type":"literal","value":"Metastasectomy"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C94626"},"def":{"xml:lang":"en","type":"literal","value":"Treatment that combines chemotherapy with radiation therapy"},"label":{"xml:lang":"en","type":"literal","value":"Chemoradiotherapy"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C95181"},"def":{"xml:lang":"en","type":"literal","value":"The amount of energy from any type of ionizing radiation (e.g., alpha, beta, gamma, neutrons, etc.) deposited in any medium (e.g. water, tissue, air). This designates energy deposition by the radiation without regard to the type of matter or any biological considerations."},"label":{"xml:lang":"en","type":"literal","value":"Absorbed Radiation Dose"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C95484"},"def":{"xml:lang":"en","type":"literal","value":"A proprietary, robotic radiosurgery system designed to deliver precise beams of high dose radiation to tumors with extreme accuracy."},"label":{"xml:lang":"en","type":"literal","value":"CyberKnife"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C95560"},"def":{"xml:lang":"en","type":"literal","value":"In medicine, something that prevents or protects."},"label":{"xml:lang":"en","type":"literal","value":"Prophylactic"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C96866"},"def":{"xml:lang":"en","type":"literal","value":"A molecular genetic abnormality indicating the presence of a mutation in the ERBB2 gene on chromosome 17q12."},"label":{"xml:lang":"en","type":"literal","value":"ERBB2 Gene Mutation"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C98304"},"def":{"xml:lang":"en","type":"literal","value":"A change in the nucleotide sequence of the AKT1 gene."},"label":{"xml:lang":"en","type":"literal","value":"AKT1 Gene Mutation"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C98357"},"def":{"xml:lang":"en","type":"literal","value":"A change in the nucleotide sequence of the EGFR gene."},"label":{"xml:lang":"en","type":"literal","value":"EGFR Gene Mutation"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/ctcae.owl#Adverse_Event_by_System_Organ_Class"},"label":{"xml:lang":"en","type":"literal","value":"Adverse Event by System Organ Class"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/ctcae.owl#Cough"},"def":{"xml:lang":"en","type":"literal","value":"A disorder characterized by sudden, often repetitive, spasmodic contraction of the thoracic cavity, resulting in violent release of air from the lungs and usually accompanied by a distinctive sound."},"label":{"xml:lang":"en","type":"literal","value":"Cough"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/ctcae.owl#Respiratory_thoracic_and_mediastinal_disorders"},"label":{"xml:lang":"en","type":"literal","value":"Respiratory, thoracic and mediastinal disorders"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/ctcae.owl#Dysphagia"},"def":{"xml:lang":"en","type":"literal","value":"A disorder characterized by difficulty in swallowing."},"label":{"xml:lang":"en","type":"literal","value":"Dysphagia"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/ctcae.owl#Gastrointestinal_disorders"},"label":{"xml:lang":"en","type":"literal","value":"Gastrointestinal disorders"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/ctcae.owl#Dyspnea"},"def":{"xml:lang":"en","type":"literal","value":"A disorder characterized by an uncomfortable sensation of difficulty breathing."},"label":{"xml:lang":"en","type":"literal","value":"Dyspnea"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/ctcae.owl#Esophageal_stenosis"},"def":{"xml:lang":"en","type":"literal","value":"A disorder characterized by a narrowing of the lumen of the esophagus."},"label":{"xml:lang":"en","type":"literal","value":"Esophageal stenosis"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/ctcae.owl#Grade_1_Cough"},"def":{"xml:lang":"en","type":"literal","value":"Mild symptoms; nonprescription intervention indicated"},"label":{"xml:lang":"en","type":"literal","value":"Grade 1 Cough"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/ctcae.owl#Grade_1_Dysphagia"},"def":{"xml:lang":"en","type":"literal","value":"Symptomatic, able to eat regular diet"},"label":{"xml:lang":"en","type":"literal","value":"Grade 1 Dysphagia"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/ctcae.owl#Grade_1_Dyspnea"},"def":{"xml:lang":"en","type":"literal","value":"Shortness of breath with moderate exertion"},"label":{"xml:lang":"en","type":"literal","value":"Grade 1 Dyspnea"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/ctcae.owl#Grade_1_Esophageal_stenosis"},"def":{"xml:lang":"en","type":"literal","value":"Asymptomatic; clinical or diagnostic observations only; intervention not indicated"},"label":{"xml:lang":"en","type":"literal","value":"Grade 1 Esophageal stenosis"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/ctcae.owl#Grade_2_Cough"},"def":{"xml:lang":"en","type":"literal","value":"Moderate symptoms, medical intervention indicated; limiting instrumental ADL"},"label":{"xml:lang":"en","type":"literal","value":"Grade 2 Cough"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/ctcae.owl#Grade_2_Dysphagia"},"def":{"xml:lang":"en","type":"literal","value":"Symptomatic and altered eating/swallowing"},"label":{"xml:lang":"en","type":"literal","value":"Grade 2 Dysphagia"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/ctcae.owl#Grade_2_Dyspnea"},"def":{"xml:lang":"en","type":"literal","value":"Shortness of breath with minimal exertion; limiting instrumental ADL"},"label":{"xml:lang":"en","type":"literal","value":"Grade 2 Dyspnea"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/ctcae.owl#Grade_2_Esophageal_stenosis"},"def":{"xml:lang":"en","type":"literal","value":"Symptomatic; altered GI function"},"label":{"xml:lang":"en","type":"literal","value":"Grade 2 Esophageal stenosis"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/ctcae.owl#Grade_3_Cough"},"def":{"xml:lang":"en","type":"literal","value":"Severe symptoms; limiting self care ADL"},"label":{"xml:lang":"en","type":"literal","value":"Grade 3 Cough"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/ctcae.owl#Grade_3_Dysphagia"},"def":{"xml:lang":"en","type":"literal","value":"Severely altered eating/swallowing; tube feeding or TPN or hospitalization indicated"},"label":{"xml:lang":"en","type":"literal","value":"Grade 3 Dysphagia"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/ctcae.owl#Grade_3_Dyspnea"},"def":{"xml:lang":"en","type":"literal","value":"Shortness of breath at rest; limiting self care ADL"},"label":{"xml:lang":"en","type":"literal","value":"Grade 3 Dyspnea"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/ctcae.owl#Grade_3_Esophageal_stenosis"},"def":{"xml:lang":"en","type":"literal","value":"Severely altered GI function; tube feeding; hospitalization indicated; elective operative intervention indicated"},"label":{"xml:lang":"en","type":"literal","value":"Grade 3 Esophageal stenosis"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/ctcae.owl#Grade_4_Dysphagia"},"def":{"xml:lang":"en","type":"literal","value":"Life-threatening consequences; urgent intervention indicated"},"label":{"xml:lang":"en","type":"literal","value":"Grade 4 Dysphagia"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/ctcae.owl#Grade_4_Dyspnea"},"def":{"xml:lang":"en","type":"literal","value":"Life-threatening consequences; urgent intervention indicated"},"label":{"xml:lang":"en","type":"literal","value":"Grade 4 Dyspnea"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/ctcae.owl#Grade_4_Esophageal_stenosis"},"def":{"xml:lang":"en","type":"literal","value":"Life-threatening consequences; urgent operative intervention indicated"},"label":{"xml:lang":"en","type":"literal","value":"Grade 4 Esophageal stenosis"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/ctcae.owl#Grade_5_Dysphagia"},"def":{"xml:lang":"en","type":"literal","value":"Death"},"label":{"xml:lang":"en","type":"literal","value":"Grade 5 Dysphagia"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/ctcae.owl#Grade_5_Dyspnea"},"def":{"xml:lang":"en","type":"literal","value":"Death"},"label":{"xml:lang":"en","type":"literal","value":"Grade 5 Dyspnea"}},{"iri":{"type":"uri","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/ctcae.owl#Grade_5_Esophageal_stenosis"},"def":{"xml:lang":"en","type":"literal","value":"Death"},"label":{"xml:lang":"en","type":"literal","value":"Grade 5 Esophageal stenosis"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/ICD9CM/32.3"},"def":{"xml:lang":"en","type":"literal","value":"A segment resection removes a larger portion of the lung lobe than a wedge resection, but does not remove the whole lobe."},"label":{"xml:lang":"en","type":"literal","value":"Segmental resection of lung"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/ICD9CM/32.4"},"def":{"xml:lang":"en","type":"literal","value":"A common surgical procedure that removes one lobe of the lung that contains cancerous cells."},"label":{"xml:lang":"en","type":"literal","value":"Lobectomy of Lung"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/RCD/X20XN"},"def":{"xml:lang":"en","type":"literal","value":"The surgical creation or closure of an opening between the colon and the surface of the body."},"label":{"xml:lang":"en","type":"literal","value":"Colostomy operation"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/RCD/X78tq"},"label":{"xml:lang":"en","type":"literal","value":"Permanent"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/RCD/X7A6g"},"def":{"xml:lang":"en","type":"literal","value":"The R classification, an auxiliary classification within the TNM system, denotes the absence or presence of residual tumor after treatment and describes residual tumor as macroscopic or microscopic in amount. The R classification considers residual tumor at the primary tumor siteThe R classification, an auxiliary classification within the TNM system, denotes the absence or presence of residual tumor after treatment and describes residual tumor as macroscopic or microscopic in amount. The R classification considers residual tumor at the primary tumor site, in the regional lymph nodes, and/or at distant sites. As such, it reflects the efficacy of primary treatment, influences the design and institution of additional therapy, and is a strong indicator of prognosis., in the regional lymph nodes, and/or at distant sites. As such, it reflects the efficacy of primary treatment, influences the design and institution of additional therapy, and is a strong indicator of prognosis."},"label":{"xml:lang":"en","type":"literal","value":"Residual tumour status stages"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/RCD/X7A6h"},"def":{"xml:lang":"en","type":"literal","value":"The  presence  of  residual  tumor  cannot  be assessed."},"label":{"xml:lang":"en","type":"literal","value":"Residual tumour stage RX"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/RCD/X7A6i"},"def":{"xml:lang":"en","type":"literal","value":"No residual tumor."},"label":{"xml:lang":"en","type":"literal","value":"Residual tumour stage R0"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/RCD/XC0fs"},"def":{"xml:lang":"en","type":"literal","value":"A stoma to the colon."},"label":{"xml:lang":"en","type":"literal","value":"Colostomy - stoma"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/RCD/XE0DI"},"def":{"xml:lang":"en","type":"literal","value":"The surgical creation of a temporary colostomy."},"label":{"xml:lang":"en","type":"literal","value":"Construction of temporary colostomy"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/RCD/XE0DJ"},"def":{"xml:lang":"en","type":"literal","value":"The surgical creation of a permanent colostomy."},"label":{"xml:lang":"en","type":"literal","value":"Construction of permanent colostomy"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/RCD/XE0DK"},"def":{"xml:lang":"en","type":"literal","value":"The surgical closure of a colostomy."},"label":{"xml:lang":"en","type":"literal","value":"Closure of colostomy"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/RCD/Xa0fY"},"def":{"xml:lang":"en","type":"literal","value":"Microscopic residual tumor."},"label":{"xml:lang":"en","type":"literal","value":"Residual tumour stage R1"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/RCD/Xa0fZ"},"def":{"xml:lang":"en","type":"literal","value":"Macroscopic residual tumor."},"label":{"xml:lang":"en","type":"literal","value":"Residual tumour stage R2"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/RCD/Xa1oS"},"def":{"xml:lang":"en","type":"literal","value":"Local excision"},"label":{"xml:lang":"en","type":"literal","value":"Excision of lesion of rectum"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/RCD/4I28"},"label":{"xml:lang":"en","type":"literal","value":"Saliva sample"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/RCD/5144"},"def":{"xml:lang":"en","type":"literal","value":"The use of radiotherapy prior to the surgical removal of a tumor."},"label":{"xml:lang":"en","type":"literal","value":"Radiotherapy - preoperative control"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/RCD/5146"},"def":{"xml:lang":"en","type":"literal","value":"A postoperative course of radiotherapy."},"label":{"xml:lang":"en","type":"literal","value":"Radiotherapy - postoperative control"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/RCD/77201"},"def":{"xml:lang":"en","type":"literal","value":"Rectosigmoidectomy, closure of rectal stump and exteriorisation of bowel."},"label":{"xml:lang":"en","type":"literal","value":"Hartmann's procedure"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T001"},"def":{"xml:lang":"en","type":"literal","value":"Generally, a living individual, including all plants and animals."},"label":{"xml:lang":"en","type":"literal","value":"Organism"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T072"},"def":{"xml:lang":"en","type":"literal","value":"An object perceptible to the sense of vision or touch."},"label":{"xml:lang":"en","type":"literal","value":"Physical Object"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T002"},"def":{"xml:lang":"en","type":"literal","value":"An organism having cellulose cell walls, growing by synthesis of inorganic substances, generally distinguished by the presence of chlorophyll, and lacking the power of locomotion. Plant parts are included here as well."},"label":{"xml:lang":"en","type":"literal","value":"Plant"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T204"},"def":{"xml:lang":"en","type":"literal","value":"One of the three domains of life (the others being Bacteria and Archaea), also called Eukarya. These are organisms whose cells are enclosed in membranes and possess a nucleus. They comprise almost all multicellular and many unicellular organisms, and are traditionally divided into groups (sometimes called kingdoms) including Animals, Plants, Fungi, various Algae, and other taxa that were previously part of the old kingdom Protista."},"label":{"xml:lang":"en","type":"literal","value":"Eukaryote"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T004"},"def":{"xml:lang":"en","type":"literal","value":"A eukaryotic organism characterized by the absence of chlorophyll and the presence of a rigid cell wall. Included here are both slime molds and true fungi such as yeasts, molds, mildews, and mushrooms."},"label":{"xml:lang":"en","type":"literal","value":"Fungus"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T005"},"def":{"xml:lang":"en","type":"literal","value":"An organism consisting of a core of a single nucleic acid enclosed in a protective coat of protein. A virus may replicate only inside a host living cell. A virus exhibits some but not all of the usual characteristics of living things."},"label":{"xml:lang":"en","type":"literal","value":"Virus"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T007"},"def":{"xml:lang":"en","type":"literal","value":"A small, typically one-celled, prokaryotic micro-organism."},"label":{"xml:lang":"en","type":"literal","value":"Bacterium"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T008"},"def":{"xml:lang":"en","type":"literal","value":"An organism with eukaryotic cells, and lacking stiff cell walls, plastids and photosynthetic pigments."},"label":{"xml:lang":"en","type":"literal","value":"Animal"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T010"},"def":{"xml:lang":"en","type":"literal","value":"An animal which has a spinal column."},"label":{"xml:lang":"en","type":"literal","value":"Vertebrate"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T011"},"def":{"xml:lang":"en","type":"literal","value":"A cold-blooded, smooth-skinned vertebrate which characteristically hatches as an aquatic larva, breathing by gills. When mature, the amphibian breathes with lungs."},"label":{"xml:lang":"en","type":"literal","value":"Amphibian"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T012"},"def":{"xml:lang":"en","type":"literal","value":"A vertebrate having a constant body temperature and characterized by the presence of feathers."},"label":{"xml:lang":"en","type":"literal","value":"Bird"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T013"},"def":{"xml:lang":"en","type":"literal","value":"A cold-blooded aquatic vertebrate characterized by fins and breathing by gills. Included here are fishes having either a bony skeleton, such as a perch, or a cartilaginous skeleton, such as a shark, or those lacking a jaw, such as a lamprey or hagfish."},"label":{"xml:lang":"en","type":"literal","value":"Fish"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T014"},"def":{"xml:lang":"en","type":"literal","value":"A cold-blooded vertebrate having an external covering of scales or horny plates. Reptiles breathe by means of lungs and are generally egg-laying."},"label":{"xml:lang":"en","type":"literal","value":"Reptile"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T015"},"def":{"xml:lang":"en","type":"literal","value":"A vertebrate having a constant body temperature and characterized by the presence of hair, mammary glands and sweat glands."},"label":{"xml:lang":"en","type":"literal","value":"Mammal"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100069"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of an Organ-At-Risk (OAR)."},"label":{"xml:lang":"en","type":"literal","value":"Organ at Risk (ROI)"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T018"},"def":{"xml:lang":"en","type":"literal","value":"An anatomical structure that exists only before the organism is fully formed; in mammals, for example, a structure that exists only prior to the birth of the organism. This structure may be normal or abnormal."},"label":{"xml:lang":"en","type":"literal","value":"Embryonic Structure"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T019"},"def":{"xml:lang":"en","type":"literal","value":"An abnormal structure, or one that is abnormal in size or location, present at birth or evolving over time as a result of a defect in embryogenesis."},"label":{"xml:lang":"en","type":"literal","value":"Congenital Abnormality"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T190"},"def":{"xml:lang":"en","type":"literal","value":"An abnormal structure, or one that is abnormal in size or location."},"label":{"xml:lang":"en","type":"literal","value":"Anatomical Abnormality"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T021"},"def":{"xml:lang":"en","type":"literal","value":"An anatomical structure in a fully formed organism; in mammals, for example, a structure in the body after the birth of the organism."},"label":{"xml:lang":"en","type":"literal","value":"Fully Formed Anatomical Structure"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T022"},"def":{"xml:lang":"en","type":"literal","value":"A complex of anatomical structures that performs a common function."},"label":{"xml:lang":"en","type":"literal","value":"Body System"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T024"},"def":{"xml:lang":"en","type":"literal","value":"An aggregation of similarly specialized cells and the associated intercellular substance. Tissues are relatively non-localized in comparison to body parts, organs or organ components."},"label":{"xml:lang":"en","type":"literal","value":"Tissue"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T025"},"def":{"xml:lang":"en","type":"literal","value":"The fundamental structural and functional unit of living organisms."},"label":{"xml:lang":"en","type":"literal","value":"Cell"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T026"},"def":{"xml:lang":"en","type":"literal","value":"A part of a cell or the intercellular matrix, generally visible by light microscopy."},"label":{"xml:lang":"en","type":"literal","value":"Cell Component"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T028"},"def":{"xml:lang":"en","type":"literal","value":"A specific sequence, or in the case of the genome the complete sequence, of nucleotides along a molecule of DNA or RNA (in the case of some viruses) which represent the functional units of heredity."},"label":{"xml:lang":"en","type":"literal","value":"Gene or Genome"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T029"},"def":{"xml:lang":"en","type":"literal","value":"An area, subdivision, or region of the body demarcated for the purpose of topographical description."},"label":{"xml:lang":"en","type":"literal","value":"Body Location or Region"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T030"},"def":{"xml:lang":"en","type":"literal","value":"An area enclosed or surrounded by body parts or organs or the place where two anatomical structures meet or connect."},"label":{"xml:lang":"en","type":"literal","value":"Body Space or Junction"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T167"},"def":{"xml:lang":"en","type":"literal","value":"A material with definite or fairly definite chemical composition."},"label":{"xml:lang":"en","type":"literal","value":"Substance"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T037"},"def":{"xml:lang":"en","type":"literal","value":"A traumatic wound, injury, or poisoning caused by an external agent or force."},"label":{"xml:lang":"en","type":"literal","value":"Injury or Poisoning"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T067"},"def":{"xml:lang":"en","type":"literal","value":"A process or state which occurs naturally or as a result of an activity."},"label":{"xml:lang":"en","type":"literal","value":"Phenomenon or Process"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T038"},"def":{"xml:lang":"en","type":"literal","value":"A state, activity or process of the body or one of its systems or parts."},"label":{"xml:lang":"en","type":"literal","value":"Biologic Function"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T070"},"def":{"xml:lang":"en","type":"literal","value":"A phenomenon or process that occurs irrespective of the activities of human beings."},"label":{"xml:lang":"en","type":"literal","value":"Natural Phenomenon or Process"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T039"},"def":{"xml:lang":"en","type":"literal","value":"A normal process, activity, or state of the body."},"label":{"xml:lang":"en","type":"literal","value":"Physiologic Function"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T041"},"def":{"xml:lang":"en","type":"literal","value":"A physiologic function involving the mind or cognitive processing."},"label":{"xml:lang":"en","type":"literal","value":"Mental Process"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T042"},"def":{"xml:lang":"en","type":"literal","value":"A physiologic function of a particular organ, organ system, or tissue."},"label":{"xml:lang":"en","type":"literal","value":"Organ or Tissue Function"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T043"},"def":{"xml:lang":"en","type":"literal","value":"A physiologic function inherent to cells or cell components."},"label":{"xml:lang":"en","type":"literal","value":"Cell Function"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T044"},"def":{"xml:lang":"en","type":"literal","value":"A physiologic function occurring at the molecular level."},"label":{"xml:lang":"en","type":"literal","value":"Molecular Function"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T045"},"def":{"xml:lang":"en","type":"literal","value":"Functions of or related to the maintenance, translation or expression of the genetic material."},"label":{"xml:lang":"en","type":"literal","value":"Genetic Function"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T048"},"def":{"xml:lang":"en","type":"literal","value":"A clinically significant dysfunction whose major manifestation is behavioral or psychological. These dysfunctions may have identified or presumed biological etiologies or manifestations."},"label":{"xml:lang":"en","type":"literal","value":"Mental or Behavioral Dysfunction"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T050"},"def":{"xml:lang":"en","type":"literal","value":"A representation in a non-human organism of a human disease for the purpose of research into its mechanism or treatment."},"label":{"xml:lang":"en","type":"literal","value":"Experimental Model of Disease"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T051"},"def":{"xml:lang":"en","type":"literal","value":"A broad type for grouping activities, processes and states."},"label":{"xml:lang":"en","type":"literal","value":"Event"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T052"},"def":{"xml:lang":"en","type":"literal","value":"An operation or series of operations that an organism or machine carries out or participates in."},"label":{"xml:lang":"en","type":"literal","value":"Activity"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T053"},"def":{"xml:lang":"en","type":"literal","value":"Any of the psycho-social activities of humans or animals that can be observed directly by others or can be made systematically observable by the use of special strategies."},"label":{"xml:lang":"en","type":"literal","value":"Behavior"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T054"},"def":{"xml:lang":"en","type":"literal","value":"Behavior that is a direct result or function of the interaction of humans or animals with their fellows. This includes behavior that may be considered anti-social."},"label":{"xml:lang":"en","type":"literal","value":"Social Behavior"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T056"},"def":{"xml:lang":"en","type":"literal","value":"An activity carried out for recreation or exercise, or as part of daily life."},"label":{"xml:lang":"en","type":"literal","value":"Daily or Recreational Activity"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T057"},"def":{"xml:lang":"en","type":"literal","value":"An activity carried out as part of an occupation or job."},"label":{"xml:lang":"en","type":"literal","value":"Occupational Activity"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T063"},"def":{"xml:lang":"en","type":"literal","value":"Any of the techniques used in the study of or the directed modification of the gene complement of a living organism."},"label":{"xml:lang":"en","type":"literal","value":"Molecular Biology Research Technique"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T064"},"def":{"xml:lang":"en","type":"literal","value":"An activity carried out by officially constituted governments, or an activity related to the creation or enforcement of the rules or regulations governing some field of endeavor."},"label":{"xml:lang":"en","type":"literal","value":"Governmental or Regulatory Activity"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T065"},"def":{"xml:lang":"en","type":"literal","value":"An activity related to the organization and provision of education."},"label":{"xml:lang":"en","type":"literal","value":"Educational Activity"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T066"},"def":{"xml:lang":"en","type":"literal","value":"An activity carried out primarily or exclusively by machines."},"label":{"xml:lang":"en","type":"literal","value":"Machine Activity"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T068"},"def":{"xml:lang":"en","type":"literal","value":"A phenomenon or process that is a result of the activities of human beings."},"label":{"xml:lang":"en","type":"literal","value":"Human-caused Phenomenon or Process"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T069"},"def":{"xml:lang":"en","type":"literal","value":"A change in the natural environment that is a result of the activities of human beings."},"label":{"xml:lang":"en","type":"literal","value":"Environmental Effect of Humans"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T071"},"def":{"xml:lang":"en","type":"literal","value":"A broad type for grouping physical and conceptual entities."},"label":{"xml:lang":"en","type":"literal","value":"Entity"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T073"},"def":{"xml:lang":"en","type":"literal","value":"A physical object made by human beings."},"label":{"xml:lang":"en","type":"literal","value":"Manufactured Object"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T074"},"def":{"xml:lang":"en","type":"literal","value":"A manufactured object used primarily in the diagnosis, treatment, or prevention of physiologic or anatomic disorders."},"label":{"xml:lang":"en","type":"literal","value":"Medical Device"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T075"},"def":{"xml:lang":"en","type":"literal","value":"A manufactured object used primarily in carrying out scientific research or experimentation."},"label":{"xml:lang":"en","type":"literal","value":"Research Device"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T081"},"def":{"xml:lang":"en","type":"literal","value":"A concept which involves the dimensions, quantity or capacity of something using some unit of measure, or which involves the quantitative comparison of entities."},"label":{"xml:lang":"en","type":"literal","value":"Quantitative Concept"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T083"},"def":{"xml:lang":"en","type":"literal","value":"A geographic location, generally having definite boundaries."},"label":{"xml:lang":"en","type":"literal","value":"Geographic Area"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T085"},"def":{"xml:lang":"en","type":"literal","value":"A broad type for grouping the collected sequences of amino acids, carbohydrates, and nucleotide sequences. Descriptions of these sequences are generally reported in the published literature and/or are deposited in and maintained by databanks such as GenBank, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories."},"label":{"xml:lang":"en","type":"literal","value":"Molecular Sequence"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T086"},"def":{"xml:lang":"en","type":"literal","value":"The sequence of purines and pyrimidines in nucleic acids and polynucleotides. Included here are nucleotide-rich regions, conserved sequence, and DNA transforming region."},"label":{"xml:lang":"en","type":"literal","value":"Nucleotide Sequence"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T087"},"def":{"xml:lang":"en","type":"literal","value":"The sequence of amino acids as arrayed in chains, sheets, etc., within the protein molecule. It is of fundamental importance in determining protein structure."},"label":{"xml:lang":"en","type":"literal","value":"Amino Acid Sequence"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T088"},"def":{"xml:lang":"en","type":"literal","value":"The sequence of carbohydrates within polysaccharides, glycoproteins, and glycolipids."},"label":{"xml:lang":"en","type":"literal","value":"Carbohydrate Sequence"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T089"},"def":{"xml:lang":"en","type":"literal","value":"An intellectual product resulting from legislative or regulatory activity."},"label":{"xml:lang":"en","type":"literal","value":"Regulation or Law"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T090"},"def":{"xml:lang":"en","type":"literal","value":"A vocation, academic discipline, or field of study, or a subpart of an occupation or discipline."},"label":{"xml:lang":"en","type":"literal","value":"Occupation or Discipline"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T091"},"def":{"xml:lang":"en","type":"literal","value":"A vocation, academic discipline, or field of study related to biomedicine."},"label":{"xml:lang":"en","type":"literal","value":"Biomedical Occupation or Discipline"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T092"},"def":{"xml:lang":"en","type":"literal","value":"The result of uniting for a common purpose or function. The continued existence of an organization is not dependent on any of its members, its location, or particular facility. Components or subparts of organizations are also included here. Although the names of organizations are sometimes used to refer to the buildings in which they reside, they are not inherently physical in nature."},"label":{"xml:lang":"en","type":"literal","value":"Organization"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T094"},"def":{"xml:lang":"en","type":"literal","value":"An organization uniting those who have a common vocation or who are involved with a common field of study."},"label":{"xml:lang":"en","type":"literal","value":"Professional Society"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T095"},"def":{"xml:lang":"en","type":"literal","value":"An organization whose purpose and function is to provide assistance to the needy or to offer support to those sharing similar problems."},"label":{"xml:lang":"en","type":"literal","value":"Self-help or Relief Organization"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T096"},"def":{"xml:lang":"en","type":"literal","value":"A conceptual entity referring to the classification of individuals according to certain shared characteristics."},"label":{"xml:lang":"en","type":"literal","value":"Group"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T097"},"def":{"xml:lang":"en","type":"literal","value":"An individual or individuals classified according to their vocation."},"label":{"xml:lang":"en","type":"literal","value":"Professional or Occupational Group"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T098"},"def":{"xml:lang":"en","type":"literal","value":"An indivdual or individuals classified according to their sex, racial origin, religion, common place of living, financial or social status, or some other cultural or behavioral attribute."},"label":{"xml:lang":"en","type":"literal","value":"Population Group"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T099"},"def":{"xml:lang":"en","type":"literal","value":"An individual or individuals classified according to their family relationships or relative position in the family unit."},"label":{"xml:lang":"en","type":"literal","value":"Family Group"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T100"},"def":{"xml:lang":"en","type":"literal","value":"An individual or individuals classified according to their age."},"label":{"xml:lang":"en","type":"literal","value":"Age Group"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T101"},"def":{"xml:lang":"en","type":"literal","value":"An individual or individuals classified according to a disability, disease, condition or treatment."},"label":{"xml:lang":"en","type":"literal","value":"Patient or Disabled Group"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T102"},"def":{"xml:lang":"en","type":"literal","value":"A conceptual entity which refers to the frequency or distribution of certain characteristics or phenomena in certain groups."},"label":{"xml:lang":"en","type":"literal","value":"Group Attribute"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T103"},"def":{"xml:lang":"en","type":"literal","value":"Compounds or substances of definite molecular composition. Chemicals are viewed from two distinct perspectives in the network, functionally and structurally. Almost every chemical concept is assigned at least two types, generally one from the structure hierarchy and at least one from the function hierarchy."},"label":{"xml:lang":"en","type":"literal","value":"Chemical"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T109"},"def":{"xml:lang":"en","type":"literal","value":"The general class of carbon-containing compounds, usually based on carbon chains or rings, and also containing hydrogen (hydrocarbons), with or without nitrogen, oxygen, or other elements in which the bonding between elements is generally covalent."},"label":{"xml:lang":"en","type":"literal","value":"Organic Chemical"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T110"},"def":{"xml:lang":"en","type":"literal","value":"One of a group of polycyclic, 17-carbon-atom, fused-ring compounds occurring both in natural and synthetic forms. Included here are naturally occurring and synthetic steroids, bufanolides, cardanolides, homosteroids, norsteroids, and secosteroids."},"label":{"xml:lang":"en","type":"literal","value":"Steroid"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T119"},"def":{"xml:lang":"en","type":"literal","value":"An inclusive group of fat or fat-derived substances that are soluble in nonpolar solvents related to fatty acid esters, fatty alcohols, sterols, waxes, etc. Included in this group are the saponifiable lipids such as glycerides (fats and oils), essential (volatile) oils, and phospholipids."},"label":{"xml:lang":"en","type":"literal","value":"Lipid"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T111"},"def":{"xml:lang":"en","type":"literal","value":"An oxygenated metabolite from polyunsaturated 20 carbon fatty acids including lipoxygenase and cyclooxygenase products and their synthetic analogs. This includes the prostaglandins and thromboxanes."},"label":{"xml:lang":"en","type":"literal","value":"Eicosanoid"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T114"},"def":{"xml:lang":"en","type":"literal","value":"A complex compound of high molecular weight occurring in living cells. These are basically of two types, ribonucleic (RNA) and deoxyribonucleic (DNA) acids. Nucleic acids are made of nucleotides (nitrogen-containing base, a 5-carbon sugar, and one or more phosphate group) linked together by a phosphodiester bond between the 5' and 3' carbon atoms. Nucleosides are compounds composed of a purine or pyrimidine base (usually adenine, cytosine, guanine, thymine, uracil) linked to either a ribose or a deoxyribose sugar."},"label":{"xml:lang":"en","type":"literal","value":"Nucleic Acid, Nucleoside, or Nucleotide"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T115"},"def":{"xml:lang":"en","type":"literal","value":"An organic compound containing phosphorus as a constituent. Included here are organic phosphinic, phosphonic and phosphoric acid derivatives and their thiophosphorus counterparts. Excluded are phospholipids, sugar phosphates, phosphoproteins, nucleotides, and nucleic acids."},"label":{"xml:lang":"en","type":"literal","value":"Organophosphorus Compound"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T116"},"def":{"xml:lang":"en","type":"literal","value":"Amino acids and chains of amino acids connected by peptide linkages."},"label":{"xml:lang":"en","type":"literal","value":"Amino Acid, Peptide, or Protein"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T118"},"def":{"xml:lang":"en","type":"literal","value":"A generic term that includes monosaccharides, oligosaccharides, and polysaccharides as well as substances derived from monosaccharides by reduction of the carbonyl group (alditols), by oxidation of one or more terminal group to carboxylic acids, or by replacement of one or more hydroxy groups by a hydrogen atom, an amino group, a thiol group or similar heteroatomic groups. It also includes derivatives of these compounds. Included here are sugar phosphates. Excluded are glycolipids and glycoproteins."},"label":{"xml:lang":"en","type":"literal","value":"Carbohydrate"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T122"},"def":{"xml:lang":"en","type":"literal","value":"A substance used in biomedicine or dentistry predominantly for its physical, as opposed to chemical, properties. Included here are biocompatible materials, tissue adhesives, bone cements, resins, toothpastes, etc."},"label":{"xml:lang":"en","type":"literal","value":"Biomedical or Dental Material"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T123"},"def":{"xml:lang":"en","type":"literal","value":"A generally endogenous substance produced or required by an organism, of primary interest because of its role in the biologic functioning of the organism that produces it."},"label":{"xml:lang":"en","type":"literal","value":"Biologically Active Substance"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T124"},"def":{"xml:lang":"en","type":"literal","value":"An endogenous substance whose activities affect or play an important role in the functioning of the nervous system. Included here are catecholamines, neuroregulators, neurophysins, etc."},"label":{"xml:lang":"en","type":"literal","value":"Neuroreactive Substance or Biogenic Amine"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T125"},"def":{"xml:lang":"en","type":"literal","value":"In animals, a chemical usually secreted by an endocrine gland whose products are released into the circulating fluid. Hormones act as chemical messengers and regulate various physiologic processes such as growth, reproduction, metabolism, etc. They usually fall into two broad classes, steroid hormones and peptide hormones."},"label":{"xml:lang":"en","type":"literal","value":"Hormone"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T126"},"def":{"xml:lang":"en","type":"literal","value":"A complex chemical, usually a protein, that is produced by living cells and which catalyzes specific biochemical reactions. There are six main types of enzymes: oxidoreductases, transferases, hydrolases, lyases, isomerases, and ligases."},"label":{"xml:lang":"en","type":"literal","value":"Enzyme"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T127"},"def":{"xml:lang":"en","type":"literal","value":"A substance, usually an organic chemical complex, present in natural products or made synthetically, which is essential in the diet of man or other higher animals. Included here are vitamin precursors, provitamins, and vitamin supplements."},"label":{"xml:lang":"en","type":"literal","value":"Vitamin"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T129"},"def":{"xml:lang":"en","type":"literal","value":"A biologically active substance whose activities affect or play a role in the functioning of the immune system."},"label":{"xml:lang":"en","type":"literal","value":"Immunologic Factor"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T130"},"def":{"xml:lang":"en","type":"literal","value":"A substance primarily of interest for its use in laboratory or diagnostic tests and procedures to detect, measure, examine, or analyze other chemicals, processes, or conditions."},"label":{"xml:lang":"en","type":"literal","value":"Indicator, Reagent, or Diagnostic Aid"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T131"},"def":{"xml:lang":"en","type":"literal","value":"A substance of concern because of its potentially hazardous or toxic effects. This would include most drugs of abuse, as well as agents that require special handling because of their toxicity."},"label":{"xml:lang":"en","type":"literal","value":"Hazardous or Poisonous Substance"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T168"},"def":{"xml:lang":"en","type":"literal","value":"Any substance generally containing nutrients, such as carbohydrates, proteins, and fats, that can be ingested by a living organism and metabolized into energy and body tissue. Some foods are naturally occurring, others are either partially or entirely made by humans."},"label":{"xml:lang":"en","type":"literal","value":"Food"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T171"},"def":{"xml:lang":"en","type":"literal","value":"The system of communication used by a particular nation or people."},"label":{"xml:lang":"en","type":"literal","value":"Language"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T184"},"def":{"xml:lang":"en","type":"literal","value":"An observable manifestation of a disease or condition based on clinical judgment, or a manifestation of a disease or condition which is experienced by the patient and reported as a subjective observation."},"label":{"xml:lang":"en","type":"literal","value":"Sign or Symptom"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T192"},"def":{"xml:lang":"en","type":"literal","value":"A specific structure or site on the cell surface or within its cytoplasm that recognizes and binds with other specific molecules. These include the proteins on the surface of an immunocompetent cell that binds with antigens, or proteins found on the surface molecules that bind with hormones or neurotransmitters and react with other molecules that respond in a specific way."},"label":{"xml:lang":"en","type":"literal","value":"Receptor"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T194"},"def":{"xml:lang":"en","type":"literal","value":"A member of one of the three domains of life, formerly called Archaebacteria under the taxon Bacteria, but now considered separate and distinct. Archaea are characterized by: 1) the presence of characteristic tRNAs and ribosomal RNAs; 2) the absence of peptidoglycan cell walls; 3) the presence of ether-linked lipids built from branched-chain subunits; and 4) their occurrence in unusual habitats. While archaea resemble bacteria in morphology and genomic organization, they resemble eukarya in their method of genomic replication."},"label":{"xml:lang":"en","type":"literal","value":"Archaeon"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T196"},"def":{"xml:lang":"en","type":"literal","value":"One of the 109 presently known fundamental substances that comprise all matter at and above the atomic level. This includes elemental metals, rare gases, and most abundant naturally occurring radioactive elements, as well as the ionic counterparts of elements (NA+, Cl-), and the less abundant isotopic forms. This does not include organic ions such as iodoacetate to which the type 'Organic Chemical' is assigned."},"label":{"xml:lang":"en","type":"literal","value":"Element, Ion, or Isotope"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T197"},"def":{"xml:lang":"en","type":"literal","value":"Chemical elements and their compounds, excluding the hydrocarbons and their derivatives (except carbides, carbonates, cyanides, cyanates and carbon disulfide). Generally inorganic compounds contain ionic bonds. Included here are inorganic acids and salts, alloys, alkalies, and minerals."},"label":{"xml:lang":"en","type":"literal","value":"Inorganic Chemical"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T200"},"def":{"xml:lang":"en","type":"literal","value":"A pharmaceutical preparation as produced by the manufacturer. The name usually includes the substance, its strength, and the form, but may include the substance and only one of the other two items."},"label":{"xml:lang":"en","type":"literal","value":"Clinical Drug"}},{"iri":{"type":"uri","value":"http://purl.bioontology.org/ontology/STY/T203"},"def":{"xml:lang":"en","type":"literal","value":"A medical device that contains a clinical drug or drugs."},"label":{"xml:lang":"en","type":"literal","value":"Drug Delivery Device"}},{"iri":{"type":"uri","value":"http://purl.obolibrary.org/obo/UO_0000000"},"def":{"xml:lang":"en","type":"literal","value":"A unit of measurement is a standardized quantity of a physical quality."},"label":{"xml:lang":"en","type":"literal","value":"unit"}},{"iri":{"type":"uri","value":"http://purl.obolibrary.org/obo/UO_0000001"},"def":{"xml:lang":"en","type":"literal","value":"A unit which is a standard measure of the distance between two points."},"label":{"xml:lang":"en","type":"literal","value":"length unit"}},{"iri":{"type":"uri","value":"http://purl.obolibrary.org/obo/UO_0000002"},"def":{"xml:lang":"en","type":"literal","value":"A unit which is a standard measure of the amount of matter/energy of a physical object."},"label":{"xml:lang":"en","type":"literal","value":"mass unit"}},{"iri":{"type":"uri","value":"http://purl.obolibrary.org/obo/UO_0000003"},"def":{"xml:lang":"en","type":"literal","value":"A unit which is a standard measure of the dimension in which events occur in sequence."},"label":{"xml:lang":"en","type":"literal","value":"time unit"}},{"iri":{"type":"uri","value":"http://purl.obolibrary.org/obo/UO_0000009"},"def":{"xml:lang":"en","type":"literal","value":"A mass unit which is equal to the mass of the International Prototype Kilogram kept by the BIPM at Svres, France."},"label":{"xml:lang":"en","type":"literal","value":"kilogram"}},{"iri":{"type":"uri","value":"http://purl.obolibrary.org/obo/UO_0000015"},"def":{"xml:lang":"en","type":"literal","value":"A length unit which is equal to one hundredth of a meter or 10^[-2] m."},"label":{"xml:lang":"en","type":"literal","value":"centimeter"}},{"iri":{"type":"uri","value":"http://purl.obolibrary.org/obo/UO_0000033"},"def":{"xml:lang":"en","type":"literal","value":"A time unit which is equal to 24 hours."},"label":{"xml:lang":"en","type":"literal","value":"day"}},{"iri":{"type":"uri","value":"http://purl.obolibrary.org/obo/UO_0000035"},"def":{"xml:lang":"en","type":"literal","value":"A time unit which is approximately equal to the length of time of one of cycle of the moon's phases which in science is taken to be equal to 30 days."},"label":{"xml:lang":"en","type":"literal","value":"month"}},{"iri":{"type":"uri","value":"http://purl.obolibrary.org/obo/UO_0000095"},"def":{"xml:lang":"en","type":"literal","value":"A unit which is a standard measure of the amount of space occupied by any substance, whether solid, liquid, or gas."},"label":{"xml:lang":"en","type":"literal","value":"volume unit"}},{"iri":{"type":"uri","value":"http://purl.obolibrary.org/obo/UO_0000097"},"def":{"xml:lang":"en","type":"literal","value":"A volume unit which is equal to one millionth of a cubic meter or 10^[-9] m^[3], or to 1 ml."},"label":{"xml:lang":"en","type":"literal","value":"cubic centimeter"}},{"iri":{"type":"uri","value":"http://purl.obolibrary.org/obo/UO_0000098"},"def":{"xml:lang":"en","type":"literal","value":"A volume unit which is equal to one thousandth of a liter or 10^[-3] L, or to 1 cubic centimeter."},"label":{"xml:lang":"en","type":"literal","value":"milliliter"}},{"iri":{"type":"uri","value":"http://purl.obolibrary.org/obo/UO_0000099"},"def":{"xml:lang":"en","type":"literal","value":"A volume unit which is equal to one millionth of a cubic meter or 10^[-9] m^[3], or to 1 ml."},"label":{"xml:lang":"en","type":"literal","value":"Liter"}},{"iri":{"type":"uri","value":"http://purl.obolibrary.org/obo/UO_0000127"},"def":{"xml:lang":"en","type":"literal","value":"A unit which is a standard measure of the amount of radiation emitted by a given radiation source as well as the amount of radiation absorbed or deposited in a specific material by a radiation source."},"label":{"xml:lang":"en","type":"literal","value":"radiation unit"}},{"iri":{"type":"uri","value":"http://purl.obolibrary.org/obo/UO_0000134"},"def":{"xml:lang":"en","type":"literal","value":"An absorbed dose unit which is equal to the absorption of one joule of radiation energy by one kilogram of matter."},"label":{"xml:lang":"en","type":"literal","value":"gray"}},{"iri":{"type":"uri","value":"http://purl.obolibrary.org/obo/UO_0000187"},"def":{"xml:lang":"en","type":"literal","value":"A dimensionless ratio unit which denotes numbers as fractions of 100."},"label":{"xml:lang":"en","type":"literal","value":"percent"}},{"iri":{"type":"uri","value":"http://purl.obolibrary.org/obo/UO_0000189"},"def":{"xml:lang":"en","type":"literal","value":"A dimensionless unit which denotes a simple count of things."},"label":{"xml:lang":"en","type":"literal","value":"count unit"}},{"iri":{"type":"uri","value":"http://purl.org/net/OCRe/statistics.owl#OCRE200021"},"def":{"xml:lang":"en","type":"literal","value":"The event occurred within an interval, but it is not known exactly when. Example: the last measurement day one person was HIV negative and the first measurement day the person was positive are known, but when the seroconversion happened within that interval is not known"},"label":{"xml:lang":"en","type":"literal","value":"Interval censored"}},{"iri":{"type":"uri","value":"http://purl.org/net/OCRe/statistics.owl#OCRE200088"},"def":{"xml:lang":"en","type":"literal","value":"Censoring type is a particular type of interval creation. Censoring means that one event prevents another event from being observed (e.g., end of study prevents possible evidence of success or failure from being observed). Though usually employed in the context of time-to-failure, this is not only about time, but it can be about any dimension of interest (e.g., if the measurement is above the maximum value in the scale used, then the measurement is right censored; if it is lower than the minimum detectable, then it is left censored)."},"label":{"xml:lang":"en","type":"literal","value":"Censoring type"}},{"iri":{"type":"uri","value":"http://purl.org/net/OCRe/statistics.owl#OCRE200064"},"def":{"xml:lang":"en","type":"literal","value":"The event occurred some time before the last measurement, but it is not known exactly when. Example: one person tests HIV positive, but there is no negative test result, so it is not possible to estalish a time interval for seroconversion"},"label":{"xml:lang":"en","type":"literal","value":"Left censored"}},{"iri":{"type":"uri","value":"http://purl.org/net/OCRe/statistics.owl#OCRE200105"},"def":{"xml:lang":"en","type":"literal","value":"The event my have occurred some time after the last measurement, but it is not known exactly whether it has, because there are no further observations. Example: one person tests HIV negative at some point, but there are no further observations (e.g., the individual moved, or died), so it is not known whether the person has seroconverted or not"},"label":{"xml:lang":"en","type":"literal","value":"Right censored"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma10014"},"label":{"xml:lang":"en","type":"literal","value":"Ninth thoracic vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma9139"},"label":{"xml:lang":"en","type":"literal","value":"Thoracic vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma10037"},"label":{"xml:lang":"en","type":"literal","value":"Tenth thoracic vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma10059"},"label":{"xml:lang":"en","type":"literal","value":"Eleventh thoracic vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma10081"},"label":{"xml:lang":"en","type":"literal","value":"Twelfth thoracic vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma10951"},"def":{"xml:lang":"en","type":"literal","value":"Trunk of systemic vein which is formed by the union of the right common iliac vein and the left common iliac vein and  terminates in  the right atrium."},"label":{"xml:lang":"en","type":"literal","value":"Inferior vena cava"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma12513"},"def":{"xml:lang":"en","type":"literal","value":"Organ with organ cavity which is connected to the optic nerve. Examples: There are only two eyeballs, the right and the left eyeballs.."},"label":{"xml:lang":"en","type":"literal","value":"Eyeball"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma12514"},"label":{"xml:lang":"en","type":"literal","value":"Right eyeball"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma12515"},"label":{"xml:lang":"en","type":"literal","value":"Left eyeball"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma12519"},"label":{"xml:lang":"en","type":"literal","value":"Atlas"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma9915"},"label":{"xml:lang":"en","type":"literal","value":"Cervical vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma12520"},"label":{"xml:lang":"en","type":"literal","value":"Axis"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma12521"},"label":{"xml:lang":"en","type":"literal","value":"Third cervical vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma12522"},"label":{"xml:lang":"en","type":"literal","value":"Fourth cervical vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma12523"},"label":{"xml:lang":"en","type":"literal","value":"Fifth cervical vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma12524"},"label":{"xml:lang":"en","type":"literal","value":"Sixth cervical vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma12525"},"label":{"xml:lang":"en","type":"literal","value":"Seventh cervical vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma12526"},"label":{"xml:lang":"en","type":"literal","value":"Sacral vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma12784"},"label":{"xml:lang":"en","type":"literal","value":"Esophageal lymph node"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma5034"},"def":{"xml:lang":"en","type":"literal","value":"Organ component of lymphatic tree organ which has as direct regional parts cortex and medulla."},"label":{"xml:lang":"en","type":"literal","value":"Lymph node"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100334"},"def":{"xml:lang":"en","type":"literal","value":"The lower zone consists of lymph nodes of nodal stations 8-9."},"label":{"xml:lang":"en","type":"literal","value":"Lower zone"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma13072"},"label":{"xml:lang":"en","type":"literal","value":"First lumbar vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma9921"},"label":{"xml:lang":"en","type":"literal","value":"Lumbar vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma13073"},"label":{"xml:lang":"en","type":"literal","value":"Second lumbar vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma13074"},"label":{"xml:lang":"en","type":"literal","value":"Third lumbar vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma13075"},"label":{"xml:lang":"en","type":"literal","value":"Fourth lumbar vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma13076"},"label":{"xml:lang":"en","type":"literal","value":"Fifth lumbar vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma13077"},"label":{"xml:lang":"en","type":"literal","value":"First sacral vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma13078"},"label":{"xml:lang":"en","type":"literal","value":"Second sacral vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma13079"},"label":{"xml:lang":"en","type":"literal","value":"Third sacral vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma13080"},"label":{"xml:lang":"en","type":"literal","value":"Fourth sacral vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma13081"},"label":{"xml:lang":"en","type":"literal","value":"Fifth sacral vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma13889"},"label":{"xml:lang":"en","type":"literal","value":"Pituitary gland"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma14192"},"label":{"xml:lang":"en","type":"literal","value":"Supraclavicular lymph node"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100290"},"def":{"xml:lang":"en","type":"literal","value":"The supraclavicular zone consists of lymph nodes of nodal station 1."},"label":{"xml:lang":"en","type":"literal","value":"Supraclavicular zone"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma14543"},"label":{"xml:lang":"en","type":"literal","value":"Colon"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma14544"},"label":{"xml:lang":"en","type":"literal","value":"Rectum"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma14626"},"label":{"xml:lang":"en","type":"literal","value":"Wall of rectum"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma15703"},"def":{"xml:lang":"en","type":"literal","value":"Organ with organ cavity which is continuous proximally with the rectum and distally terminates with the anus. Examples: There is only one anal canal."},"label":{"xml:lang":"en","type":"literal","value":"Anal canal"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma15710"},"label":{"xml:lang":"en","type":"literal","value":"Internal anal sphincter"}},{"iri":{"type":"uri","value":"http://www.owl-ontologies.com/Ontology1415135201.owl#RID165"},"def":{"xml:lang":"en","type":"literal","value":"Either of two sphincters controlling the closing of the anus: \na :  an outer sphincter of striated muscle extending from the coccyx to the central tendinous part of the perineum and surrounding the anus immediately beneath the skincalled also external anal sphincter, sphincter ani externus \nb :  an inner sphincter formed by thickening of the circular smooth muscle of the rectumcalled also internal anal sphincter, sphincter ani internus pecify internal or external."},"label":{"xml:lang":"en","type":"literal","value":"Anal sphincter"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma15900"},"def":{"xml:lang":"en","type":"literal","value":"Organ with organ cavity which is continuous proximally with the right and left ureters and distally with the urethra. Examples: There is only one urinary bladder."},"label":{"xml:lang":"en","type":"literal","value":"Urinary bladder"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma15902"},"label":{"xml:lang":"en","type":"literal","value":"Wall of urinary bladder"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma16202"},"def":{"xml:lang":"en","type":"literal","value":"Bone complex which has as its direct parts five sacral vertebrae."},"label":{"xml:lang":"en","type":"literal","value":"Sacrum"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma16580"},"label":{"xml:lang":"en","type":"literal","value":"Bony pelvis"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma16950"},"label":{"xml:lang":"en","type":"literal","value":"Pubic symphysis"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma17558"},"def":{"xml:lang":"en","type":"literal","value":"Organ with organ cavity which is continuous proximally with the right and left uterine tubes and distally is connected to the vagina. Examples: There is only one uterus."},"label":{"xml:lang":"en","type":"literal","value":"Uterus"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma17740"},"label":{"xml:lang":"en","type":"literal","value":"Cervix of uterus"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma19386"},"label":{"xml:lang":"en","type":"literal","value":"Seminal vesicle"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma19387"},"label":{"xml:lang":"en","type":"literal","value":"Right seminal vesicle"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma19388"},"label":{"xml:lang":"en","type":"literal","value":"Left seminal vesicle"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma19614"},"label":{"xml:lang":"en","type":"literal","value":"Bulb of penis"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma19667"},"def":{"xml:lang":"en","type":"literal","value":"Organ with organ cavity which connects the cavity of the urinary bladder to the exterior. Examples: There is only one urethra."},"label":{"xml:lang":"en","type":"literal","value":"Urethra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma19949"},"def":{"xml:lang":"en","type":"literal","value":"Organ with organ cavity which connects the cervical canal of uterus to the vestibule of vagina. Examples: There is only one vagina."},"label":{"xml:lang":"en","type":"literal","value":"Vagina"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma20462"},"label":{"xml:lang":"en","type":"literal","value":"Vulva"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma20484"},"label":{"xml:lang":"en","type":"literal","value":"Parametrium of body of uterus"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma21930"},"label":{"xml:lang":"en","type":"literal","value":"External anal sphincter"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma232719"},"label":{"xml:lang":"en","type":"literal","value":"Left supraclavicular lymph node"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma232721"},"label":{"xml:lang":"en","type":"literal","value":"Right supraclavicular lymph node"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma24474"},"label":{"xml:lang":"en","type":"literal","value":"Right femur"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma9611"},"label":{"xml:lang":"en","type":"literal","value":"Femur"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma24475"},"label":{"xml:lang":"en","type":"literal","value":"Left femur"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma25912"},"label":{"xml:lang":"en","type":"literal","value":"Glenohumeral joint"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma25927"},"label":{"xml:lang":"en","type":"literal","value":"Right glenohumeral joint"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma25929"},"label":{"xml:lang":"en","type":"literal","value":"Left glenohumeral joint"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma26660"},"label":{"xml:lang":"en","type":"literal","value":"Bronchial tree"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma26661"},"label":{"xml:lang":"en","type":"literal","value":"Right bronchial tree"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma26662"},"label":{"xml:lang":"en","type":"literal","value":"Left bronchial tree"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma275020"},"label":{"xml:lang":"en","type":"literal","value":"Hippocampus"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma275022"},"label":{"xml:lang":"en","type":"literal","value":"Right hippocampus"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma275024"},"label":{"xml:lang":"en","type":"literal","value":"Left hippocampus"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma276813"},"label":{"xml:lang":"en","type":"literal","value":"Aortopulmonary lymph node"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100316"},"def":{"xml:lang":"en","type":"literal","value":"The aortopulmonary zone consists of lymph nodes of nodal stations 5-6."},"label":{"xml:lang":"en","type":"literal","value":"AP zone"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma276820"},"label":{"xml:lang":"en","type":"literal","value":"Para-aortic thoracic lymph node"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma276828"},"label":{"xml:lang":"en","type":"literal","value":"Interlobar lymph node"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100336"},"def":{"xml:lang":"en","type":"literal","value":"The hilar/interlobar zone consists of lymph nodes of nodal stations 10-11."},"label":{"xml:lang":"en","type":"literal","value":"Hilar/interlobar zone"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma276849"},"label":{"xml:lang":"en","type":"literal","value":"Lobar lymph node"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100339"},"def":{"xml:lang":"en","type":"literal","value":"The peripheral zone consists of lymph nodes of nodal stations 12-14."},"label":{"xml:lang":"en","type":"literal","value":"Peripheral zone"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma276855"},"label":{"xml:lang":"en","type":"literal","value":"Segmental lymph node"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma276861"},"label":{"xml:lang":"en","type":"literal","value":"Subsegmental lymph node"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma276867"},"label":{"xml:lang":"en","type":"literal","value":"Lymph node of inferior pulmonary ligament"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma276897"},"label":{"xml:lang":"en","type":"literal","value":"Prevertebral lymph node"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100322"},"def":{"xml:lang":"en","type":"literal","value":"The upper zone consists of lymph nodes of nodal stations 2-4."},"label":{"xml:lang":"en","type":"literal","value":"Upper zone"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma276907"},"label":{"xml:lang":"en","type":"literal","value":"Pre-vascular lymph node"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma276928"},"label":{"xml:lang":"en","type":"literal","value":"Highest mediastinal lymph node"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma276936"},"label":{"xml:lang":"en","type":"literal","value":"Right upper paratracheal lymph node"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma276938"},"label":{"xml:lang":"en","type":"literal","value":"Left upper paratracheal lymph node"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma321496"},"label":{"xml:lang":"en","type":"literal","value":"Right breast"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma9601"},"def":{"xml:lang":"en","type":"literal","value":"Region of pectoral part of chest which has as its parts nipple, areola, breast proper."},"label":{"xml:lang":"en","type":"literal","value":"Breast"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma321497"},"label":{"xml:lang":"en","type":"literal","value":"Left breast"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma323954"},"label":{"xml:lang":"en","type":"literal","value":"Mesorectal lymph node group"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma70776"},"def":{"xml:lang":"en","type":"literal","value":"Set of organ components of lymphatic tree organ consisting of lymph nodes without connecting lymphatic vessels."},"label":{"xml:lang":"en","type":"literal","value":"Lymph node group"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma35178"},"label":{"xml:lang":"en","type":"literal","value":"Hip joint"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma35179"},"label":{"xml:lang":"en","type":"literal","value":"Right hip joint"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma35180"},"label":{"xml:lang":"en","type":"literal","value":"Left hip joint"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma3734"},"label":{"xml:lang":"en","type":"literal","value":"Aorta"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma3932"},"label":{"xml:lang":"en","type":"literal","value":"Brachiocephalic artery"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma3939"},"label":{"xml:lang":"en","type":"literal","value":"Common carotid artery"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma3941"},"label":{"xml:lang":"en","type":"literal","value":"Right common carotid artery"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma3951"},"def":{"xml:lang":"en","type":"literal","value":"Systemic artery the trunk of which is continuous with either the trunk of brachiocephalic artery on the right side, or the aorta on the left side."},"label":{"xml:lang":"en","type":"literal","value":"Subclavian artery"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma3953"},"def":{"xml:lang":"en","type":"literal","value":"Subclavian artery the trunk of which is continuous with trunk of brachiocephalic artery."},"label":{"xml:lang":"en","type":"literal","value":"Right subclavian artery"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma4058"},"label":{"xml:lang":"en","type":"literal","value":"Left common carotid artery"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma45244"},"label":{"xml:lang":"en","type":"literal","value":"Right brachial nerve plexus"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma5906"},"label":{"xml:lang":"en","type":"literal","value":"Brachial nerve plexus"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma45245"},"label":{"xml:lang":"en","type":"literal","value":"Left brachial nerve plexus"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma46620"},"label":{"xml:lang":"en","type":"literal","value":"Constrictor muscle of pharynx"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma46688"},"label":{"xml:lang":"en","type":"literal","value":"Pharynx"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma4694"},"label":{"xml:lang":"en","type":"literal","value":"Left subclavian artery"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma4720"},"def":{"xml:lang":"en","type":"literal","value":"Trunk of systemic vein  which is  formed by the union of the right and left brachiocephalic veins and  terminates in the right atrium."},"label":{"xml:lang":"en","type":"literal","value":"Superior vena cava"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma4725"},"label":{"xml:lang":"en","type":"literal","value":"Subclavian vein"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma4755"},"label":{"xml:lang":"en","type":"literal","value":"Right subclavian vein"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma4763"},"label":{"xml:lang":"en","type":"literal","value":"Left subclavian vein"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma4838"},"label":{"xml:lang":"en","type":"literal","value":"Azygos vein"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma48996"},"label":{"xml:lang":"en","type":"literal","value":"Masseter"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma48997"},"label":{"xml:lang":"en","type":"literal","value":"Right masseter"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma48998"},"label":{"xml:lang":"en","type":"literal","value":"Left masseter"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma49182"},"label":{"xml:lang":"en","type":"literal","value":"Oral cavity proper"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma49846"},"label":{"xml:lang":"en","type":"literal","value":"Inferior hypophysial artery"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma49847"},"label":{"xml:lang":"en","type":"literal","value":"Right inferior hypophyseal artery"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma49848"},"label":{"xml:lang":"en","type":"literal","value":"Left inferior hypophyseal artery"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma49849"},"label":{"xml:lang":"en","type":"literal","value":"Superior hypophysial artery"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma49850"},"label":{"xml:lang":"en","type":"literal","value":"Right superior hypophyseal artery"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma49851"},"label":{"xml:lang":"en","type":"literal","value":"Left superior hypophyseal artery"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma49893"},"def":{"xml:lang":"en","type":"literal","value":"Systemic artery which supplies the heart."},"label":{"xml:lang":"en","type":"literal","value":"Coronary artery"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma49908"},"label":{"xml:lang":"en","type":"literal","value":"Superior pulmonary vein"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma66643"},"def":{"xml:lang":"en","type":"literal","value":"Vein in the pulmonary vemnous system."},"label":{"xml:lang":"en","type":"literal","value":"Pulmonary vein"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma49910"},"label":{"xml:lang":"en","type":"literal","value":"Inferior pulmonary vein"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma49911"},"label":{"xml:lang":"en","type":"literal","value":"Right inferior pulmonary vein"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma49913"},"label":{"xml:lang":"en","type":"literal","value":"Left inferior pulmonary vein"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma49914"},"label":{"xml:lang":"en","type":"literal","value":"Right superior pulmonary vein"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma49916"},"label":{"xml:lang":"en","type":"literal","value":"Left superior pulmonary vein"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma50039"},"def":{"xml:lang":"en","type":"literal","value":"Coronary artery which emerges from the anterior aortic sinus, between the right auricle and the pulmonary trunk, and supplies the right side of the heart."},"label":{"xml:lang":"en","type":"literal","value":"Right coronary artery"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma50040"},"def":{"xml:lang":"en","type":"literal","value":"Coronary artery which emerges from the left posterior aortic sinus, between the left auricle and the pulmonary trunk, and supplies the left side of the heart."},"label":{"xml:lang":"en","type":"literal","value":"Left coronary artery"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma50801"},"def":{"xml:lang":"en","type":"literal","value":"Segment of neuraxis which consists of portion of neural tissue organized and subdivided into forebrain, midbrain and hindbrain, contained in cranial cavity and continuous with and rostral to spinal cord."},"label":{"xml:lang":"en","type":"literal","value":"Brain"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma50863"},"def":{"xml:lang":"en","type":"literal","value":"Nerve trunk which is continuous with the retina and the optic chiasm."},"label":{"xml:lang":"en","type":"literal","value":"Optic nerve"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma50864"},"def":{"xml:lang":"en","type":"literal","value":"Cranial nerve which connects the midbrain to the extra-ocular and intra-ocular muscles."},"label":{"xml:lang":"en","type":"literal","value":"Oculomotor nerve"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma5865"},"def":{"xml:lang":"en","type":"literal","value":"Neural tree organ which is continuous with the brain. Examples: Trochlear nerve, facial nerve."},"label":{"xml:lang":"en","type":"literal","value":"Cranial nerve"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma50865"},"label":{"xml:lang":"en","type":"literal","value":"Trochlear nerve"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma50866"},"label":{"xml:lang":"en","type":"literal","value":"Trigeminal nerve"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma50867"},"label":{"xml:lang":"en","type":"literal","value":"Abducens nerve"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma50868"},"label":{"xml:lang":"en","type":"literal","value":"Facial nerve"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma50869"},"label":{"xml:lang":"en","type":"literal","value":"Vestibulocochlear nerve"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma50870"},"label":{"xml:lang":"en","type":"literal","value":"Glossopharyngeal nerve"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma50871"},"label":{"xml:lang":"en","type":"literal","value":"Hypoglossal nerve"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma50872"},"label":{"xml:lang":"en","type":"literal","value":"Right pulmonary artery"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma66326"},"label":{"xml:lang":"en","type":"literal","value":"Pulmonary artery"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma50873"},"label":{"xml:lang":"en","type":"literal","value":"Left pulmonary artery"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma50875"},"def":{"xml:lang":"en","type":"literal","value":"Optic nerve which is continuous with the right retina and the optic chiasm."},"label":{"xml:lang":"en","type":"literal","value":"Right optic nerve"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma50878"},"def":{"xml:lang":"en","type":"literal","value":"Optic nerve which is continuous with the left retina and the optic chiasm."},"label":{"xml:lang":"en","type":"literal","value":"Left optic nerve"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma50888"},"label":{"xml:lang":"en","type":"literal","value":"Right facial nerve"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma50889"},"label":{"xml:lang":"en","type":"literal","value":"Left facial nerve"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma50890"},"label":{"xml:lang":"en","type":"literal","value":"Right vestibulocochlear nerve"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma50891"},"label":{"xml:lang":"en","type":"literal","value":"Left vestibulocochlear nerve"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma52590"},"label":{"xml:lang":"en","type":"literal","value":"Cauda equina"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma52748"},"label":{"xml:lang":"en","type":"literal","value":"Mandible"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma52781"},"def":{"xml:lang":"en","type":"literal","value":"Subdivision of auriculotemporal part of head which has its direct parts pinna and external acoustic tube. Examples: Ther are only two external ears."},"label":{"xml:lang":"en","type":"literal","value":"External ear"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma53643"},"label":{"xml:lang":"en","type":"literal","value":"Right external ear"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma53644"},"label":{"xml:lang":"en","type":"literal","value":"Left external ear"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma54448"},"def":{"xml:lang":"en","type":"literal","value":"Subdivision of face which has as its direct parts orbital cavity and its content and eyelids."},"label":{"xml:lang":"en","type":"literal","value":"Eye"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma54449"},"label":{"xml:lang":"en","type":"literal","value":"Right eye"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma54450"},"label":{"xml:lang":"en","type":"literal","value":"Left eye"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma54640"},"label":{"xml:lang":"en","type":"literal","value":"Tongue"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma54645"},"label":{"xml:lang":"en","type":"literal","value":"Posterior part of tongue"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma54832"},"label":{"xml:lang":"en","type":"literal","value":"Temporomandibular joint"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma54833"},"label":{"xml:lang":"en","type":"literal","value":"Right temporomandibular joint"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma54834"},"label":{"xml:lang":"en","type":"literal","value":"Left temporomandibular joint"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma55093"},"label":{"xml:lang":"en","type":"literal","value":"Submandibular gland"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma55097"},"def":{"xml:lang":"en","type":"literal","value":"Heterogeneous cluster that connects the pharynx to the tracheobronchial tree. Examples: There is only one larynx."},"label":{"xml:lang":"en","type":"literal","value":"Larynx"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma55414"},"def":{"xml:lang":"en","type":"literal","value":"Subdivision of the larynx which consists of the right and left vocal cords and the rima glottidis. Examples: There is only one glottis."},"label":{"xml:lang":"en","type":"literal","value":"Glottis"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma56513"},"label":{"xml:lang":"en","type":"literal","value":"Middle ear"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma56514"},"label":{"xml:lang":"en","type":"literal","value":"Right middle ear"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma56515"},"label":{"xml:lang":"en","type":"literal","value":"Left middle ear"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma5731"},"label":{"xml:lang":"en","type":"literal","value":"Vagus nerve"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma58238"},"label":{"xml:lang":"en","type":"literal","value":"Cornea"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma58239"},"label":{"xml:lang":"en","type":"literal","value":"Right cornea"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma58240"},"label":{"xml:lang":"en","type":"literal","value":"Left cornea"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma58241"},"label":{"xml:lang":"en","type":"literal","value":"Lens"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma58242"},"label":{"xml:lang":"en","type":"literal","value":"Right lens"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma58243"},"label":{"xml:lang":"en","type":"literal","value":"Left lens"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma58301"},"def":{"xml:lang":"en","type":"literal","value":"Layer of wall of eyeball which is continuous with optic nerve."},"label":{"xml:lang":"en","type":"literal","value":"Retina"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma58302"},"def":{"xml:lang":"en","type":"literal","value":"Layer of wall of right eyeball which is continuous with right optic nerve."},"label":{"xml:lang":"en","type":"literal","value":"Right retina"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma58303"},"def":{"xml:lang":"en","type":"literal","value":"Layer of wall of left eyeball which is continuous with left optic nerve."},"label":{"xml:lang":"en","type":"literal","value":"Left retina"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma59101"},"def":{"xml:lang":"en","type":"literal","value":"Lobular organ the parenchyma of which consists of glandular acini which communicate the lacrimal sac. Examples: There only two, right lacrimal and left lacrimal glands."},"label":{"xml:lang":"en","type":"literal","value":"Lacrimal gland"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma59102"},"label":{"xml:lang":"en","type":"literal","value":"Right lacrimal gland"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma59103"},"label":{"xml:lang":"en","type":"literal","value":"Left lacrimal gland"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma5960"},"label":{"xml:lang":"en","type":"literal","value":"Right superior tracheobronchial lymph node"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma5961"},"label":{"xml:lang":"en","type":"literal","value":"Left superior tracheobronchial lymph node"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma5962"},"label":{"xml:lang":"en","type":"literal","value":"Inferior tracheobronchial lymph node"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100333"},"def":{"xml:lang":"en","type":"literal","value":"The subcarinal zone consists of lymph nodes of nodal station 7."},"label":{"xml:lang":"en","type":"literal","value":"Subcarinal zone"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma5965"},"label":{"xml:lang":"en","type":"literal","value":"Bronchopulmonary lymph node"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma59790"},"label":{"xml:lang":"en","type":"literal","value":"Parotid gland"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma59797"},"label":{"xml:lang":"en","type":"literal","value":"Right parotid gland"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma59798"},"label":{"xml:lang":"en","type":"literal","value":"Left parotid gland"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma59802"},"label":{"xml:lang":"en","type":"literal","value":"Right submandibular gland"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma59803"},"label":{"xml:lang":"en","type":"literal","value":"Left submandibular gland"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma59816"},"def":{"xml:lang":"en","type":"literal","value":"Region of labial part of mouth sharing upper or lower boundary of oral orifice."},"label":{"xml:lang":"en","type":"literal","value":"Lip"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma60201"},"label":{"xml:lang":"en","type":"literal","value":"Cochlea"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma60202"},"label":{"xml:lang":"en","type":"literal","value":"Right cochlea"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma60203"},"label":{"xml:lang":"en","type":"literal","value":"Left cochlea"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma61817"},"def":{"xml:lang":"en","type":"literal","value":"Segment of telencephalon which has as its direct proper parts cerebral cortex and cerebral medulla."},"label":{"xml:lang":"en","type":"literal","value":"Cerebral hemisphere"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma61819"},"def":{"xml:lang":"en","type":"literal","value":"Left cerebral hemisphere is one of two bilateral, largely symmetrical organ subdivisions within the telencephalon which contain the cerebral cortex and cerebral white matter."},"label":{"xml:lang":"en","type":"literal","value":"Left cerebral hemisphere"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma61824"},"def":{"xml:lang":"en","type":"literal","value":"Frontal lobe is the anterior-most of five lobes of the cerebral hemisphere.  It is bounded by the central sulcus on its posterior border and by the longitudinal cerebral fissure on its medial border."},"label":{"xml:lang":"en","type":"literal","value":"Frontal lobe"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma61825"},"def":{"xml:lang":"en","type":"literal","value":"Temporal lobe is the ventrolateral lobe of five lobes comprising each cerebral hemisphere.  It is bounded dorsally by the lateral fissure and posteriorly by an arbitrary border shared with the occipital lobe."},"label":{"xml:lang":"en","type":"literal","value":"Temporal lobe"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma61826"},"def":{"xml:lang":"en","type":"literal","value":"Parietal lobe is the one of five lobes of the cerebral hemisphere which occupies the dorsal-posterior portion of the hemisphere.  It is bounded by the central sulcus on its anterior border and and by the longitudinal cerebral fissure on its medial border. Posteriorly it shares an arbitrary border with the occipital lobe."},"label":{"xml:lang":"en","type":"literal","value":"Parietal lobe"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma62008"},"label":{"xml:lang":"en","type":"literal","value":"Hypothalamus"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma62045"},"def":{"xml:lang":"en","type":"literal","value":"Nerve trunk which is continuous with right and left optic nerves and right and left optic tracts."},"label":{"xml:lang":"en","type":"literal","value":"Optic chiasm"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma63183"},"def":{"xml:lang":"en","type":"literal","value":"Segment of blood vessel tree organ which is a tubular structure the lumen of which contains blood; together with other spatially associated blood vessels constitute blood vessel tree organ."},"label":{"xml:lang":"en","type":"literal","value":"Blood vessel"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma67292"},"def":{"xml:lang":"en","type":"literal","value":"The right cerebral hemisphere is one of two bilateral, largely symmetrical organ subdivisions within the telencephalon which contain the cerebral cortex and cerebral white matter."},"label":{"xml:lang":"en","type":"literal","value":"Right cerebral hemisphere"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma67325"},"def":{"xml:lang":"en","type":"literal","value":"Occipital lobe is the one of five lobes of the cerebral hemisphere which occupies the posterior-most portion of the hemisphere.  Anteriorly, it shares an arbitrary border with the parietal lobe and temporal lobe.  Medially, it is bounded by the longitudinal cerebral fissure."},"label":{"xml:lang":"en","type":"literal","value":"Occipital lobe"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma67944"},"def":{"xml:lang":"en","type":"literal","value":"Segment of neuraxis that has as its parts the cerebellar cortex, cerebellar nuclear complex and cerebellar white matter. Examples: There is only one cerebellum."},"label":{"xml:lang":"en","type":"literal","value":"Cerebellum"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7088"},"def":{"xml:lang":"en","type":"literal","value":"Organ with cavitated organ parts, which is continuous with the systemic and \npulmonary arterial and venous trees. Examples: There is only one heart."},"label":{"xml:lang":"en","type":"literal","value":"Heart"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7096"},"def":{"xml:lang":"en","type":"literal","value":"Right cardiac chamber which is continuous with the superior vena cava and inferior vena cava."},"label":{"xml:lang":"en","type":"literal","value":"Right atrium"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7099"},"def":{"xml:lang":"en","type":"literal","value":"Cardiac chamber which consists of a wall that surrounds the cavity of an atrium."},"label":{"xml:lang":"en","type":"literal","value":"Cardiac atrium"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7097"},"def":{"xml:lang":"en","type":"literal","value":"Left cardiac chamber which is continuous with the pulmonary venous trunk."},"label":{"xml:lang":"en","type":"literal","value":"Left atrium"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7098"},"def":{"xml:lang":"en","type":"literal","value":"Right cardiac chamber which is continuous with the pulmonary arterial trunk."},"label":{"xml:lang":"en","type":"literal","value":"Right ventricle"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7100"},"def":{"xml:lang":"en","type":"literal","value":"Cardiac chamber which consists of a wall that surrounds the cavity of a ventricle."},"label":{"xml:lang":"en","type":"literal","value":"Cardiac ventricle"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7101"},"def":{"xml:lang":"en","type":"literal","value":"Left cardiac chamber which is continuous with the aorta."},"label":{"xml:lang":"en","type":"literal","value":"Left ventricle"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7131"},"def":{"xml:lang":"en","type":"literal","value":"Organ with organ cavity which is continuous superiorly with  the pharynx and inferiorly with the stomach. Examples: There is only one esophagus."},"label":{"xml:lang":"en","type":"literal","value":"Esophagus"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7148"},"def":{"xml:lang":"en","type":"literal","value":"Organ with organ cavity which is continuous proximally with the esophagus and distally with the small intestine. Examples: There is only one stomach."},"label":{"xml:lang":"en","type":"literal","value":"Stomach"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7163"},"def":{"xml:lang":"en","type":"literal","value":"Nonparenchymatous organ that consists of the epidermis, dermis and sets of hair and nails and which surrounds the entire body. Subdivisions of the skin surround various body parts; as a whole, the skin constitutes the external layer of the body.  Examples: There is only one skin."},"label":{"xml:lang":"en","type":"literal","value":"Skin"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7195"},"def":{"xml:lang":"en","type":"literal","value":"Lobular organ which has as its parts alveoli connected to the tracheobronchial tree. Examples: There are only two lungs, right lung and left lung."},"label":{"xml:lang":"en","type":"literal","value":"Lung"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7196"},"label":{"xml:lang":"en","type":"literal","value":"Spleen"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7197"},"def":{"xml:lang":"en","type":"literal","value":"Lobular organ which has as its parts lobules connected to the biliary tree. Examples: There is only one liver."},"label":{"xml:lang":"en","type":"literal","value":"Liver"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7198"},"def":{"xml:lang":"en","type":"literal","value":"Lobular organ the parenchyma of which consists of glandular acini which communicate via a duct system with the duodenum. Examples: There is only one pancreas."},"label":{"xml:lang":"en","type":"literal","value":"Pancreas"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7200"},"def":{"xml:lang":"en","type":"literal","value":"Organ with organ cavity which is continuous proximally with the stomach and distally with the large intestine. Examples: There is only one small intestine."},"label":{"xml:lang":"en","type":"literal","value":"Small intestine"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7201"},"def":{"xml:lang":"en","type":"literal","value":"Organ with organ cavity which is continuous proximally with the small intestine and distally with the anal canal. Examples: There is only large intestine."},"label":{"xml:lang":"en","type":"literal","value":"Large intestine"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7203"},"def":{"xml:lang":"en","type":"literal","value":"Corticomedullary organ which has as its part renal pelvis shared with and connected to ureter. Examples: There are only two, right kidney and left kidney."},"label":{"xml:lang":"en","type":"literal","value":"Kidney"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7204"},"def":{"xml:lang":"en","type":"literal","value":"Kidney located right of sagittal midplane of body."},"label":{"xml:lang":"en","type":"literal","value":"Right kidney"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7205"},"def":{"xml:lang":"en","type":"literal","value":"Kidney located left of sagittal midplane of body."},"label":{"xml:lang":"en","type":"literal","value":"Left kidney"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7206"},"label":{"xml:lang":"en","type":"literal","value":"Duodenum"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7209"},"label":{"xml:lang":"en","type":"literal","value":"Ovary"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7210"},"def":{"xml:lang":"en","type":"literal","value":"Lobular organ the parenchyma of which consists of seminiferous tubules which communicate with the duct of the epididymis. Examples: There only two, right testis and left testis."},"label":{"xml:lang":"en","type":"literal","value":"Testis"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7211"},"def":{"xml:lang":"en","type":"literal","value":"Testis located right of sagittal midplane of body."},"label":{"xml:lang":"en","type":"literal","value":"Right testis"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7212"},"def":{"xml:lang":"en","type":"literal","value":"Testis located left of sagittal midplane of body."},"label":{"xml:lang":"en","type":"literal","value":"Left testis"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7213"},"label":{"xml:lang":"en","type":"literal","value":"Right ovary"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7214"},"label":{"xml:lang":"en","type":"literal","value":"Left ovary"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma72969"},"label":{"xml:lang":"en","type":"literal","value":"Right frontal lobe"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma72970"},"label":{"xml:lang":"en","type":"literal","value":"Left frontal lobe"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma72971"},"label":{"xml:lang":"en","type":"literal","value":"Right temporal lobe"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma72972"},"label":{"xml:lang":"en","type":"literal","value":"Left temporal lobe"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma72973"},"label":{"xml:lang":"en","type":"literal","value":"Right parietal lobe"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma72974"},"label":{"xml:lang":"en","type":"literal","value":"Left parietal lobe"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma72975"},"label":{"xml:lang":"en","type":"literal","value":"Right occipital lobe"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma72976"},"label":{"xml:lang":"en","type":"literal","value":"Left occipital lobe"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7309"},"def":{"xml:lang":"en","type":"literal","value":"Lung located right of sagittal midplane of body and which consists of the right upper lobe, middle lobe and right lower lobe."},"label":{"xml:lang":"en","type":"literal","value":"Right lung"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7310"},"def":{"xml:lang":"en","type":"literal","value":"Lung located left of sagittal midplane of body and which consists of the left upper lobe and left lower lobe."},"label":{"xml:lang":"en","type":"literal","value":"Left lung"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7330"},"label":{"xml:lang":"en","type":"literal","value":"Pulmonary hilum"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7333"},"label":{"xml:lang":"en","type":"literal","value":"Upper lobe of right lung"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7334"},"label":{"xml:lang":"en","type":"literal","value":"Upper lobe of lung"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7335"},"label":{"xml:lang":"en","type":"literal","value":"Lower lobe of lung"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7337"},"label":{"xml:lang":"en","type":"literal","value":"Lower lobe of right lung"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7370"},"label":{"xml:lang":"en","type":"literal","value":"Upper lobe of left lung"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100388"},"def":{"xml:lang":"en","type":"literal","value":"An area in the body consisting of both left lung lobes. E.g. a lung cancer may have grown into both lobes of the left lung."},"label":{"xml:lang":"en","type":"literal","value":"Both Lobes of the Left Lung"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7371"},"label":{"xml:lang":"en","type":"literal","value":"Lower lobe of left lung"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7383"},"label":{"xml:lang":"en","type":"literal","value":"Middle lobe of right lung"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7394"},"label":{"xml:lang":"en","type":"literal","value":"Trachea"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7395"},"label":{"xml:lang":"en","type":"literal","value":"Right main bronchus"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7405"},"label":{"xml:lang":"en","type":"literal","value":"Main bronchus"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7396"},"label":{"xml:lang":"en","type":"literal","value":"Left main bronchus"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7433"},"label":{"xml:lang":"en","type":"literal","value":"Lingula of left lung"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7456"},"label":{"xml:lang":"en","type":"literal","value":"Right pulmonary hilum"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7465"},"label":{"xml:lang":"en","type":"literal","value":"Carina of trachea"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7480"},"label":{"xml:lang":"en","type":"literal","value":"Rib cage"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7574"},"label":{"xml:lang":"en","type":"literal","value":"Rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7592"},"label":{"xml:lang":"en","type":"literal","value":"True rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7593"},"label":{"xml:lang":"en","type":"literal","value":"Typical rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7594"},"label":{"xml:lang":"en","type":"literal","value":"False rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7595"},"label":{"xml:lang":"en","type":"literal","value":"Floating rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7596"},"label":{"xml:lang":"en","type":"literal","value":"Atypical rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7597"},"label":{"xml:lang":"en","type":"literal","value":"First rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7620"},"label":{"xml:lang":"en","type":"literal","value":"Second rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7638"},"label":{"xml:lang":"en","type":"literal","value":"Third rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7647"},"def":{"xml:lang":"en","type":"literal","value":"Segment of neuraxis which consists of portion of neural tissue continuous with and caudal to brain, surround central canal and contained in space of vertebral canal."},"label":{"xml:lang":"en","type":"literal","value":"Spinal cord"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7749"},"label":{"xml:lang":"en","type":"literal","value":"Fourth rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7776"},"label":{"xml:lang":"en","type":"literal","value":"Fifth rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7830"},"label":{"xml:lang":"en","type":"literal","value":"Seventh rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7857"},"label":{"xml:lang":"en","type":"literal","value":"Right first rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7882"},"label":{"xml:lang":"en","type":"literal","value":"Right second rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7909"},"label":{"xml:lang":"en","type":"literal","value":"Right third rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7957"},"label":{"xml:lang":"en","type":"literal","value":"Right fourth rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma7987"},"label":{"xml:lang":"en","type":"literal","value":"Left first rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma79876"},"label":{"xml:lang":"en","type":"literal","value":"Brainstem"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma8012"},"label":{"xml:lang":"en","type":"literal","value":"Left second rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma8039"},"label":{"xml:lang":"en","type":"literal","value":"Left third rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma8066"},"label":{"xml:lang":"en","type":"literal","value":"Right fifth rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma8093"},"label":{"xml:lang":"en","type":"literal","value":"Left fifth rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma8120"},"label":{"xml:lang":"en","type":"literal","value":"Eighth rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma8147"},"label":{"xml:lang":"en","type":"literal","value":"Sixth rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma8148"},"label":{"xml:lang":"en","type":"literal","value":"Left fourth rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma8175"},"label":{"xml:lang":"en","type":"literal","value":"Right sixth rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma8202"},"label":{"xml:lang":"en","type":"literal","value":"Left sixth rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma8229"},"label":{"xml:lang":"en","type":"literal","value":"Right seventh rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma8256"},"label":{"xml:lang":"en","type":"literal","value":"Left seventh rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma8283"},"label":{"xml:lang":"en","type":"literal","value":"Right eighth rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma8310"},"label":{"xml:lang":"en","type":"literal","value":"Left eighth rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma8337"},"label":{"xml:lang":"en","type":"literal","value":"Ninth rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma8364"},"label":{"xml:lang":"en","type":"literal","value":"Right ninth rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma8391"},"label":{"xml:lang":"en","type":"literal","value":"Left ninth rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma8418"},"label":{"xml:lang":"en","type":"literal","value":"Tenth rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma8445"},"label":{"xml:lang":"en","type":"literal","value":"Right tenth rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma8472"},"label":{"xml:lang":"en","type":"literal","value":"Left tenth rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma8499"},"label":{"xml:lang":"en","type":"literal","value":"Eleventh rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma8515"},"label":{"xml:lang":"en","type":"literal","value":"Twelfth rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma8531"},"label":{"xml:lang":"en","type":"literal","value":"Right eleventh rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma8532"},"label":{"xml:lang":"en","type":"literal","value":"Left eleventh rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma8533"},"label":{"xml:lang":"en","type":"literal","value":"Right twelfth rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma8534"},"label":{"xml:lang":"en","type":"literal","value":"Left twelfth rib"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma9165"},"label":{"xml:lang":"en","type":"literal","value":"First thoracic vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma9187"},"label":{"xml:lang":"en","type":"literal","value":"Second thoracic vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma9209"},"label":{"xml:lang":"en","type":"literal","value":"Third thoracic vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma9248"},"label":{"xml:lang":"en","type":"literal","value":"Fourth thoracic vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma9579"},"def":{"xml:lang":"en","type":"literal","value":"Subdivision of trunk proper, which is demarcated from the pelvis by the inferior surface of the pelvic diaphragm and from the lower limbs by the perineofemoral lines; together with the thorax, and abdomen, it constitutes the trunk proper. Examples: There is only one perineum."},"label":{"xml:lang":"en","type":"literal","value":"Perineum"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma9597"},"def":{"xml:lang":"en","type":"literal","value":"Lobular organ the parenchyma of which consists of glandular acini which communicate with oral cavity. Examples: parotid gland, sublingual gland, lingual salivary gland."},"label":{"xml:lang":"en","type":"literal","value":"Salivary gland"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma9600"},"def":{"xml:lang":"en","type":"literal","value":"Lobular organ the parenchyma of which has as its parts glandular acini which are continuous with the prostatic part of the urethra. Examples: There is only one prostate."},"label":{"xml:lang":"en","type":"literal","value":"Prostate"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma9603"},"def":{"xml:lang":"en","type":"literal","value":"Lobular organ the parenchyma of which consists of ductless, glandular follicles filled with colloid. Examples: thyroid gland proper, accessory thyroid gland, lingual thyroid gland."},"label":{"xml:lang":"en","type":"literal","value":"Thyroid gland"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma9707"},"label":{"xml:lang":"en","type":"literal","value":"Penis"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma9751"},"label":{"xml:lang":"en","type":"literal","value":"Left pulmonary hilum"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma9826"},"def":{"xml:lang":"en","type":"literal","value":"Subdivsion of thoracic compartment which has as its parts the superior mediastinum and inferior mediastinum."},"label":{"xml:lang":"en","type":"literal","value":"Mediastinum"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma9869"},"def":{"xml:lang":"en","type":"literal","value":"Organ cluster which has as its direct parts the fibrous pericardium and the pericardial sac."},"label":{"xml:lang":"en","type":"literal","value":"Pericardium"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma9922"},"label":{"xml:lang":"en","type":"literal","value":"Fifth thoracic vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma9945"},"label":{"xml:lang":"en","type":"literal","value":"Sixth thoracic vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma9968"},"label":{"xml:lang":"en","type":"literal","value":"Seventh thoracic vertebra"}},{"iri":{"type":"uri","value":"http://purl.org/sig/ont/fma/fma9991"},"label":{"xml:lang":"en","type":"literal","value":"Eighth thoracic vertebra"}},{"iri":{"type":"uri","value":"http://semantic-dicom.org/dcm#InformationEntity"},"label":{"xml:lang":"en","type":"literal","value":"InformationEntity"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100321"},"def":{"xml:lang":"en","type":"literal","value":"A concept which is of interest because it pertains to the DICOM protocol.\nExamples are target and other Information Object Defintion and Entities."},"label":{"xml:lang":"en","type":"literal","value":"DICOM Functional Concept"}},{"iri":{"type":"uri","value":"http://semantic-dicom.org/dcm#InformationObjectDefinition"},"def":{"xml:lang":"en","type":"literal","value":"An Information Object Definition (IOD) is an object-oriented abstract data model used to specify information about Real-World Objects. An IOD provides communicating Application Entities with a common view of the information to be exchanged. (DICOM)"},"label":{"xml:lang":"en","type":"literal","value":"InformationObjectDefinition"}},{"iri":{"type":"uri","value":"http://semantic-dicom.org/dcm#Patient"},"label":{"xml:lang":"en","type":"literal","value":"Patient"}},{"iri":{"type":"uri","value":"http://semantic-dicom.org/dcm#RTDose"},"label":{"xml:lang":"en","type":"literal","value":"RTDose"}},{"iri":{"type":"uri","value":"http://semantic-dicom.org/dcm#RTImage"},"label":{"xml:lang":"en","type":"literal","value":"RTImage"}},{"iri":{"type":"uri","value":"http://semantic-dicom.org/dcm#RTPlan"},"label":{"xml:lang":"en","type":"literal","value":"RTPlan"}},{"iri":{"type":"uri","value":"http://semantic-dicom.org/dcm#RTStructureSet"},"label":{"xml:lang":"en","type":"literal","value":"RTStructureSet"}},{"iri":{"type":"uri","value":"http://semantic-dicom.org/dcm#Series"},"label":{"xml:lang":"en","type":"literal","value":"Series"}},{"iri":{"type":"uri","value":"http://semantic-dicom.org/dcm#Study"},"label":{"xml:lang":"en","type":"literal","value":"Study"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C000000"},"def":{"xml:lang":"en","type":"literal","value":"Elapsed time two or more years that a person has been alive since a related observation, procedure, event or finding."},"label":{"xml:lang":"en","type":"literal","value":"Two or More Years Survival"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100014"},"def":{"xml:lang":"en","type":"literal","value":"Elapsed time that a person has been alive since a related observation, procedure, event or finding."},"label":{"xml:lang":"en","type":"literal","value":"Survival"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C000001"},"def":{"xml:lang":"en","type":"literal","value":"Elapsed time is less than two years that a person has been alive since a related observation, procedure, event or finding. The person has died."},"label":{"xml:lang":"en","type":"literal","value":"Less Than Two Years Survival"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100001"},"def":{"xml:lang":"en","type":"literal","value":"The Adult Comorbidity Evaluation - 27 is a 27-item comorbidity index for patients with cancer.  It identifies the important medical comorbidities and grades severity using the index. For more information: https://www.rtog.org/LinkClick.aspx?fileticket=xMGEfaLHRuM%3D&tabid=290."},"label":{"xml:lang":"en","type":"literal","value":"Adult comorbidity evaluation-27"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100002"},"def":{"xml:lang":"en","type":"literal","value":"Age at the time of diagnosis of the disease."},"label":{"xml:lang":"en","type":"literal","value":"'Age at Diagnosis'"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100002"},"def":{"xml:lang":"en","type":"literal","value":"Age at the time of diagnosis of the disease."},"label":{"xml:lang":"en","type":"literal","value":"Age at Diagnosis"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100003"},"def":{"xml:lang":"en","type":"literal","value":"The age of the patient at the start of radiotherapy."},"label":{"xml:lang":"en","type":"literal","value":"Age at Start RT"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100006"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the Gross Tumor Volume. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"GTV (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100068"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of a Target Volume."},"label":{"xml:lang":"en","type":"literal","value":"Target Volume (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100007"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the Planning Target Volume. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"PTV (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100614"},"def":{"xml:lang":"en","type":"literal","value":"The Planning Target Volume of a primary tumor."},"label":{"xml:lang":"en","type":"literal","value":"Planning Target Volume - Primary Tumor"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100009"},"def":{"xml:lang":"en","type":"literal","value":"The maximum tracer uptake in a given region of interest calculated standardized using the bdy weight and the injected activity."},"label":{"xml:lang":"en","type":"literal","value":"SUVmax"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100010"},"def":{"xml:lang":"en","type":"literal","value":"The mean tracer uptake in a given region of interest calculated standardized using the bdy weight and the injected activity."},"label":{"xml:lang":"en","type":"literal","value":"SUVmean"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100011"},"def":{"xml:lang":"en","type":"literal","value":"The total absorbed radiation dose delivered to a tumor in a complete radiotherapy treatment."},"label":{"xml:lang":"en","type":"literal","value":"Delivered Radiotherapy Total Treatment Dose"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100012"},"def":{"xml:lang":"en","type":"literal","value":"The absorbed radiation dose actually delivered to a tissue."},"label":{"xml:lang":"en","type":"literal","value":"Delivered Radiation Dose"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100352"},"def":{"xml:lang":"en","type":"literal","value":"The total absorbed radiation dose prescribed or delivered to a tumor in a complete radiotherapy treatment."},"label":{"xml:lang":"en","type":"literal","value":"Radiotherapy Total Treatment Dose"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100013"},"def":{"xml:lang":"en","type":"literal","value":"The absorbed radiation dose prescribed to be delivered to a tissue."},"label":{"xml:lang":"en","type":"literal","value":"Prescribed Radiation Dose"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100043"},"def":{"xml:lang":"en","type":"literal","value":"Chemotherapy given before and/or after radiotherapy."},"label":{"xml:lang":"en","type":"literal","value":"Sequential Chemoradiotherapy"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100044"},"def":{"xml:lang":"en","type":"literal","value":"The social circumstance where a persons lives with a partner in a romantic relantionship."},"label":{"xml:lang":"en","type":"literal","value":"Living with partner"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100045"},"def":{"xml:lang":"en","type":"literal","value":"The circumstance or condition that resulted in the death of a living being was related to cancer."},"label":{"xml:lang":"en","type":"literal","value":"Cause of death related to cancer"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100048"},"def":{"xml:lang":"en","type":"literal","value":"The circumstance or condition that resulted in the death of a living being was not related to cancer."},"label":{"xml:lang":"en","type":"literal","value":"Cause of death not related to cancer"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100046"},"def":{"xml:lang":"en","type":"literal","value":"The circumstance or condition that resulted in the death of a living being was directly related to cancer. An example is death due to respiratory failure cause by metastases in the lung."},"label":{"xml:lang":"en","type":"literal","value":"Cause of death directly related to cancer"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100047"},"def":{"xml:lang":"en","type":"literal","value":"The circumstance or condition that resulted in the death of a living being was directly related to cancer. An example is death due to respiratory failure cause by radiation pneuomnitis after lung cancer radiotherapy."},"label":{"xml:lang":"en","type":"literal","value":"Cause of death indirectly related to cancer"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100049"},"def":{"xml:lang":"en","type":"literal","value":"Number of positive lymph node stations (PLNS), assessed by FDG-PET scan, using the Naruke map."},"label":{"xml:lang":"en","type":"literal","value":"Positive Lymph Node Stations"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100050"},"def":{"xml:lang":"en","type":"literal","value":"The count of images in a given image set."},"label":{"xml:lang":"en","type":"literal","value":"Number of Images"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100052"},"def":{"xml:lang":"en","type":"literal","value":"Seventh edition of the American Joint Commission on Cancer (AJCC) Cancer Staging Manual."},"label":{"xml:lang":"en","type":"literal","value":"AJCC 7th Edition"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100053"},"def":{"xml:lang":"en","type":"literal","value":"Sixth edition of the American Joint Commission on Cancer (AJCC) Cancer Staging Manual."},"label":{"xml:lang":"en","type":"literal","value":"AJCC 6th Edition"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100054"},"def":{"xml:lang":"en","type":"literal","value":"The volume of the primary tumor."},"label":{"xml:lang":"en","type":"literal","value":"Volume of the Primary Tumor"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100055"},"def":{"xml:lang":"en","type":"literal","value":"The total volume of all macroscopic lymph nodes metastases in the body."},"label":{"xml:lang":"en","type":"literal","value":"Volume of the Positive Macroscopic Nodes"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100056"},"def":{"xml:lang":"en","type":"literal","value":"A therapeutic procedure or session in which part of the full radiotherapy course is delivered. Commonly  radiotherapy is given in daily fractions. This allows healthy cells to recover between fractions."},"label":{"xml:lang":"en","type":"literal","value":"Radiotherapy Fraction"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100057"},"def":{"xml:lang":"en","type":"literal","value":"The total absorbed radiation dose prescribed to a tumor in a complete radiotherapy treatment."},"label":{"xml:lang":"en","type":"literal","value":"Prescribed Radiotherapy Total Treatment Dose"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100058"},"def":{"xml:lang":"en","type":"literal","value":"The first fraction of a radiotherapy treatment."},"label":{"xml:lang":"en","type":"literal","value":"First Radiotherapy fraction"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100059"},"def":{"xml:lang":"en","type":"literal","value":"The last fraction of a radiotherapy treatment."},"label":{"xml:lang":"en","type":"literal","value":"Last Radiotherapy fraction"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100062"},"def":{"xml:lang":"en","type":"literal","value":"The social circumstance where a persons lives alone."},"label":{"xml:lang":"en","type":"literal","value":"Living alone"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100063"},"def":{"xml:lang":"en","type":"literal","value":"Time elapsed between time of fist treatment and the patient's time of death."},"label":{"xml:lang":"en","type":"literal","value":"Survival Time Since First Treatment"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100064"},"def":{"xml:lang":"en","type":"literal","value":"An area in the body consisting of more than one lung lobe. E.g. a lung cancer may have grown into multiple lobes of the lung."},"label":{"xml:lang":"en","type":"literal","value":"Multiple Lobes of the Lung"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100065"},"def":{"xml:lang":"en","type":"literal","value":"A secondary neoplasm which is not found in the thorax."},"label":{"xml:lang":"en","type":"literal","value":"Non-Thoracic Secondary Neoplasm"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100066"},"def":{"xml:lang":"en","type":"literal","value":"A secondary neoplasm which is found in the thorax."},"label":{"xml:lang":"en","type":"literal","value":"Thoracic Secondary Neoplasm"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100067"},"def":{"xml:lang":"en","type":"literal","value":"The class of regions of interest used in Radiation Oncology and adhering to the Standardized Naming Conventions in Radiation Oncology."},"label":{"xml:lang":"en","type":"literal","value":"Radiation Oncology Region of Interest"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100609"},"def":{"xml:lang":"en","type":"literal","value":"The Organ-At-Risk (OAR) or critical normal structures are tissues that if irradiated could suffer significant morbidity and thus might influence the treatment planning and/or the absorbed-dose prescription. (ICRU 83)\nFor more information: http://dx.doi.org/10.1093/jicru/ndq001"},"label":{"xml:lang":"en","type":"literal","value":"Organ at Risk"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100070"},"def":{"xml:lang":"en","type":"literal","value":"Chemotherapy administered during radiotherapy."},"label":{"xml:lang":"en","type":"literal","value":"Concurrent Chemoradiotherapy"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100071"},"def":{"xml:lang":"en","type":"literal","value":"A radiotherapy margin provides a buffer in the delineation of tissues to account for uncertainties. (ICRU 83)"},"label":{"xml:lang":"en","type":"literal","value":"Radiotherapy Margin"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100072"},"def":{"xml:lang":"en","type":"literal","value":"A radiotherapy margin which is not the same in all directions."},"label":{"xml:lang":"en","type":"literal","value":"Nonuniform Margin"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100073"},"def":{"xml:lang":"en","type":"literal","value":"A radiotherapy margin which is the same in all directions."},"label":{"xml:lang":"en","type":"literal","value":"Uniform Margin"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100074"},"def":{"xml:lang":"en","type":"literal","value":"A one-dimensional size determination of the tumor along the length axis. Typically tumors in elongated organs (e.g. esophagus, rectum) are measured along the long axis of the organ rather than the traverse or other axes."},"label":{"xml:lang":"en","type":"literal","value":"Tumor Length"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100075"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the anal canal as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"AnalCanal (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100078"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left kidney as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Kidney_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100079"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right kidney as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Kidney_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100080"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left main bronchus as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"MainBronchus_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100084"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the pulmonary artery as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"A_Pulmonary (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100085"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the common carotid artery as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"A_Carotid (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100086"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the brachiocephalic artery as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"A_Brachiocephali (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100087"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the coronary artery as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"A_Coronary (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100088"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the subclavian artery as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"A_Subclavicular (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100089"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the superior hypophysial artery as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"A_HypophysealSuperior (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100090"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the aorta as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Aorta (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100091"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the anal sphincter as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"AnalSphincter (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100092"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the cardiac atrium as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Atrium (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100093"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the urinary bladder as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Bladder (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100094"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the wall of urinary bladder as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"BladderWall (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100095"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the brachial nerve plexus as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"BrachialPlexus (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100096"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the brain as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Brain (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100097"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the brainstem as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"BrainStem (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100098"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the breast as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Breast (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100099"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the bronchial tree as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"BronchialTree (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100100"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the posterior part of tongue as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"BaseOfTongue (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100101"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the carina of trachea as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Carina (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100102"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the cauda equina as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"CaudaEquina (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100103"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the cerebellum as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Cerebellum (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100104"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the cerebral hemisphere as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Cerebrum (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100105"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the optic chiasm as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Chiasm (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100106"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the facial nerve as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"CN_VII (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100107"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the vestibulocochlear nerve as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"CN_VIII (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100108"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the cervix of uterus as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Cervix (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100109"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the cochlea as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Cochlea (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100110"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the colon as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Colon (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100111"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the constrictor muscle of pharynx as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"ConstrMuscle (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100112"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the cornea as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Cornea (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100113"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the duodenum as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Duodenum (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100114"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the middle ear as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Ear_Middle (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100115"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the external ear as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Ear_External (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100116"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the esophagus as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Esophagus (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100117"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the upper third of the esophagus as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Esophagus_Upper (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100118"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the lower third of the esophagus as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Esophagus_Lower (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100119"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the middle third of the esophagus as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Esophagus_Middle (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100120"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the skin as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"External (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100121"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the eye as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Eye (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100122"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the femur as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Femur (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100123"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the hip joint as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"FemoralJoint (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100124"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the frontal lobe as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"FrontalLobe (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100125"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the glenohumeral joint as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"GHJoint (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100126"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the eyeball as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Globe (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100127"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the glottis as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Glottis (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100128"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the great blood vessel as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"GreatVessel (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100129"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the heart as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Heart (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100130"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the hippocampus as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Hippocampus (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100131"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the hypothalamus as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Hypothalamus (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100132"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the kidney as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Kidney (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100133"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the large intestine as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"LargeBowel (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100134"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the larynx as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Larynx (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100135"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the lacrimal gland as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"LacrimalGland (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100136"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the lens as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Lens (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100137"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the lip as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Lips (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100138"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the liver as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Liver (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100139"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the lung as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Lung (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100140"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the mandible as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Mandible (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100141"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the masseter as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"MassMuscle (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100142"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the mediastinum as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Mediastinum (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100143"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the main bronchus as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"MainBronchus (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100144"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the occipital lobe as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"OccipitalLobe (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100145"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the optic nerve as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"OpticNerve (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100146"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the oral cavity proper as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"OralCavity (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100147"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the ovary as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Ovary (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100148"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the parametrium of body of uterus as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Parametrium (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100149"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the parietal lobe as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"ParietalLobe (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100150"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the pancreas as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Pancreas (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100151"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the parotid gland as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Parotid (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100152"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the bony pelvis as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"PelvicBones (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100153"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the bulb of penis as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"PenileBulb (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100154"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the penis as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Penis (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100155"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the perineum as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Perineum (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100156"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the pericardium as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Pericardium (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100157"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the pharynx as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Pharynx (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100158"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the constrictor muscle of pharynx as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"PharynxConst (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100159"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the pituitary gland as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Pituitary (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100160"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the prostate as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Prostate (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100161"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the pubic symphysis as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"PubicSymphysis (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100162"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the rectum as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Rectum (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100163"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the wall of rectum as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"RectalWall (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100164"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the retina as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Retina (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100165"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the rib as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Rib (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100166"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the sacrum as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Sacrum (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100167"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the salivary gland as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"SalivaryGland (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100168"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the seminal vesicle as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"SeminalVesicle (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100169"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the small intestine as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"SmallBowel (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100170"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the spinal cord as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"SpinalCord (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100171"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the spleen as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Spleen (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100172"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the stomach as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Stomach (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100173"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the submandibular gland as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Submandibular (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100174"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the supratentorial brain as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Supertentorial (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100175"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the temporal lobe as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"TemporalLobe (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100176"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the testis as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Testis (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100177"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the thyroid gland as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Thyroid (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100178"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the temporomandibular joint as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"TMjoint (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100179"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the trachea as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Trachea (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100180"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the tongue as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Tongue (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100181"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the urethra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Urethra (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100182"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the uterus as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Uterus (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100183"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the azygos vein as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"V_Azygos (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100184"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the inferior vena cava as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"V_CavaInferior (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100185"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the superior vena cava as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"V_CavaSuperior (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100186"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the pulmonary vein as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"V_Pulmonary (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100187"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the subclavian vein as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"V_SubClav (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100188"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the vagina as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Vagina (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100189"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the cervical vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_Cervical (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100190"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the thoracic vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_Thoracic (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100191"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the lumbar vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_Lumbar (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100192"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the sacral vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_Sacrum (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100193"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the cardiac ventricle as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Ventricle (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100194"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the blood vessel as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Vessels (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100195"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the vulva as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Vulva (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100237"},"def":{"xml:lang":"en","type":"literal","value":"The social circumstance where a persons lives with one of more of their children."},"label":{"xml:lang":"en","type":"literal","value":"Living with children"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100240"},"def":{"xml:lang":"en","type":"literal","value":"The social circumstance where a persons lives with one of more of their children and a partner."},"label":{"xml:lang":"en","type":"literal","value":"Living with partner and children"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100245"},"def":{"xml:lang":"en","type":"literal","value":"Number of positive lymph node stations (PLNS), assessed by FDG-PET scan, using the Naruke map using only mediastinal stations (excluding stations 10-14)."},"label":{"xml:lang":"en","type":"literal","value":"Positive Mediastinal Lymph Node Stations"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100266"},"def":{"xml:lang":"en","type":"literal","value":"Lymph nodes classified in zones and stations according to lymph node map of the AJCC 7th edition of the TNM classification for lung cancer. \nFor prognostic purposes, thoracic lymph nodes can be divided into prognostic zones which is easier to remember than individual thoracic lymph node stations/levels.\nFor more information see http://dx.doi.org/10.1097/JTO.0b013e3181a0d82e"},"label":{"xml:lang":"en","type":"literal","value":"Lymph Node by Zone and Station"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100270"},"def":{"xml:lang":"en","type":"literal","value":"Version of the Common Terminology Criteria for Adverse Events (CTCAE) system published by the US National Cancer Institute (NCI)."},"label":{"xml:lang":"en","type":"literal","value":"CTCAE version"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100289"},"def":{"xml:lang":"en","type":"literal","value":"Second version (published 1998-1999) of the Common Terminology Criteria for Adverse Events (CTCAE) system published by the US National Cancer Institute (NCI)."},"label":{"xml:lang":"en","type":"literal","value":"CTCAE v2.0"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100294"},"def":{"xml:lang":"en","type":"literal","value":"Artic nodes are lymph nodes in the subaortic or para-aortic zones (nodal stations 5-6)."},"label":{"xml:lang":"en","type":"literal","value":"Aortic Nodes"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100320"},"def":{"xml:lang":"en","type":"literal","value":"Supoerior mediastinal nodes are lymph nodes in the upper zone (nodal stations 2-4)."},"label":{"xml:lang":"en","type":"literal","value":"Superior Mediastinal Nodes"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100323"},"def":{"xml:lang":"en","type":"literal","value":"Minimum dose to at least 95% of the volume of a target volume or organ at risk. D95 is often reported for target volumes."},"label":{"xml:lang":"en","type":"literal","value":"D95"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100357"},"def":{"xml:lang":"en","type":"literal","value":"Minimum radiation dose to at least x% of the  volume."},"label":{"xml:lang":"en","type":"literal","value":"Dose Volume Histogram - Dx"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100324"},"def":{"xml:lang":"en","type":"literal","value":"Minimum dose to at least 98% of the volume of a target volume or organ at risk. D98 is often called the near minimum dose."},"label":{"xml:lang":"en","type":"literal","value":"D98"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100325"},"def":{"xml:lang":"en","type":"literal","value":"Minimum dose to at least 50% of the volume of a target volume or organ at risk. Equivalent to the median dose."},"label":{"xml:lang":"en","type":"literal","value":"D50"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100326"},"def":{"xml:lang":"en","type":"literal","value":"Minimum dose to at least 2% of the volume of a target volume or organ at risk. D98 is often called the near maximum dose."},"label":{"xml:lang":"en","type":"literal","value":"D2"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100328"},"def":{"type":"literal","value":"Elapsed time that a person has been living with/without a related observation/procedure/event/finding of local control/recurrence."},"label":{"xml:lang":"en","type":"literal","value":"Local control time"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100329"},"def":{"xml:lang":"en","type":"literal","value":"Inferior mediastinal nodes are lymph nodes in the subcarinal or lower zones (nodal stations 7-9)."},"label":{"xml:lang":"en","type":"literal","value":"Inferior Mediastinal Nodes"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100330"},"def":{"type":"literal","value":"Elapsed time that a person has been living with/without a related observation/procedure/event/finding of distant control/recurrence."},"label":{"xml:lang":"en","type":"literal","value":"Distant control time"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100335"},"def":{"xml:lang":"en","type":"literal","value":"N1 nodes are lymph nodes in the hilar/interlobar or peripheral zones (nodal stations 10-14)."},"label":{"xml:lang":"en","type":"literal","value":"N1 nodes"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100344"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left lung as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Lung_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100345"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right lung as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Lung_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100346"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the Gross Tumor Volume of a primary tumor. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"GTVp (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100606"},"def":{"xml:lang":"en","type":"literal","value":"The gross tumor volume of a primary tumor."},"label":{"xml:lang":"en","type":"literal","value":"Gross Tumor Volume - Primary Tumor"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100347"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the Gross Tumor Volume of a metastatic regional node. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"GTVn (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100605"},"def":{"xml:lang":"en","type":"literal","value":"The gross tumor volume of a metastatic regional node of a tumor."},"label":{"xml:lang":"en","type":"literal","value":"Gross Tumor Volume - Node"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100348"},"def":{"xml:lang":"en","type":"literal","value":"Overall treatment time calculated from first until the last day of radiotherapy"},"label":{"xml:lang":"en","type":"literal","value":"Overall Treatment Time - Radiotherapy"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100349"},"def":{"xml:lang":"en","type":"literal","value":"A treatment where only radiation is given. This is in contract to e.g. chemoradiotherapy or a combination of surgery and radiation. Can refer to use of two or more radiotherapy modalities (e.g. a combination of brachytherapy and teletherapy)."},"label":{"xml:lang":"en","type":"literal","value":"Radiation Therapy Alone"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100350"},"def":{"xml:lang":"en","type":"literal","value":"Parallel opposed fields radiotherapy is a simple form of radiotherapy when using multiple fields. By aiming the two beams along the same axis, the dose fall off in one will be compensated for by the increased dose in the other."},"label":{"xml:lang":"en","type":"literal","value":"Parallel-Opposed Fields Radiation Therapy"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100351"},"def":{"xml:lang":"en","type":"literal","value":"Two-dimensional (2-D) radiotherapy is a simple form of radiotherapy where treatment planning is based on standardized treatment techniques applied to classes of patients thought to be similar. The process makes use of an X-ray simulator and a 2-D computer treatment planning system used for calculation of dose distributions."},"label":{"xml:lang":"en","type":"literal","value":"2-Dimensional Radiation Therapy"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100353"},"def":{"xml:lang":"en","type":"literal","value":"Radiation dose delivered per fraction"},"label":{"xml:lang":"en","type":"literal","value":"Radiotherapy Fraction Dose"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100354"},"def":{"xml:lang":"en","type":"literal","value":"The count of radiotherapy fractions given in a certain time interval (e.g. per day) or in a certain coherent context (e.g. per treatment)."},"label":{"xml:lang":"en","type":"literal","value":"Number of Radiotherapy Fractions"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100355"},"def":{"xml:lang":"en","type":"literal","value":"The count of radiotherapy fractions given per day."},"label":{"xml:lang":"en","type":"literal","value":"Number of Radiotherapy Fractions Per Day"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100356"},"def":{"xml:lang":"en","type":"literal","value":"The count of radiotherapy fractions given in a radiotherapy treatment as a whole."},"label":{"xml:lang":"en","type":"literal","value":"Number of Radiotherapy Fractions Per Treatment"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100360"},"def":{"xml:lang":"en","type":"literal","value":"A radiation dose quantity derived from a Dose Volume Histogram."},"label":{"xml:lang":"en","type":"literal","value":"Radiation Dose From Dose Volume Histogram"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100358"},"def":{"xml:lang":"en","type":"literal","value":"The percentage volume receiving at least x Gy"},"label":{"xml:lang":"en","type":"literal","value":"Dose Volume Histogram - Vx"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100359"},"def":{"xml:lang":"en","type":"literal","value":"The percentage of the lung volume (with subtraction of the volume involved by lung cancer) which receives radiation doses of 20 Gy or more."},"label":{"xml:lang":"en","type":"literal","value":"V20 of Lung"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100361"},"def":{"xml:lang":"en","type":"literal","value":"The mean radiation dose in a given region of interest."},"label":{"xml:lang":"en","type":"literal","value":"Dmean"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100362"},"def":{"xml:lang":"en","type":"literal","value":"The mean radiation dose to the lung as an organ at risk (with subtraction of the volume involved by lung cancer)."},"label":{"xml:lang":"en","type":"literal","value":"Mean Lung Dose"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100363"},"def":{"xml:lang":"en","type":"literal","value":"The mean radiation dose to the esophagus as an organ at risk."},"label":{"xml:lang":"en","type":"literal","value":"Mean Esophagus Dose"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100365"},"def":{"xml:lang":"en","type":"literal","value":"The maximum radiation dose to the esophagus as an organ at risk."},"label":{"xml:lang":"en","type":"literal","value":"Maximum Esophagus Dose"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100366"},"def":{"xml:lang":"en","type":"literal","value":"The mininum radiation dose given to at least 0% of the volume (i.e. to a single point ) of the target volume or organ at risk. Equivalent to the maximum radiation dose."},"label":{"xml:lang":"en","type":"literal","value":"D0"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100367"},"def":{"xml:lang":"en","type":"literal","value":"The FEV1 measured during bronchodilation and/or steroid use."},"label":{"xml:lang":"en","type":"literal","value":"FEV1 with Medication"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100368"},"def":{"xml:lang":"en","type":"literal","value":"The degree to which inhaled carbon monoxide diffuses from the alveoli into the blood, expressed as a proportion of the predicted normal value."},"label":{"xml:lang":"en","type":"literal","value":"Percent Predicted Diffusion Capacity of the Lung for Carbon Monoxide"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100369"},"def":{"xml:lang":"en","type":"literal","value":"Toxicity from radiation therapy. The critera are relevant from day 1, the commencement of therapy, through day 90. (RTOG definition)"},"label":{"xml:lang":"en","type":"literal","value":"Acute Radiation Therapy Adverse Event"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100370"},"def":{"xml:lang":"en","type":"literal","value":"Adverse event categorized by the time of onset. Typically adverse events are considered either acute/early or late relative to an intervention."},"label":{"xml:lang":"en","type":"literal","value":"Adverse Event by Time of Onset"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100371"},"def":{"xml:lang":"en","type":"literal","value":"All effects seen after 90 days from the beginning of radiation therapy."},"label":{"xml:lang":"en","type":"literal","value":"Late Radiation Therapy Adverse Event"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100372"},"def":{"xml:lang":"en","type":"literal","value":"A characteristic used to qualify the adverse event as certainly related to cancer."},"label":{"xml:lang":"en","type":"literal","value":"Definitely Related to Cancer"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100373"},"def":{"xml:lang":"en","type":"literal","value":"A characteristic used to qualify the adverse event as clearly not related to cancer."},"label":{"xml:lang":"en","type":"literal","value":"Unrelated to Cancer"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100374"},"def":{"xml:lang":"en","type":"literal","value":"A characteristic used to qualify the adverse event as unlikely related to cancer."},"label":{"xml:lang":"en","type":"literal","value":"Unlikely Related to Cancer"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100375"},"def":{"xml:lang":"en","type":"literal","value":"A characteristic indicating that an adverse event may be related to cancer."},"label":{"xml:lang":"en","type":"literal","value":"Possibly Related to Cancer"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100376"},"def":{"xml:lang":"en","type":"literal","value":"A characteristic used to qualify the adverse event as likely related to cancer."},"label":{"xml:lang":"en","type":"literal","value":"Probably Related to Cancer"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100377"},"def":{"xml:lang":"en","type":"literal","value":"A characteristic used to qualify the adverse event as likely related to pre-existing comorbidity."},"label":{"xml:lang":"en","type":"literal","value":"Probably Related to Pre-existing Comorbidity"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100378"},"def":{"xml:lang":"en","type":"literal","value":"A characteristic indicating that an adverse event may be related to pre-existing comorbidity."},"label":{"xml:lang":"en","type":"literal","value":"Possibly Related to Pre-existing Comorbidity"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100379"},"def":{"xml:lang":"en","type":"literal","value":"A characteristic used to qualify the adverse event as certainly related to pre-existing comorbidity."},"label":{"xml:lang":"en","type":"literal","value":"Definitely Related to Pre-existing Comorbidity"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100380"},"def":{"xml:lang":"en","type":"literal","value":"A characteristic used to qualify the adverse event as unclassified in term of its relation to pre-existing comorbidity."},"label":{"xml:lang":"en","type":"literal","value":"Conditionally Related to Pre-existing Comorbidity"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100381"},"def":{"xml:lang":"en","type":"literal","value":"A characteristic used to qualify the adverse event as unclassified in term of its relation to cancer."},"label":{"xml:lang":"en","type":"literal","value":"Conditionally Related to Cancer"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100382"},"def":{"xml:lang":"en","type":"literal","value":"A characteristic used to qualify the adverse event as clearly not related to pre-existing comorbidity."},"label":{"xml:lang":"en","type":"literal","value":"Unrelated to Pre-existing Comorbidity"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100383"},"def":{"xml:lang":"en","type":"literal","value":"A characteristic used to qualify the adverse event as unlikely related to pre-existing comorbidity."},"label":{"xml:lang":"en","type":"literal","value":"Unlikely Related to Pre-existing Comorbidity"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100384"},"def":{"xml:lang":"en","type":"literal","value":"A characteristic used to qualify the adverse event as unclassifiable in term of its relation to cancer."},"label":{"xml:lang":"en","type":"literal","value":"Relation to Cancer Unclassifiable"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100385"},"def":{"xml:lang":"en","type":"literal","value":"A characteristic used to qualify the adverse event as unclassifiable in term of its relation to pre-existing comorbidity."},"label":{"xml:lang":"en","type":"literal","value":"Relation to Pre-existing Comorbidity Unclassifiable"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100386"},"def":{"xml:lang":"en","type":"literal","value":"A performance status which is ECOG 2 or worse."},"label":{"xml:lang":"en","type":"literal","value":"ECOG Performance Status2"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100387"},"def":{"xml:lang":"en","type":"literal","value":"A person who was not smoking at the time of consideration and may or may not have smoked in the past."},"label":{"xml:lang":"en","type":"literal","value":"Never or Former Smoker"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100390"},"def":{"xml:lang":"en","type":"literal","value":"A count of at least 5 positive lymph node stations assessed by FDG-PET scan."},"label":{"xml:lang":"en","type":"literal","value":"Minimum of 5 Positive Lymph Node Stations"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100393"},"def":{"xml:lang":"en","type":"literal","value":"A primary tumor TNM finding indicating that there is either no evidence of primary tumor (T0) or that the cancer is limited to the site of growth (T1)."},"label":{"xml:lang":"en","type":"literal","value":"T0 or T1 Stage Finding"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100453"},"def":{"xml:lang":"en","type":"literal","value":"A symptom or medical condition that makes a concurrent chemoradiotherapy inadvisable because a person is likely to have a bad reaction."},"label":{"xml:lang":"en","type":"literal","value":"Medical Contraindication to Concurrent Chemoradiotherapy"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100454"},"def":{"xml:lang":"en","type":"literal","value":"Equivalent 2Gy dose: EQD2 = n * d * (d + /) / (2 + /)"},"label":{"xml:lang":"en","type":"literal","value":"Equivalent 2Gy Dose"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100455"},"def":{"xml:lang":"en","type":"literal","value":"A count of at least 5 positive lymph node stations assessed by FDG-PET scan using only mediastinal stations (excluding stations 10-14)."},"label":{"xml:lang":"en","type":"literal","value":"Minimum of 5 Positive Mediastinal Lymph Node Stations"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100456"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right main bronchus as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"MainBronchus_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100457"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left pulmonary artery as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"A_Pulmonary_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100458"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right pulmonary artery as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"A_Pulmonary_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100459"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right common carotid artery as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"A_Carotid_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100460"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left common carotid artery as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"A_Carotid_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100461"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left coronary artery as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"A_Coronary_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100462"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right coronary artery as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"A_Coronary_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100463"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the inferior hypophysial artery as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"A_HypophysealInferior (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100464"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left subclavian artery as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"A_Subclavicular_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100465"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right subclavian artery as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"A_Subclavicular_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100466"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left inferior hypophyseal artery as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"A_HypophysealInferior_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100467"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right inferior hypophyseal artery as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"A_HypophysealInferior_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100468"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left superior hypophyseal artery as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"A_HypophysealSuperior_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100469"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right superior hypophyseal artery as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"A_HypophysealSuperior_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100470"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left atrium as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Atrium_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100471"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right atrium as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Atrium_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100472"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left brachial nerve plexus as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"BrachialPlexus_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100473"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right brachial nerve plexus as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"BrachialPlexus_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100474"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left breast as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Breast_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100475"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right breast as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Breast_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100476"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left bronchial tree as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"BronchialTree_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100477"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right bronchial tree as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"BronchialTree_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100478"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left cerebral hemisphere as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Cerebrum_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100479"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right cerebral hemisphere as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Cerebrum_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100480"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left facial nerve as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"CN_VII_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100481"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right facial nerve as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"CN_VII_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100482"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left vestibulocochlear nerve as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"CN_VIII_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100483"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right vestibulocochlear nerve as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"CN_VIII_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100484"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left cochlea as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Cochlea_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100485"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right cochlea as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Cochlea_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100486"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left cornea as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Cornea_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100487"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right cornea as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Cornea_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100488"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left external ear as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Ear_External_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100489"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right external ear as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Ear_External_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100490"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left middle ear as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Ear_Middle_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100491"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right middle ear as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Ear_Middle_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100492"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left eye as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Eye_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100493"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right eye as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Eye_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100494"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left hip joint as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"FemoralJoint_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100495"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right hip joint as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"FemoralJoint_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100496"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left femur as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Femur_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100497"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right femur as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Femur_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100498"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left frontal lobe as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"FrontalLobe_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100499"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right frontal lobe as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"FrontalLobe_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100500"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left glenohumeral joint as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"GHJoint_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100501"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right glenohumeral joint as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"GHJoint_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100502"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left eyeball as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Globe_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100503"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right eyeball as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Globe_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100504"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left hippocampus as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Hippocampus_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100505"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right hippocampus as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Hippocampus_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100506"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left masseter as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"MassMuscle_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100507"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right masseter as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"MassMuscle_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100508"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left occipital lobe as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"OccipitalLobe_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100509"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right occipital lobe as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"OccipitalLobe_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100510"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left optic nerve as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"OpticNerve_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100511"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right optic nerve as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"OpticNerve_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100512"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left ovary as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Ovary_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100513"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right ovary as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Ovary_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100514"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left parietal lobe as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"ParietalLobe_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100515"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right parietal lobe as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"ParietalLobe_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100516"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left parotid gland as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Parotid_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100517"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right parotid gland as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Parotid_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100519"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left retina as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Retina_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100520"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left retina as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Retina_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100521"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left first rib as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Rib1_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100522"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left second rib as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Rib2_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100523"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left third rib as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Rib3_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100524"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left fourth rib as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Rib4_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100525"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left fifth rib as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Rib5_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100526"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left sixth rib as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Rib6_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100527"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left seventh rib as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Rib7_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100528"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left eighth rib as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Rib8_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100529"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left ninth rib as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Rib9_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100530"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left tenth rib as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Rib10_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100531"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left eleventh rib as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Rib11_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100532"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left twelfth rib as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Rib12_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100533"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right twelfth rib as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Rib12_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100534"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right eleventh rib as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Rib11_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100535"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right tenth rib as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Rib10_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100536"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right ninth rib as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Rib9_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100537"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right eighth rib as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Rib8_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100538"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right seventh rib as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Rib7_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100539"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right sixth rib as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Rib6_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100540"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right fifth rib as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Rib5_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100541"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right fourth rib as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Rib4_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100542"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right third rib as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Rib3_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100543"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right second rib as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Rib2_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100544"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right first rib as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Rib1_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100545"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left seminal vesicle as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"SeminalVesicle_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100546"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right seminal vesicle as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"SeminalVesicle_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100547"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left submandibular gland as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Submandibular_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100548"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right submandibular gland as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Submandibular_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100549"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left temporal lobe as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"TemporalLobe_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100550"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right temporal lobe as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"TemporalLobe_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100551"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left testis as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Testis_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100552"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right testis as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Testis_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100553"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left temporomandibular joint as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"TMjoint_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100554"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right temporomandibular joint as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"TMjoint_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100555"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left subclavian vein as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"V_SubClav_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100556"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right subclavian vein as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"V_SubClav_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100558"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the atlas as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_C1 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100559"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the axis as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_C2 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100560"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the third cervical vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_C3 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100561"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the fourth cervical vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_C4 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100562"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the fifth cervical vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_C5 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100563"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the sixth cervical vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_C6 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100564"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the seventh cervical vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_C7 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100565"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the first lumbar vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_L1 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100566"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the second lumbar vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_L2 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100567"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the third lumbar vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_L3 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100568"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the fourth lumbar vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_L4 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100569"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the fifth lumbar vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_L5 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100570"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the first sacral vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_S1 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100571"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the second sacral vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_S2 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100572"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the third sacral vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_S3 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100573"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the fourth sacral vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_S4 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100574"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the fifth sacral vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_S5 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100575"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the first thoracic vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_T1 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100576"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the second thoracic vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_T2 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100577"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the third thoracic vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_T3 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100578"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the fourth thoracic vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_T4 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100579"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the fifth thoracic vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_T5 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100580"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the sixth thoracic vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_T6 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100581"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the seventh thoracic vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_T7 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100582"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the eighth thoracic vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_T8 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100583"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the ninth thoracic vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_T9 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100584"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the tenth thoracic vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_T10 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100585"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the eleventh thoracic vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_T11 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100586"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the twelfth thoracic vertebra as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"VB_T12 (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100587"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the left ventricle as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Ventricle_L (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100588"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the right ventricle as an organ at risk in radiation oncology. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"Ventricle_R (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100589"},"def":{"xml:lang":"en","type":"literal","value":"The gross tumor volume of a distant metastasis of a tumor."},"label":{"xml:lang":"en","type":"literal","value":"Gross Tumor Volume - Metastasis"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100590"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the Clinical Target Volume. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"CTV (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100601"},"def":{"xml:lang":"en","type":"literal","value":"The Clinical Target Volume (CTV) is a volume of tissue that contains a demonstrable GTV and/or subclinical malignant disease with a certain probability of occurrence considered relevant for therapy. There is no general consensus on what probability is considered relevant for therapy, but typically a probability of occult disease higher than from 5 % to 10 % is assumed to require treatment. This remains a clinical judgment in which the type of malignancy, the consequence of failure, and the expected feasibility of salvage treatment need to be considered. (ICRU 83)\nFor more information: http://dx.doi.org/10.1093/jicru/ndq001"},"label":{"xml:lang":"en","type":"literal","value":"Clinical Target Volume"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100591"},"def":{"xml:lang":"en","type":"literal","value":"The clinical target volume of a metastatic regional node of a tumor."},"label":{"xml:lang":"en","type":"literal","value":"Clinical Target Volume - Node"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100594"},"def":{"xml:lang":"en","type":"literal","value":"The clinical target volume of a primary tumor."},"label":{"xml:lang":"en","type":"literal","value":"Clinical Target Volume - Primary Tumor"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100595"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the Internal Target Volume."},"label":{"xml:lang":"en","type":"literal","value":"ITV (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100599"},"def":{"xml:lang":"en","type":"literal","value":"In ICRU Report 62 (ICRU, 1999), the Internal Target Volume (ITV) was defined as the CTV plus a margin taking into account uncertainties in size, shape, and position of the CTV within the patient. Such a margin was called the internal margin as opposed to the set-up margin. In ICRU Report 62, it was recommended that internal and external margins be added quadratically, but often in practice they are instead added linearly, which can lead to an unacceptably large margin. The ITV might be useful only in clinical situations in which uncertainty concerning the CTV location dominates setup uncertainties and/or when they are independent. The ITV is considered an optional tool in helping to delineate the PTV. (ICRU 83)\nFor more information: http://dx.doi.org/10.1093/jicru/ndq001"},"label":{"xml:lang":"en","type":"literal","value":"Internal Target Volume"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100596"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of a Planning Organ at Risk Volume (PRV). The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"PRV (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100597"},"def":{"xml:lang":"en","type":"literal","value":"A concept which is of interest because it pertains to the carrying out of radiation oncology.\nExamples are target and other irradiated volumes, margins etc."},"label":{"xml:lang":"en","type":"literal","value":"Radiation Oncology Functional Concept"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100600"},"def":{"xml:lang":"en","type":"literal","value":"The Planning Target Volume (PTV) is a geometrical concept introduced for treatment planning and evaluation. It is the recommended  tool  to  shape  absorbed-dose  distributions to ensure that the prescribed absorbed dose will actually be delivered to all parts of the CTV with a clinically acceptable probability, despite geometrical uncertainties such as organ motion and setup variations. It is also used for absorbed-dose prescription and reporting. It surrounds the representation of the CTV with a margin such that the planned absorbed dose is delivered to the CTV. This margin takes into account both the internal and the setup uncertainties. The setup margin accounts specifically for uncertainties in patient positioning  and  alignment  of  the  therapeutic beams during the treatment planning, and through all treatment sessions. (ICRU 83)\nFor more information: http://dx.doi.org/10.1093/jicru/ndq001"},"label":{"xml:lang":"en","type":"literal","value":"Planning Target Volume"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100602"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the Clinical Target Volume of a metastatic regional node. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"CTVn (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100603"},"def":{"xml:lang":"en","type":"literal","value":"The clinical target volume of a distant metasasis of a tumor."},"label":{"xml:lang":"en","type":"literal","value":"Clinical Target Volume - Metastasis"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100604"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the Clinical Target Volume of a primary tumor. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"CTVp (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100608"},"def":{"xml:lang":"en","type":"literal","value":"The Planning Organ at Risk Volume (PRV) is a geometrical concept introduced for treatment planning and evaluation. It surrounds the representation of the Organ at Risk (OAR) with a margin. This margin takes into account both the internal and the setup uncertainties. The setup margin accounts specifically for uncertainties in patient positioning  and  alignment  of  the  therapeutic beams during the treatment planning, and through all treatment sessions. (ICRU 83)\nFor more information: http://dx.doi.org/10.1093/jicru/ndq001"},"label":{"xml:lang":"en","type":"literal","value":"Planning Organ at Risk Volume"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100610"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the Planning Target Volume of a metastatic regional node. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"PTVn (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100611"},"def":{"xml:lang":"en","type":"literal","value":"A region of interest based on a delineation of the Planning Target Volume of a primary tumor. The label adheres to the standardized naming convention proposed by Santanam et al (http://dx.doi.org/10.1016/j.ijrobp.2011.09.054)."},"label":{"xml:lang":"en","type":"literal","value":"PTVp (ROI)"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100612"},"def":{"xml:lang":"en","type":"literal","value":"The Planning Target Volume of a distant metasasis of a tumor."},"label":{"xml:lang":"en","type":"literal","value":"Planning Target Volume - Metastasis"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100613"},"def":{"xml:lang":"en","type":"literal","value":"The Planning Target Volume of a metastatic regional node of a tumor."},"label":{"xml:lang":"en","type":"literal","value":"Planning Target Volume - Node"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100615"},"def":{"xml:lang":"en","type":"literal","value":"The TV is the volume of tissue enclosed within a specific isodose envelope, with the absorbed dose specified by the radiation oncology team as appropriate to achieve tumor eradication or palliation, within the bounds of acceptable complications. As proposed in proton therapy (ICRU, 2007), D98% could be selected to determine  the  TV  in  photon  therapy.  When reported, the value of the isodose selected to define the TV should be quoted either relative to the prescribed absorbed dose or in absolute terms. It is important to identify the shape, size, and position of the TV in relation to the PTV for several reasons. One reason is to provide information to evaluate causes for local recurrences (inside or outside the TV).(ICRU 83)\nFor more information: http://dx.doi.org/10.1093/jicru/ndq001"},"label":{"xml:lang":"en","type":"literal","value":"Treated Volume"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100616"},"def":{"xml:lang":"en","type":"literal","value":"Metabolic tumor volume (MTV) is the volume of tumor tissues with increased FDG uptake measured by an 18F-FDG PET scan."},"label":{"xml:lang":"en","type":"literal","value":"Metabolic Tumor Volume"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100620"},"def":{"xml:lang":"en","type":"literal","value":"Regimen combining Mitomycin and Fluorouracil (with concurrent radiation)"},"label":{"xml:lang":"en","type":"literal","value":"FUMIR Regimen"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100622"},"def":{"xml:lang":"en","type":"literal","value":"Tumor regression grade according to the Dworak system."},"label":{"xml:lang":"en","type":"literal","value":"Tumor Regression Grade - Dworak"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100623"},"def":{"xml:lang":"en","type":"literal","value":"Tumor regression grade according to the Mandard system."},"label":{"xml:lang":"en","type":"literal","value":"Tumor Regression Grade - Mandard"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100624"},"label":{"xml:lang":"en","type":"literal","value":"TRG1 - Mandard"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100625"},"label":{"xml:lang":"en","type":"literal","value":"Complete Regression"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100626"},"label":{"xml:lang":"en","type":"literal","value":"Near Complete Regression"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100627"},"label":{"xml:lang":"en","type":"literal","value":"Moderate Regression"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100628"},"label":{"xml:lang":"en","type":"literal","value":"Minimal Regression"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100629"},"label":{"xml:lang":"en","type":"literal","value":"No Regression"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100630"},"label":{"xml:lang":"en","type":"literal","value":"TRG2 - Mandard"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100631"},"label":{"xml:lang":"en","type":"literal","value":"TRG3 - Mandard"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100632"},"label":{"xml:lang":"en","type":"literal","value":"TRG4 - Mandard"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100633"},"label":{"xml:lang":"en","type":"literal","value":"TRG5 - Mandard"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100634"},"label":{"xml:lang":"en","type":"literal","value":"TRG0 - Dworak"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100635"},"label":{"xml:lang":"en","type":"literal","value":"TRG1 - Dworak"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100636"},"label":{"xml:lang":"en","type":"literal","value":"TRG2 - Dworak"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100637"},"label":{"xml:lang":"en","type":"literal","value":"TRG3 - Dworak"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100638"},"label":{"xml:lang":"en","type":"literal","value":"TRG4 - Dworak"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100644"},"def":{"xml:lang":"en","type":"literal","value":"Deep Inspiration Breath-Hold is mostly used in radiotherapy and involves the patient inspiring to a specified threshold and then holding that level of inspiration during the delivery of radiation."},"label":{"xml:lang":"en","type":"literal","value":"Deep Inspiration Breath-Hold"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100645"},"def":{"xml:lang":"en","type":"literal","value":"A class of procedures where respiratory motion is managed by patients temporarily changing the way they breath, either forced or voluntary and for either therapeutic or diagnostic procedures."},"label":{"xml:lang":"en","type":"literal","value":"Breathing Modification Procedure"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100646"},"def":{"xml:lang":"en","type":"literal","value":"A procedure which compresses the abdomen and thereby forcing the patient to use shallow breathing. This in turn reduces the motion associated with respiration."},"label":{"xml:lang":"en","type":"literal","value":"Abdominal Compression"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100647"},"def":{"xml:lang":"en","type":"literal","value":"In respiratory gated radiation therapy the beam is switched on when the tumor is in the right phase of the respiration."},"label":{"xml:lang":"en","type":"literal","value":"Respiratory Gated Radiation Therapy"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100648"},"def":{"xml:lang":"en","type":"literal","value":"In tumor tracking radiation therapy the beam is always on and follows the tumor during respiration. It often involves implanting fiducial markers into the tumor."},"label":{"xml:lang":"en","type":"literal","value":"Tumor Tracking Radiation Therapy"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100660"},"def":{"xml:lang":"en","type":"literal","value":"Surgical procedure for rectosigmoid and upper rectal cancers where the rectum is transected 5 cm below the tumor."},"label":{"xml:lang":"en","type":"literal","value":"Partial Mesorectal Excision"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100684"},"def":{"xml:lang":"en","type":"literal","value":"Lymph node dissection on only one side of regional lymph nodes. This is usually done when the tumor is located on that side of the body."},"label":{"xml:lang":"en","type":"literal","value":"Unilateral Lymph Node Dissection"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100685"},"def":{"xml:lang":"en","type":"literal","value":"Lymph node dissection on both sides of regional lymph nodes. This is usually done when the tumor is centrally located ."},"label":{"xml:lang":"en","type":"literal","value":"Bilateral Lymph Node Dissection"}},{"iri":{"type":"uri","value":"http://www.cancerdata.org/roo/C100701"},"def":{"type":"literal","value":"Lymph nodes outside the mesorectum."},"label":{"xml:lang":"en","type":"literal","value":"Extra mesorectal lymph node group"}}]}}